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/ Arteriosus in the Adult 
1035 160 Transcatheter Therapy for Patent Ductus 
Grant H. Burch, Carl Y. Gwada, David Teitel, Phillip Moore. Oregon HealN, 
Sciences Universifi: Portland, Oregon: Universiiy of California, San 
Francisco, San Francisco, California, USA 
Background: Transcatheter coil closure has become the treatment of choice 
for patent ductus arteriosus (PDA) in children. Little is known about the 
efficacy and morbidity of this procedure in adults. This study evaluates the 
immediate and short-term efficacy, and the morbidity of transcatheter closure 
of PDA in adults. 
Methods: Retrospective review of all records, hemodynamic data, an- 
giograms, and echocardiograms for 31 patients (pts) 216 years old who 
underwent attempted transcatheter closure of PDA at OHSU or UCSF. 
Results: 27 females and 4 males: aged 16-67 yeai-s old (median 27 
y), have undergone attempted transcatheter occlusion at OHSU or UCSF 
between 7/94 and 6/99. A left-to-right shunt was detectable by hemoximetry 
in 28 pts (Qp:Qs 1.4 * 0.6). Angiographic shunts were graded as moderate 
in 21 pts (68%) and small in 10 (32%). Type A PDA was the most common 
(13131, 42%) and the minimum ductal diameter ranged from 1.5-7.2 mm 
(median 2.9 mm). Gianturco coils were successfully used in 29 of 30 attempts 
(97%). Of these 29, 5 required 2 or 3 coils for closure. Two pts, one a failed coil 
closure, had successful closure with a28 mm CardioSEAL device, making the 
overall technical success rate 100%. Post-procedural angiograms showed 
a decrease in the angiographic shunt in all cases, with 90% of pts having 
complete occlusion (n = 22) or a trivial residual angiographic leak (n = 6). Both 
pts closed with CardioSEAL devices had persistent moderate, but decreased, 
angiographic shunts. Minor complications without sequela occurred in 4 pts 
(12.9%) including coil embolization, pulmonary contusion, and transient atrial 
fibrillation. All patients with residual post procedure shunts who have had 
transthoracic echocardiography 6 months after their procedure, including 
one patient that received a CardioSEAL device, have no residual shunt. 
Conclusion: A strategy of transcatheter closure of PDA using Gianturco 
coils, and CardioSEAL occlusion devices for coil failures, is highly effective 
for adult patients and can be performed with minimal morbidity. Residual 
leaks resolve spontaneously within 6 months of the procedure. 
m 1035161 Angiographic Profile of Adult Tetralogy of Fallot 
Dhiraj Gupta, K.N. Raju, Anita Saxena, Shyam S. Kothari, Rajnish Juneja, 
Subhash C.B. Reddy, P. Venugopal. Cardiothoracic Cenfre, All India 
lnsfitufe of Medical Sciences, New De/hi, lndia 
Background: Adult tetralogy of Fallot (TGF) is a syndrome characterised 
by unique problems and management issues. No large study has specifi- 
cally compared the angiographic profile of adult TGF with that of the TOF 
presenting in infancy and childhood. 
Material and Methods: From 1990 to 1998, 1486 consecutive patients 
of TGF were catheterised at our institution as a part of their preoperative 
workup. Of these, 132 patients (9.2%) were adults (~18 years) and form the 
subjects of this study. Cardiac catheterisation and cineangiographic data was 
analysed for these patients and compared with the other patients aged ~18 
years (n = 1354). The major angiographic variables studied included details of 
pulmonary artery (PA) anatomy, presence and size of aortopulmonay collat- 
erals (APCs), coronary artery (CA) anomalies, presence and degree of aortic 
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regurgitation (AR), right ventricular (RV) function and tricuspid regurgitation 
VW. 
Results: The age of patients with adult TGF (M:F -97:35) ranged from 
18-51 years (mean 24.9 f 6.2). The comparative data of the two groups is 
shown in the table. 
There was a significant inverse correlation between abnormal PA anatomy 
and presence and size of APCs (p < 0.01). However, multivariate analysis 
showed age to be independently associated with APCs (p = 0.007). 
Conclusions: In this largest angiographic series reported, we found that 
the profile of TGF in adults is distinct from that in younger patients. Most 
of these cases have good arterial oxygen saturations and favourable PA 
anatomy. However the higher prevalence of APCs, AR and TR in them are 
issues of concern during surgery. 
1 1035-i 62 1 Thrombocytopenia in Cyanotic Congenital Heart 
Disease 
Michael C. Lill, Joseph K. Perloff, Malka Frantzen, Alice Runge, Pamela 
D. Miner. Ahmanson/lJCLA Adult Congenital Heart Disease Center, Los 
Angeles, CA, USA 
Background: Patients with cyanotic congenital heart disease (CCHD) have 
inherent hemostatic defects and a bleeding diathesis. In an important minority 
of these patients, platelet (PLT) counts are cl 00 x 1 09/L. This is the first study 
seeking to determine whether the thrombocytopenia is due to decreased 
platelet production or to increased destruction or activation. 
Methods: Fourteen adults with CCHD and PLT counts < 100 x log/L 
were studied to determine platelet activation [Platelet Factor 4 (PF4) and 6 
Thromboglobulin (BTG)], coagulation factor consumption [Prothrombin Time 
(PT)], activated partial thromboplastin time (APTT), D-dimers and throm- 
bopoietin (TPO) levels using standard techniques. Reticulated PLT content 
(a measure of platelet production) was determined by flow cytometry. A 
reference range was established using 20 normal volunteers. Experimental 
results are presented as Mean f Standard Error. 
Results: Absolute reticulated PLTs were significantly reduced (p < O.OOOl), 
reflecting decreased production, Pi, APTT and D-dimers were normal, ex- 
cluding disseminated intravascular coagulation. PF4 and BTG were either 
normal or only slightly elevated, implying minimal or no platelet activation. 
TPG levels were either normal or moderately elevated, excluding primary 
hepatic failure of production of TPG (Tables). 
Tables 
N Plt. Count Retie. Plt BTG (n = 9) PF4 (n = 9) TPO (n = 13) --- 
Controls 20 246& 13 722566 Ref. Range 1 O-78 o-35 <0.52 
Patients 12 58 + 5 224i 38 Patients 73 f a 36C5 4.01 + 0.53 - 
Conclusions: Thrombocytopenia, which may contribute to the bleed- 
ing diathesis in CCHD, is not due to increased destruction or activation of 
platelets, but to a decrease in PLT production. Normal or only moderately el- 
evated TPG levels suggest that the megakaryocyte mass is not significantly 
decreased. These results may reflect ineffective thrombopoiesis, possibly 
due to loss of shunted systemic venous megakatyocytes. 
L-L 1035 163 Atrial Septal Defect Closure in Adult Patients 
With the Amplatzer ASD Occluder 
Horst Sievert, Ulrike Krumsdorf, Kathrin Horvath, Patrick Keppeler, 
Rainer Schrader, Harald Zeplin, Hans Spies, Andreas Fach, Detlef Scherer, 
Roland Ensslen, Hartmut Merle. Cardiovascular Center Bethanien CCB, 
Frankfurt, Germany 
Catheter closure of an atrial septal defect was attempted with an Amplatzer 
ASD occluder in 50 adult patients with a mean age of 46 Z!Z 17. The diameter 
of the defect ranged from 11 to 30 mm (21 * 4) and was larger than 20 
mm in 25 patients. The Qp:Qs-ratio ranged from 1.5 to 3.6 (2.1 i- 0.5). The 
pulmonary artery pressure was elevated in 12/50 patients. 5 patients suffered 
from congestive heart failure, 12 patients from hypertension and 2 patients 
from coronary heart disease. 
The implantation of the occluder was successful in all 50 patients (two 
attempts in one patient). The procedure was performed under local anesthe- 
sia in 75% of the patients. No complications occurred. The mean procedure 
time was 41 f 14 min., the X-ray time 6.6 & 3.2 min. and the mean length 
of hospital stay 0.8 +Z 0.5 days. Transoesophageal echocardiography after 
2 weeks and after 6 months showed complete closure of the defect without 
any residual shunt in 49/50 patients and a minimal shunt in one patient. No 
thrombus and no recurrent shunt could be detected. During follow up (1 to 
21 months, mean 9.1 f 5.5) no complications occurred. 
In conclusion, transcatheter ASD closure with the Amplatzer occluder 
in adult patients is reliable and safe. It can usually be performed as an 
out-patient procedure. 
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r-I 1035 164 The Fontan Operation in Adult Patients 
Deborah R. Gersony, Majid Alfayyadh, Welton M. Gersony, 
Jan Quaegebeur, Daphne T. Hsu, Marlon S. Rosenbaum. Columbia 
University: New York, New York, USA 
Background: Although the Fontan operation is usually performed in children, 
some patients do not undergo this procedure until adulthood. Published 
reports concerning the follow-up of these patients have been sparse. 
Methods: Between 1984 and 1999, 20 adult patients underwent the 
Fontan operation at Columbia-Presbyterian hospital. The age at surgery was 
17 to 33 yrs (median = 21.3 yrs). Diagnoses included single ventricle (14), 
tricuspid atresia (3), and unbalanced atrioventricular canal (3). Sixteen of 
the 20 patients had had prior cardiac operations. The mean follow-up time 
was 5.6 years. ‘Eight patients (40%) had right atrial to pulmonary artery 
anastomoses and 12 patients (60%) had cavopulmonary connections. 
Results: There were no operative deaths, The hospital stay was 7 to 63 
days (median = 13 days). Significant perioperative complications occurred 
in 3 patients. These included: sustained ventricular tachycardia, pulmonary 
infarct, transient multiorgan failure, and complete heart block requiring per- 
manent pacemaker implantation. There were 2 late deaths in the series One 
patient died 1 year after the Fontan operation of unknown causes and a sec- 
ond died 12 years later following heart transplantation. Nine patients (43%) 
had late arrhythmias; atrial flutter (4), atrial fibrillation (2), and supraventric- 
ular tachycardia (3). Protein losing enteropathy occurred in 2 patients and 
thrombotic complications occurred in 4 patients. No pre- or post-operative 
risk factors for mortality or late morbidity could be identified. At last follow-up, 
among 15 patients, 13 were in NYHA functional class I or II, 1 was class Ill, 
and 1 was limited by a CVA that occurred prior to the Fontan procedure. Late 
follow-up was not available for 3 patients who are known to be alive. 
Conclusion: It is concluded that the Fontan operation can be performed 
safely in adults, but late postoperative arrhythmias are common. Medium- 
term survival in this series was 90%; however long-term outcome is not yet 
known. 
r-i 1035 165 Determinants of Exercise Tolerance After Total 
Repair of Tetralogy of Fallot 
Jean F. Aupetit’, Didier Vabre’, Robert N. Verney’, Bernard WintzeP, 
Sylvie Di Filippoa, Gerard Champsaura, Andre Bozio2. ‘C. H. St-Joseph et 
St-L& 9 rue du Pr. Grignard, 69365 Lyon Cedex 07; *Hr?pital 
Cardiovasculaire L. Pradel, 28 Avenue Doyen Lgpine, 69003 Lyon, France 
Background: The aim of the study was to evaluate the components which 
influence the cardiorespiratory response to exercise after total repair of tetral- 
ogy of Fallot (TOF). 
Methods: We studied 35 patients (pts) (15 females and 20 males) after 
total repair of TOF at a mean age of 20.5 f 3.5 y. 23 pts had a prior aor- 
ticopulmonary anastomosis (3 Waterston, 1 Potts and 19 Blalock-Taussig). 
Lung function tests, resting echocardiography and maximal bicycle exercise 
test (ET) with gas exchange measurement were performed in all patients. 
Mean time interval between TOF repair and ET was 16.5 * 3.3 y in pts 
with palliative surgery (Pal S) prior to correction and 10.7 f 3.4 in pts with 
primarily repair (Pri R). 
Results: The main findings are 1”) mean peak oxygen uptake is signif- 
icantly reduced 33.6 * 6.8 ml/mn/kg (77.1 f 5.7% of the normal values). 
2’) Mean vital lung capacity (VC) is significantly decreased (76% i 5.5% 
of the normal values). 3”) Metabolic chronotropic relation slope calculated 
according to the mathematical model developped by Wilkofl is significantly 
decreased (0.71 rt 0.2). 4”) Lung restriction is significantly higher in pts with 
Pal S vs pts with Pri R (80 rt 14.4% vs 97.5 * 9.7 p < 0.01). 5%) Lung 
restriction is associated with decreased peak oxygen uptake (peak V02 = 
69.1 f 5.2% normal of values if VC < 85% vs peak V02 = 86.1 f 3.4 if VC 
> 85% p < 0.01). 6”) Impaired chronotropic response; residual pulmonary 
regurgitation, age of repair, time interval between Pal S and total repair do 
not correlate with any of exercise tolerance parameters. 
Conclusion: after total repair of TOF exercise tolerance appears to be 
mainly determined by lung restriction only in pts with prior palliative surgery. 
1035-l 66 Differences in Physical Performance in Right 
Atrium to Right Ventricular Conduit as 
Compared to Right Atrium to Pulmonary Artery 
Connectiont in Adult Patients With Modified 
Fontan Procedure 
Per Morten Fredriksen, Judith Therrien, Gruschen Veldtman, Mohammed 
Ali Warsi, Peter Liu, Gary Webb. University of Toronto Congenital Cardiac 
Centre for Adults, Toronto, Ontario, Canada 
Background: Right atrium to right ventricular conduit (RA-RV) has been used 
in the modified Fontan procedure in order to use the systemic right ventricle 
JACC February 2000 
providing blood flow to the lungs. Currently, no data regarding physical 
performance in patients with RA-RV conduit compared to patients with right 
atrium to pulmonary artery connection (RA-PA) have been published. 
Methods: A study of 54 patients with a modified Fontan procedure was 
conducted using the cardiopulmonary database at the University of Toronto 
Congenital Cardiac Centre for Adults. 39 patients with RA-PA connection 
(mean age surgery 20.0 years, SD 8.7 and age at test 27.4 years, SD 7.7) 
and 15 patients with RA-RV conduit (mean age at surgery 15.5 years, SD 
6.3 and mean age at test 27.9, SD 5.6) were analyzed for maximal oxygen 
uptake, maximal heart rate, maximal ventilation and systolic blood pressure. 
Mean values for these two groups were compared using the t-test. 
Results: No significant differences between the two groups were detected 
for any variables. 
Conclusion: Regarding the physical performance, the theoretical benefits 
of including the right ventricle in Fontan circulation do not find support in our 
present study. 
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LIrl 1057 160 Fontan Fenestration Closure Using the Amplatzer Septal Occluder 
Collin G. Cowley, Sarah Badran, Albert P. Rocchini, Thomas R. Lloyd. 
University of Michigan, Ann Arbor, Michigan, USA 
Background: Fontan fenestration closure has been reported using a variety 
of techniques. We have recently begun using the Amplatzer Septal Occluder 
for this purpose. 
Methods: Between June 1998 and April 1999, 11 patients, median age 3.2 
years (range 2.8-19.5) median weight 13.6 kg (range 11.5-50.6) underwent 
transcatheter occlusion of their Fontan fenestrations. Four patients required 
transhepatic access due to femoral vein occlusion (n = 3) or congenital 
interruption of the IVC (n = 1). A 4 mm device was used in all but two 
patients, one with two significant shunts in whom both a 4 mm and a 5 mm 
device were placed, and another in whom a 7 mm device was placed. 
Results: The average procedure time was 2.8 hours (range 2.0-4.4) re- 
quiring 22.1 minutes of fluoroscopy exposure (range 9.7-46.4). The average 
systemic arterial saturation was 90% (range 80-94) before the procedure 
and 96% (range 88-99) following the procedure. Average systemic blood 
flow decreased by 0.9 liters/min/m” (range 0.1-2.2). Average pulmonary 
blood flow decreased by 0.1 liters/min/m* (range 0.8 to 0.2). All fenestrations 
were effectively closed although 5 patients had trivial residual shunts through 
additional communications. One patient had a mild-moderate residual com- 
munication outside the closed fenestration. Three patients had complications 
from the procedure. In one patient, a left-sided atrial thrombus was detected 
by echocardiography, but no clinical sequelae were evident. One patient 
developed bleeding at the femoral vascular access sites during recovery. 
One patient developed severe tricuspid regurgitation following the procedure 
requiring surgical removal of the device. Upon direct examination, the fen- 
estration site was very close to the valve apparatus allowing the device to 
entrap portions of the anterior and septal leaflets. The valve was success- 
fully repaired and the patient has done well since. Six month follow-up in five 
patients showed all to be doing well with no shunts detectable through or 
around the devices by echocardiography. There was no evidence of baffle 
obstruction, thrombosis or AV valve problems. 
Conclusion: The Amplatzer Septal Occluder effectively eliminates right to 
left shunting through Fontan fenestrations with acceptable procedure length 
and radiation time. Further experience is needed to compare this approach 
to other techniques. Our experience indicates that the location of the fen- 
estration in the Fontan baffle is critical to avoiding device interference with 
other intracardiac structures. 
1057-l 61 Acute and Long-term Follow-up Results with the 
HELEX’” Septal Occluder in an Animal Model 
Evan M. Zahn, Larry A. Latson’ , Neil Wilsona. Miami Children’s Hospital, 
Miami, FL; ‘Cleveland Clinic, C/eve/and, OH, USA; “Royal Hospital for Sick 
Children, Glasgow, UK 
Background: The HELEX’” occluder is a unique transcatheter device de- 
signed to close atrial septal defects (ASD). It is composed of a single strand 
of nitinol wire that supports two opposing, circular polytetraflouroethyline 
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patches. The design addresses several concerns which exist with current 
occlusion systems including: low septa! profile, round atraumatic edges, 
decreased metal involved in construction and easy repositioning and retriev- 
ability. 
Methods: Thirty-one devices were utilized in 24 dogs with surgically cre- 
ated ASD. Foilow-up included: transesophageai echo (TEE) and fluoroscopy 
2 weeks after implant and monthly thereafter. Prior to sacrifice (1, 3, 6, 12 
months) right and left atrial angiography, contrast TEE and epicardial echo 
was performed. Heart, lung, kidney, and brain were examined microscopically 
for thromboemboli. Surrounding tissue was assayed for nickel and explanted 
devices sent for electron microscopy. 
Results: Successful implantation was achieved in all animals. Reposi- 
tioning of the device was always possible. Seven devices were retrieved 
prior to/or following release from the catheter without complication. Immedi- 
ate post-implantation complete closure rate was 88% (21/24) with 3 animals 
having trivial residual shunts. Two weeks after implant TEE closure rate 
was lOO%, however, more sensitive epicardial contrast echo detected a 
trivial residual ASD in one animal (overall complete closure rate = 96%). 
All animals remained healthy during follow-up. Early pathologic examination 
demonstrated close adherence of the device to the septai surface with rapid 
formation of a benign fibrocoilagenous covering. With time, adherence to the 
septal surface intensified and a smooth layer of endothelial cells covered the 
device surface. Examination for intracardiac and distal organ thromboemboli 
was negative. Scanning electron microscopy showed no excessive material 
wear and adjacent tissue nickel levels were below the minimal detectable 
levels. One wire fracture was noted at 4 month-follow secondary to abnormal 
loading conditions placed on this particular device. There were no adverse 
sequelae and the ASD remained completely closed. 
Conclusion: The HELEX’” septal occluder is safe, effective and offers a 
number of potential advantages over existing systems including: high acute 
closure rate, simple retrievability, low septal profile, atraumatic design and 
avoidance of a large metal load. Clinical trials are warranted. 
[-1 1 O57- I 62 Transcatheter Closure of Atrial Septal Defects in Chit&en and Adults Usina the Amolatzer 
evice: initial and 6-months Transesophageal 
Echocardiographic Results 
David Waight, Ziyad M. Hijazi, Qi-Ling Cao, Hitendra T. Patel, 
Jonathan Rhodes, Peter Koenig. The University of Chicago, Chicago. IL; 
T&s-New England Medical Center, Boston, MA, USA 
Background: Catheter closure of secundum atrial septal defects (ASD) 
using the Ampiatzer septal occluder (ASO) is associated with a high suc- 
cess rate. Little is known about the short-term (6.months) transesophageal 
echocardiographic (TEE) results. 
Methods: From 5/97 to 9/99, eighty-two patients (65 female/l7 male) 
underwent an attempt of device closure of their ASD’s using the AS0 at a 
median age of 11.8 yr. (0.5-71.5 yr.) and median weight of 45 kg (5.6-130 kg). 
The median Qp/Qs ratio was 2 (0.7-5.3). The median size of the ASD by TEE 
was 12 mm (3-25 mm). Successful closure was considered in any patient 
who had: complete closure (CC); trivial residual shunt (TS)[color jet width ~1 
mm] or small residual shunt (SS)[color jet width 1-2 mm] as documented by 
color Doppler TEE. If the patient had moderate residual shunt (MS) [color 
2-4 jet width mm] or large residual shunt (LS) [color jet width ~4 mm], the 
procedure was considered to be a failure. 
Results: The median size of the balloon stretched diameter of the ASD 
was 16.9 mm (7-35 mm) and the median size of the device (size of the 
connecting waist between the left and right atrial disks) used for closure was 
18 mm (8-34 mm). Tie median fluoroscopy time was 9.3 min. (3.3-38.3 
min.). The device was deployed successfully in all but one patient who 
had immediate device embolization. Immediate CC as documented by color 
Doppler TEE was achieved in 66 patients, 6 had TS, 8 had SS, and 1 had LS. 
Complications were encountered in 3 patients [two had device embolization: 
one immediate and another one within 24-hours from closure. One patient 
with junctional rhythm alternating with sinus rhythm developed complete heart 
block]. Two patients died from their underlying cardiac conditions. Fifty-two 
patients completed 6-months follow-up and underwent TEE evaluation. 49 
had CC, 2 patients had SS and one patient had LS. A second device was 
implanted in the patient with LS resulting in CC. So far, there have been no 
episodes of endocarditis, thromboembolism or wire/device disruption. 
Conclusion: The AS0 is a safe and effective device for catheter closure 
of small-large secundum ASD’s up to a diameter of 25mm in children and 
adults with a success rate of 97.6% and 98% immediately and at S-months 
follow-up as assessed by TEE. 
/ 1057 163 0.052 Inch Coil Occlusion of a Moderate to Large PDA: Controlled Coil Delivery Using a Bioptome 
Through a 4 French Sheath - - 
Ronald G. Grifka, Howaida El-Said, Michael R. Nihill, Sandra K. Clapp, 
Charles E. Mullins, Thomas K. Jones, Troy A. Johnson. Texas Children’s 
Hospital, Houston, TX; Chi/dren’s Hospital and Regional Medical Center, 
Seattle, WA, USA 
Background: The standard of care for closure of patent ductus arteriosus 
(PDA) is transcatheter occlusion using 0.038 inch Gianturco embolization 
coils. For large diameter PDAs, these coils afford minimal control during 
implant, and often multiple coils are needed. The 0.052 inch embolization 
coils provide more stability during implant, but require a large catheter. We 
developed a technique to close large PDAs by holding onto 0.052 inch coils 
with a 3 Fr bioptome and delivering them through a 4 French (Fr) transseptal 
sheath. 
Methods: A 4 Fr transseptal sheath is advanced prograde through the 
femoral vein and right heart, across the PDA, into the aorta. The beaded 
end of the 0.052 inch coil is pulled out just enough so the jaws of the 3 
Fr bioptome grasp the bead. The coil-bioptome are advanced through the 
transseptal sheath and deployed in the aorta near the PDA; after the coil 
forms 3 loops, the sheath and coil are pulled into the PDA ampulla. An 
angiogram is performed to asses coil position; if coil position is suboptimal, 
the coil is pulled back into the sheath, the sheath repositioned, then the 
coil redeployed; if indicated, the coil may be exchanged for a different size 
(without having to remove the sheath). When the coil position is optimal, 
it is released from the bioptome. If an additional coil is needed, a smaller 
diameter 0.038 inch coil is easily deployed inside the 0.052 inch coil. 
Results: 21 pts with moderate-large PDA (~2.5 mm) underwent tran- 
scatheter occlusion using 0.052 inch coils/bioptome/sheath. Median age = 
4.0 yr (0.13 to 40 yr). Median wt = 15 kg (4 to 64 kg). Minimal PDA diameter 
(mean) = 3.3 mm (2.5 to 5.6 mm): Mean Qp:Qs = 1.8:1 (1.3 to 3.8:1). In 7121 
pts, the 052 inch coil was easily repositioned before release from the biop- 
tome. In 9/21 pts, additional 0.038 inch coil was implanted. No complications 
occurred. 5/21 had trace residual angiographic shunt; at follow-up evaluation 
(1 to IO months), color Doppler revealed complete PDA occlusion and no 
LPA stenosis. 
Conclusion: Transcatheter occlusion of moderate to large PDA using 
0.052 inch coils, held with a 3 Fr bioptome and delivered through a 4 Fr 
transseptal sheath is a safe procedure which provides excellent coil control 
and positioning, superb clinical results, and can be applied to very small chil- 
dren. This technique can be applied to aorta-pulmonary collaterals, shunts, 
and other unwanted vascular structures. 
L--l 1057 164 Transcatheter Closure of Patent Ductus Arteriosus Using Self-Expandable Amplatzer 
Device 
Ramesh Arora, Gurcharan S. Kalra, Sandeep Singh, Rajiv Passey, 
Sumeet Sinha, Madhuri Nigam. GB Panf Hospital, New Delhi, lndia 
Background: Since the introduction of transcatheter closure of patent ductus 
arteriosus, many devices have undergone clinical application with variable 
success. We report our short-term experience of PDA occlusion using a new 
self-expandable Amplatzer device. 
Methods: Ninety-five consecutive patients of PDA were subjected to 
device closure using Amplatzer device at our cenire over the last 1 i years. 
This cohort included 3 (3.2%) patients having significant residual shunt on 
follow-up after Rashkind Umbrella Device (RUD) closure. Their age ranged 
0.6-28 (mean: 8.3 f 6.6) years. All patients underwent detailed transthoracic 
echocardiographic evaluation before, 24 hours after and at regular followup. 
The narrowest diameter of PDA as measured during aottography was 4.9 & 
1.6 (range: 2.5-10) mm. In 29 (30.5%) patients, this diameter was ~6 mm. 
The procedure was done in all the patients through antegrade transvenous 
route. Amplatzer PDA device of 6 mm was used in 4 (4.2%): 8 mm in 19 
(20%), 10 mm in 41 (43.2%) 12 mm in 15 (15.8%), 14 mm in 10 (10.5%) and 
16 mm in 4 (4.2) patients. In 2 (2.1%) patients with window type ductus, 14 
and 16 mm Amplatzer ASD device were successfully deployed. 
Results: The procedure was successful using Amplatzer device in 93 
(97.9%) patients. In the remaining 2 (2.1%) patients, RUD and Cardioseal 
devices were deployed due to non-availability of the appropriate sizes of the 
Amplatzer device. Complete closure of the ductus was seen in 90 (94.7%) 
patients at 24 hours. Residual shunt disappeared in 3 (3.2%) patients at one 
month follow-up, while it persisted in the remaining 2 (2.1%) patients. Over 
a follow-up period of 1-17 (mean: 7.4 f 4.7) months, no episode of device 
embolisation or intravascular hemolysis was seen. There was no significant 
gradient m either left pulmonary artery or aorta. 
Conclusion: PDA closure using Amplatzer device is safe and efficacious. 
It can close large defects even m small children and in the majority, there is 
complete closure of the defect. 
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L___I 1057 165 Transcatheter Device Closure of Ventricular Septal Defects With Amplatzer Device: Initial 
Results 
Gurcharan S. Kalra, Sanjeev Bhardwaj, Ramesh Arora. G.5. Pant Hospital, 
New Delhi, lndia 
Background: Transcatheter closure is an accepted mode of treatment in 
selected cases of congenital heart disease. Lately this technology has been 
applied to closure of ventricula: septal defects (VSD). We report our initial 
experience of transcatheter closure of VSD with Amplatzer device. 
Methods: Transcatheter closure of VSD was attempted in 15 patients. 
There were 10 males and 5 female subjects, with an age range of 5 to 31 
years (mean 12.7 f 8.1 years). The location of VSD was perimembranous 
in 4 patients and muscular trabecular in 11. Two patients had left ventricular 
to right atrial communication. In one patient an associated PDA was closed 
with a 10 mm Amplatzer PDA device. The diameter of VSD ranged from 4 
to 8 mm (mean 5.79 rt 1.5 mm). The Qp/Qs ranged from 1.5 to 2.6 (mean 
1.87 * 0.70). In 8 patients, the QpiQs was ?2:1. VSDs were crossed via the 
lefl ventricle and a guide wire was advanced into the pulmonary artery or 
superior vena cava. The wire was snared with avenous catheter, and used to 
direct a long sheath, through which the device was advanced. In 14 patients 
VSD Amplatzer device was used (6 mm in 3 patient, 8 mm in 4 patients, 10 
mm in 2 patients, 12 mm in 4 patients and 14 mm in 1 patient) and in one 
patient 10 mm ASD Amplatzer device was used. The sheath used was 6 to 
8 F. 
Results: The device was successfully deployed in all patients. The pro- 
cedure time was 60 to 100 m’inutes (mean 71.07 f 13.04 minutes). No 
patient had residual flow on color Doppler echocardiograhy done 24 hours 
after device implantation. Two patients had transient complete heart block. 
Follow-up of 1 to 12 months (3.5 f 4.0 months) was uneventful. At follow-up 
no patient developed infective endocarditis or late valvular insufficiency. 
Conclusion: Transcatheter closure of VSD with Amplatzer device results 
in complete closure in selected cases of VSD. The need for a small sheath 
size is of advantage in VSD closure. 
1057-l 66 Retrograde Transcatheter Coil Occlusion of 
Congenital Coronary Artery Fistulas in Young 
Children and Infants 
Grace C. Kung, Phillip M. Moore, Doff 8. McElhinney, David F. Teitel. The 
University of California at San Francisco, San Francisco, California, USA 
Background: Transcatheter coil occlusion of coronary artery fistulas has 
been used successfully in the adult population. However, reports on its use 
and success in the pediatric population, especially in infants, are limited. 
We report our results on the use of retrograde transcatheter coil occlusion 
of congenital coronary artery fistulas in young children and infants with 
introduction of a coaxial delivery system. 
Methods: Ten patients underwent transcatheter coil occlusion of congen- 
ital coronary artery fistulas between January 1993 and August 1999, median 
age 4.5 yrs (range 5 wks-9 yrs). Two patients had increased chamber dimen- 
sions but only the youngest infant, 5 wks of age, was symptomatic. Seven 
fistulas originated from the left coronary artery system, 3 from the fight. Eight 
fistulas drained to the right ventricle, 2 to the right atrimn. The calculated 
shunt (Qp:Qs) at time of catheterization ranged from 1 .I:1 to 3.1:1. All coils 
were delivered retrograde from the arterial side using either complex platinum 
or standard steel coils. A coaxial system was used in 8 patients. 
Results: Angiography immediately after placement of coils revealed no 
residual shunt in any patient. In 3 patients, coils embolized to the pulmonary 
arterial or systemic circulation. In all cases, the embolized coils were retrieved 
successfully. Early in our series, 1 patient was placed on a continuous heparin 
infusion overnight and a murmur was noted the following morning. Echocar- 
diography revealed residual flow through the fistula. That patient has since 
been lost to follow-up. Recent follow-up evaluation is available for the remain- 
ing 9 patients (median duration of follow-up 6.7 mos). Echocardiographic and 
clinical evaluations show complete occlusion in 8 of 9 patients, One patient 
has evidence of re-cannulization first noted at two years after coil occlusion. 
All patients are asymptomatic with normalization of coronary artery caliber 
and chamber dimensions. 
Conclusions: Transcatheter coil occlusion of congenital coronary artery 
fistulas can be performed safely and successfully in young children, and 
symptomatic infants. Follow-up shows absence of fistula flow in 8 of 9 pa- 
tients The use of a retrograde approach and coaxial system is safe and 
effective and may provide better accuracy, stability and precision for place- 
ment of coils. 
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I 1080 160 A New Technique for Implantation of Large Stents Through Small Sheaths in Infants and 
Children With Branch Pulmonary Artery 
Stenoses 
Frank F. Ing, James W. Mathewson, Mark Cocalis, James Perry, Charles 
E. Mullins. Children’s Hospital of San Diego, San Diego, CA; Texas 
Children’s Hospifal, Houston, TX, USA 
Background: Stent implantation for branch pulmonary artey.stenosis (BPAS) 
in congenital heart disease is well established. However, the need for rela- 
tively large sheaths (9-11 Fr) for delivery of large stents (dilatable to 18 mm) 
renders this technique difficult if not impossible in infants and small children. 
Although smaller stents (dilatable to IO mm) can be delivered through smaller 
sheaths, these stents cannot be further expanded to accommodate growth of 
the pulmonary arteries to adult size. A new “dilator-tipped” balloon catheter 
was developed to permit delivery of large stents through small sheaths (7-8 
Fr) in infants & small children. 
Methods: The “dilator-tipped” balloon is created by cutting off the dilator 
tip of a long sheath and attaching it over the balloon tip. This balloon is then 
passed through a long sheath and a large stent (P308, P188) is front-loaded 
onto the balloon and withdrawn into the sheath. After assembly, only the 
dilator tip is exposed beyond the end of the long sheath. The dilator tip 
on the balloon permits a smooth transition for delivery of the entire “stent- 
balloon-sheath” unit from the skin to the site of stenosis. This method was 
used to deliver 12 stents (P308 and P188) in 10 infants and children from 
IO/98 to 8/99. With experience gained from the first 3 pts who were larger 
(wt 30.8-38.7 kg), this technique was extended to the last 7 pts who were 
smaller (median wt 14.1 kg, range 6-26). 
Results: Stent delivery was successful in all. 9 stents mounted on IO-14 
mm diameter balloons were delivered through 8 Fr sheaths while 3 stents 
mounted on 8 mm diameter balloons were delivered through 7 Fr sheaths in 
the 2 smallest pts (6 & 9 kg). The mean diameter increased from 4.8 f 2.5 
mm to 11 .O i 1.6 mm and the gradient decreased from 17 & 13.8 to 3.3 =t 
5 mmHg (p-value ~0.05). The only complications were balloon perforation 
during stent inflation in 3. All balloons were removed and the partially inflated 
stents were implanted in good position with a new balloon without difficulty. 
No dilator tip dislodged from the balloon. 
Conclusion: This new technique can deliver large stents through small 
sheaths safely and effectively and is particularly beneficial to infants and 
small children with BPAS. 
1080-I 61 Pulsatile Work Efficiency of a Stented Aorta: 
A Model of Compliance Mismatch With 
implications to Correction of Aortic Coarctation 
Arun K.S. lyengar, Michael D. VanAuker, Theresa A. Tacy. Cardiac 
Dynamics Lab, Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA 
Transcatheter placement of a balloon-expandable stent has been proposed 
as a means for treatment of coarctation of the aorta. However, interposition 
of a noncompliant stent within the aorta may result in compliance mismatch, 
with a consequent increase in pulsatile left ventricular (LV) workload when 
compared with surgical correction without an interposed rigid stent. This 
study investigates the effects of aortic stent placement on the pulsatile and 
steady components of LV work as determined by aortic input impedance. 
Methods: A pulsatile flow model simulated a compliant aortic vessel using 
a 20 cm long latex tube, diameter 25 mm and radial distensibility 0.32% per 
mm of Hg. Aorlic stent placement was modeled by placing stiff plastic tubes 
with OD = 24 mm and ID = 21 mm within the aorta, 30 cm from the sonic 
valve. Stent length (L) was varied from 0 mm (no stent) to 50 mm in IO mm 
increments, and the cardiac output for each L varied from 4, 6, to 8 I/min at a 
heart rate of 60 bpm. Ascending aottic pressure (P) and flow (Q) waveforms 
were recorded simultaneously and resolved into ten harmonics using Fourier 
series. Pulsatile work (PW) was calculated as 112C Pi Qr CosB,, where P, 
and Q, are the ith pressure and flow harmonics respectively and 8, is the 
phase between them; Steady work (SW) as P,,,,. Qrnean. Total work (TW) 
is the sum of PW and SW. For each stent length and cardiac output, percent 
pulsatile work was calculated as PWiTW. This value is 10% or less in normal 
adults. 
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Results: There were no significant differences between the percent PW 
for the stented cases and the no-stent condition, the maximum variation 
being about 2.5%. Further, the percent PW was not related to stent length (r 
= 0.4), and was weakly affected by cardiac output (r = 0.61). For all situations, 
the PWlTW was less than 10%. 
Conclusion: The placement of a noncompliant aortic stent of up to 50 
mm length in an adult-sized aorta does not affect the pulsatile workload of 
the LV, despite the known compliance mismatch it produces. 
lZI2 the Aorta 
1080-162 Stent Dilation of Long Segment Coarctation of 
Frank F. Ing, Farhouch Berdjis, John W.M. Moore. Children’s Hospital-San 
Diego, San Diego, CA; Children’s Hospital of Orange County Orange 
Co&l: CA; Nemours Cardiac Center, Wilmington, DE, USA 
Background: While discrete coarctation of the aorta (COA) can be treated 
with balloon dilation alone, long segment COA is not amenable to this mode 
of therapy. We report our experience with using stents to dilate these difficult 
lesions. 
Methods: Records of patients with long segment COA brought to the oath 
lab for stent implantation between 3194 and 5/99 were reviewed. Data ana- 
lyzed included patient profile, previous surgery, type and number of stents 
balloon size used, and complications. Coarctation anatomy and hemody- 
namics pre and post stem were compared using paired t-test. 
Results: Nine patients were identified. Median age and weight were 17.7 
yrs and 75.4 kg. Six pts had unrepaired long segment COA of whom 3 had 
coarctation involving the lower thoracic and abdominal aorta. Three pts had 
post-surgical recoarctation. The mean length of the coarctation segment was 
40.7 t 10.6 mm. Following stem implantation, the mean minimum diameter 
increased from 7.8 & 3.4 to 13.9 i 3.3 mm. The mean systolic pressure 
gradie.nt decreased from 47.5 to 6.1 mmHg (p-value < 0.05). Palmaz P308 
stents were used in all cases and balloon diameter size used ranged from 12 
to 18 mm. An average of 2 overlapping stents was necessary to eliminate the 
gradient, Complications included balloon perforation during stent inflation in 
2 patients (16 and 18 mm diameter balloons). Both balloons were removed 
and the pariiaily inflated stents were successfully implanted in good position 
with a new balloon. However, 1 patient developed a small left occipital infarct. 
Ail except 1 patient were discharged within 24 hours. 
Conclusion: Early results indicate that stent implantation of long segment 
COA is effective in relieving significant pressure gradients. While the implant 
technique itself issafe, using currently available balloons in larger sizes (216 
mm diameter) for stent implantation of long segment COA carries some risk 
related to balloon perforation. Longer-term follow-up is warranted. 
/ 
1 1080-l 63 1 Transcatheter Therapy of Critical Stenoses in 
Infants & Neonates Usina a New Low Profile 
High Pressure Balloon &theter 
James Y. Coe, John D. Dyck. Universify of Alberta, Edmonton, Alberta, 
Canada 
Background: A high pressure (IO atmosphere), low profile (3.5 Fr shaft) 
catheter was developed in 1994 to deliver stents and dilate stenoses in 
infants and neonates. Over the past 5 years, the catheter (NuMED Inc., 
Hopkinton, NY. USA) was used in critical aortic stenosis (AS, n = 7, mean 
age 42.6 days, range 6 hrs-82 days), pulmonary stenoses (PS, n = 12, mean 
age 67.3 days, range 2-89 days); recoarctation (CoA, n = 4, mean age 161.5 
days, range 116-l 93 days). It was used to deliver stents in a 3.8 month old 
with severe left pulmonary artery (LPA) stenosis, and one of the CoA age 4.7 
months. 
Methods: Transvenous antegrade approach was used in all AS & PS and 
one CoA. Transductal guidewire (GW) “rail” approach was used in all PS. 
Llmbilical arterial-venous GW loop was used in 2 AS. 0.018 inch GW was 
used in all procedures. 
Results: Inflating the balloon (7-10 mm diameter) 2-4 times reduced 
the peak systolic gradient in AS from 57 & 7.4 to 13 i 2.5 mmHg, in PS 
from 58.8 i 4.4 to 11.8 + 2 mmHg, and in CoA from 29.3 i 1.5 to 5.3 
* 1.4 mmHg. Only one AS needed reballooning and surgery. Three PS 
with hypoplastic right ventricle needed aorta-pulmonary shunts. One of the 
remaining 9 PS was successfully treated by reballooning. Restenosis in one 
CoA was successfully stented. The pulmonary blood flow was normalized 
(radionucleide scan) after stenting the severe LPA stenosis. Apart from brief 
hypotension with the first inflation and transient arrhythmia, the procedure 
was well tolerated without peripheral vascular or myocardial injury. 
Conciusion: This new general purpose high pressure balloon catheter 
permits effective and safe dilatation of critical stenoses in neonates and 
infants via an antegrade approach. 
I 1080 164 Use of Tissue Type Plasminogen Activator 
Thrombolysis to Restore Arterial Pulse 
Following-Interventional and Diagnostic Cardiac 
Catheterization in Infants and Small Children 
Duraisamy Balaguru, Wolfgang A.K. Radtke. Children’s Heart Center, 
Medical University of South Carolina, Charleston, South Carolina, USA 
Background: Infants and small children have a significant incidence of 
arterial pulse loss especially after interventional procedures resulting in lim- 
ited future access or even impaired limb growth. Heparin, streptokinase or 
urokinase are used routinely. We have used tissue type plasminogen activa- 
tor (TPA) for the past six years and reviewed our experience between May 
1997-June 1999. 9 children received TPA therapy for loss of palpable arterial 
pulse among 983 children who had undergone cardiac catheterization. 
Method: Medical records of all patients who received TPA therapy be- 
tween May 1997 and June 1999 were reviewed retrospectively for outcome 
and complications. Treafmenf protocol: Children who had weak or absent 
arterial pulse following cardiac catheterization, were started on heparin in- 
fusion @400 units/kg/day after a ‘100 units/kg bolus dose. If there was no 
improvement in 4 hours, the patient was transferred to the ICU and TPA 
therapy was started. A bolus dose of 0.1 mg/kg was given over IO-5 min, 
followed by an infusion of 0.5 mgikgihr. After 2 hours of TPA infusion, heparin 
infusion was resumed at the initial dose. If the pulse did not improve in the 
next 4 hours, the dose of TPA was repeated, followed by heparin infusion for 
6 hours. The patient is observed for any adverse reaction or bleeding in the 
ICU. 
Result: 9 patients received TPA therapy between July 1997June 1999. 
All of them were 511 kg of body weight. Age range = 1 day to 17 mo (mean 
= 7.7 months). 7 were intetventional procedures and 2 were diagnostic. Size 
of the largest catheter/sheath size used for each procedure ranged from 20G 
Quicath (n = I), 4Fr sidearm sheath (n = 3) and 5Fr sidearm sheath (n = 5). 
Outcome: Return of equally or easily palpable arterial pulse was consid- 
ered successful therapy. Thrombolysis therapy with TPA was successful in 
8 of 9 patients. In one patient the pulse was only barely palpable. 2 patients 
developed bleeding from access sites with large hematoma formation. Bleed- 
ing was controlled with local pressure in all patients. No other complications 
were noted. The mean length of stay for patients admitted exclusively for 
catheterization was 1.3 days. 
Conclusion: TPAtherapy for restoration of arterial pulse is highly effective 
and safe in infants and small children, following cardiac catheterization using 
the proposed dose regimen. Close observation is necessary to observe for 
bleeding from access sites during thrombolytic therapy. 
1 1080-l 65 / Coronary Artery Anomalies in Tetralogy of Fallot 
-An Angiographic Study Spanning a Decade 
Dhiraj Gupta, Anita Saxena, Rajnish Juneja, Shyam S. Kothari, 
Sanjeev Sharma, Meera Rajani, Savitri Shrivastava. Cardiofhoracic Centre, 
A// lndia lnsfitute of Medical Sciences, New De/hi, lndia 
Background: Tetralogy of Fallot (TOF) is known to be associated with coro- 
nary artery (CA) anomalies some of which are of relevance at the time of 
surgery. Hence it is important to ascertain the exact coronary anatomy; in 
fact, this may be the only indication for catheterization of these patients in 
today’s era of echocardiography. 
Methods: We performed cineangiograms in patients of TOF according 
to a prespecified protocol to enable delineation of coronary anatomy. This 
included flush aortography in the LAO view in all patients. Additional selec- 
tive coronary angiography in 157 (10.6%) patients was carried out in older 
patients (~15 years), in those cases where the coronary anatomy could not 
be adequately delineated or in those with suspected coronary anomalies. 
Results: From 1989 to 1998, 1486 consecutive patients of TOF were 
catheterized. Of these, 96 (M : F - 73:23, median age 5 years) were found 
to have coronary anomalies on angiography (incidence 6.5%). These are 
tabulated below: 
-- 
Type of anomaly Number Median % of CA % of TOF 
age anomalies (n = 96) (n = 1486) 
Sole LAD from RCAIRCS 29 3.5 yrs. 30.2 1.95 
Addl. LAD from RCAJRCS 25 6.0 yrs. 26.0 1.68 
Single CA from LCS 15 4.5 yrs. 15.6 1 .oi 
Single CA from RCS 5 5.0 yrs. 5.2 0.34 
RCA, LCA from LCS 8 5.0 yrs. 5.0 0.54 
RCA, LCA from RCS 5 5.5 yrs. 5.2 0.34 
Others 
i. Circumflex from RCS 3 3.12 0.20 
ii. LCA from RCS, 
RCA from LCS 1 1.04 0.07 
iii. ALCAPA 1 1.04 0.07 
ALCAPA-Anomalous CA from Pulmonary Artery: LAD-Left Anterior Descending Artery; 
LCS-Left Coronary Sinus; RCA-Right Coronary Artery; RCS-Right Coronary Sinus 
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Conclusions: In the largest angiographic series of TOF ever reported, 
we found that coronary anomalies are present in a greater proportion than 
erstwhile suspected. Besides the common anomalies of an aberrant LAD 
from the RCA/RCS and a single coronary artery, other anomalies are also 
rarely associated with this condition, some of which have been described in 
our series for the first time. 
I 1080 166 Quantitative Angiographic Comparison of the 
Aortic Arch in Normal and Isolated Coarctation 
of the Aorta 
Vincent P.R. Aluquin, Deborah Shutte, Michael Nihill, Javier Gelvez, Arthur 
Y. Lu, Lingyu Chen, Thomas Forbes. Stanford Universi@ Palo Alfo, CA; 
Baylor College of Medicine, Houston, TX: Miami Children’s Hospital, Miami, 
FL; Stanford University, Pa/o A/to, CA; Wayne State Universifx Detroit, M/, 
USA 
Background: Tranverse arch and isthmic hypoplasia have been implicated 
in the controversy regarding the optimal management of coarctation of the 
aorta. The type of surgical repair or use of balloon angioplasty versus stent 
placement may vary depending upon its severity. To date, extensive an- 
giographic evaluation of the normal aorlic arch in comparison with isolated 
coarctation of the aorta has not been done. 
Methods: We established the normal growth pattern of the thoracic aorta 
by reviewing biplane angiograms in 187 patients aged 1 day to 47 years 
(median 3.6 years) who were considered to have normal left heart anatomy. 
Measurement of 8 different aortic sites were performed at end-systole on the 
lateral projection: aortic root (Al), sino-tubular junction (A2), distal ascending 
aorta (A3), proximal transverse arch (A4), distal transverse arch (A$ aortic 
isthmus (A6), descending aorta (A7) and transverse arch length (A8). The 
percentile growth curve for each measurement was determined by regres- 
sion models. identical measurements were obtained in 23 patients aged 1 
month to 26 years (median 4.6 years) with isolated coarctation of the aorta 
and accordingly plotted on the normal curves. Comparison was done using 
analysis of covariance. 
Results: Aortic sites Al, AZ, A7 and A8 with median percentile values of 
77% (3-99%), 87% (3-99%), 90% (28-99%) and 98% (7-99%) respectively 
were significantly larger in coarctation (p < 0.01). Measurement A3 was 
likewise larger (p < 0.05) with a median of 80% (4-99%). In contrast, A5 and 
A6 were significantly smaller in coarctation (p < 0.05) with median values of 
15% (l-95%) and 14% (i-99%) respectively. The proximal transverse arch 
was not significantly different from normal. 
Conclusion: In comparison with the normal thoracic aorta, isolated coarc- 
tation of the aorta was associated with significant distal transverse arch and 
isthmic hypoplasia. This may have implications in the surgical or interven- 
tional approach used to repair isolated coarctation of the aorta. 
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I 1103 160 Decision Analysis Comparing Treatment Strategies for Hypoplastic Left Heart Syndrome 
Pamela C. Jenkins, Anna N.A. Tosteson, Michael F. Flanagan, James 
D. Sargent, Gerald T. O’Connor, Charles E. Canter, Richard E. Chinnock, 
Kathy J. Jenkins, Robert N. Vincent. Dartmouth Medical School, Lebanon, 
NH, USA 
Background: Optimizing the treatment of hypoplastic left heart syndrome 
(HLHS) requires integration of survival rates for staged surgery and trans- 
plantation (tx), organ availability, and individual risk factors for mortality. 
Methods: Decision analysis was used to compare 6 treatment paths: 
staged surgery; stage 1 surgery then list for tx; wait up to one, two or three 
months for tx before performing stage 1 surgery; or wait indefinitely for a 
donor. Survival probabilities were derived from a dataset of 221 patients 
with HLHS born between 1989-i 994 and from the literature. One-way and 
two-way sensitivity analyses were performed. 
Results: The optimal path changed based on center-specific or individual 
probabilities of receiving a tx in three months and stage 1 survival. Under 
baseline survival probabilities, waiting two months for a donor before per- 
forming stage 1 surgery was the optimal path; 55% survival at one year was 
expected for this path, compared to 48% for the path of waiting indefinitely for 
tx, and 42% for the staged surgical path. When survival and organ donation 
probabilities were varied, waiting up to three months on the tx list was the op- 
timal path when the three-month organ donation rate was 130%. Performing 
stage 1 surgery then placing the infant on the tx list, or waiting indefinitely for 
tx, were almost never the optimal choices. 
Conclusions: The best choice for individual patients with HLHS can be 
guided by local probabilities of organ donation and stage 1 survival, and by 
an individual patient’s predicted mortality risk. 
1 1103-l 61 1 A Pro.spective Randomized Trial of Azathioprine 
in Children Receiving Cryopreserved Valved 
Allografts for Repair of Congenital Heart Defects 
Robert E. Shaddy, Linda M. Lambett, Thomas C. Fuller, Tracie Profaizer, 
Dixie D. Thompson, Shawna Baker, Karen A. Osborne, John A. Hawkins. 
Departments of Pediatrics, Pathology and Surgery, Primary Children’s 
Medical Center and the University of Utah, Salt Lake Ci% U7; USA 
Background: We have previously shown that cryopresetved valved allo- 
grafts used to repair congenital heart defects in children induce a marked 
HLA antibody response. The purpose of this study was to prospectively 
study the effects of azathioprine (Aza) on the immune response and allograft 
function in children who receive a cryopreserved valved allograft at surgery. 
Methods: We prospectively randomized 20 children to receive either Aza 
or no Aza (controls) after receiving an allografi in the pulmonary position. 
Diagnoses were tetralogy of Fallot (n = 9), transposition of the great arteries (n 
= 4), truncus arteriosus (n = 4), and aortic valve disease (n = 3). Aza patients 
received 4 mgikg IV Aza intraoperatively, and 2.0 f 0.2 mg/kg (mean f SE) 
daily for 3 months after surgery. In both groups, panel reactive antibodies 
(PRA) against HLA Class I and II antigens, white blood count (WBC), and 
liver enzymes (ALT/AST) were measured before, 1 week, 1 month, and 3 
months after surgery. 
Results: 7 patients withdrew: 4 Aza patients (1 died of low cardiac output, 
I because of blood draws, 1 sepsis, one C. difficile colitis), and 3 control 
patients: (2 died [I low cardiac output, 1 sepsis], 1 because of blood draws). 
Ages were similar in the Aza (n = 6; 0.2-15 yrs old) and control groups (n = 
7; 0.2-7 yrs old). Both groups showed a marked immune response against 
the allograft that was not significant y different between the Aza and control 
groups: 
PRA (%) Before 1 wk post-op 1 month post-op 3 months post-op 
surgery 
Aza Class I 0.0 + 0 0.8 i 0.8 59.2 i 17 84.0 i 12 
Class II 0.0 zt 0 0.5 5 0.5 27.4 + 11 55.0 h 12 
Control Class I 2.9 zk 2.1 10.9 Z!! 7.0 87.8 * 5.3 96.0 * 1.3 
Class II 0.0 5 0 20.8 f 13 55.0 + 14.4 71.6 zt 9.2 
Aza dose was reduced in 3 patients due to transient change in AST/ALT (n = 
2) and WBC (n = 1). There were no differences in echocardiographic estimate 
of allograft stenosis between Aza (32 i 13 mm Hg, 13 * 4 months post-op) 
and control groups (25 f 4 mm Hg, 17 f 4 months post-op), or allograft 
valve insufficiency (Aza: 3 mild, 3 moderate; control: 4 mild, 3 moderate). 
Conclusions: Azathioprine does not significantly decrease the immune 
response to or affect the function of cryopreserved valved allografts used in 
children to repair congenital heart defects. 
I 1103 162 Ministernotomy for Repair of Congenital Heart 
Disease in Children 
Marcos Nores, Craig Sable, James Obney, Gerard Martin, Frank Midgely, 
Jeffrey Sell. Children’s National Medical Center, Washington, DC, USA 
Background: Benefits provided by minimally invasive cardiovascular surgery 
include decreased surgical trauma, less patient discomfort, earlier extubation, 
less bleeding, and shorter intensive care unit (ICU) and hospital stay resulting 
in a significant reduction in medical costs. These benefits prompted us to 
apply the ministernotomy to correction of congenital heart defects in children. 
Methods: Between November 1997 and August 1999 we approached 
several types of congenital heart disease through a ministernotomy. The 
incision consisted of a 1.5 to 2 inch surgical skin opening with the sternum 
partially split from an upper or lower approach depending on the procedure. 
Surgical procedure, perioperative course, length of stay, and complications 
were analyzed. 
Results: Ministernotomies were performed in 42 females and 30 males 
with an age of 4.1 j; 3.8 years (range 2 months to 19 years) and weight of 
18.2 f 16.7 kg. (range 3.3 to 91 kg.) Operative procedures included atrial 
septal defect closure (n = 40), ventricular septal defect closures (n = 24), 
sub-aotiic stenosis resection and myotomy (n = 3), right ventricle outflow tract 
patch angioplasty (n = 2), supravalvular aortic stenosis patch angioplasty (n 
= I), main pulmonary artery patch angioplasty (n = l), and mitral valve 
repair (n = 1). One patient required extension of the incision to the standard 
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median sternotomy. Cross clamp time was 30 & 17 minutes and bypass 
time was 56 & 23 minutes. Extubation occurred in the operating room in 
62 (86%) patients. The mediastinal drainage tube was removed within 24 
hours of the operation in 66 (91%) cases. ICU stay was 1.2 It 1 .O days; 67 
(93%) patients spent less than 24 hours in the ICU. Hospital admission was 
3.2 & 1.2 days; 55 (76%) patients were discharged home within 72 hours 
of surgery. There was no mortality. Complications occurred in 8 patients 
and included post-pericardiotomy syndrome (n = 3), excessive bleeding not 
requiring reoperation (n = I), supraventricular tachycardia (n = Z), sternal 
dehiscence (n = I), and superficial wound infection (n = I). 
Conclusions: The ministernotomy is a safe approach to repair of many 
congenital heart defects in children. This procedure promotes early extuba- 
tion, mediastinal tube removal, ICU transfer, and hospital discharge. 
1 1103-l 63 / VanPro Contegrd” Pulmonary Valved Conduit, 
Preliminary Results From a Multicenter, 
European Trial 
Rodolfo C. Quijano, Thomas Breymann, Carlo Marcelletti, Gail Macko, 
George Sarris, Ludwig von Segesser, Neil J. Weissman, Michal Wojtalik. 
For the VenPro Investigators; Herz-und Diabeteszentrum, NRW, Bad 
Oeyenhausen, Germany: Hesperia Hospital, Modena, ltaly 
Background: A variety of congenital pathologies involving the right ventricu- 
lar outilow tract require surgical correction. Research and development of the 
VenPro Contegra’“, a bovine jugular vein valved conduit, focuses on over- 
coming complications and/or restrictions inherent in composite conduits and 
homografts, such as correct size availability limitations, intimal peel, stenosis, 
reoperative events occurring as early a$ 3 months after implantation and an 
overall mortality rate reported as high as 25%. 
Methods: Serial echocardiography and hematology data collection points 
serve to evaluate safety and clinical performance of the conduit in a pediatric 
population (less than 20 years of age). Primary analysis includes endpoints 
of procedural success and freedom from serious adverse events. Long term 
safety and efficacy of the device is evaluated through patient contact intervals 
to one year. 
Results: Of the population (n = 36) reported procedural success of im- 
plantation is noted at 100% with no reoperation performed. With a mean 
contact point of 56.4 days (f26.2), 69% are considered event free. Events 
reported are non-device related and have occurred prior to discharge. (SVT, 
pneumonia (Z), bronchitis, gastroenteritis, high pulmonary resistance due 
to mechanical compression, residual stenosis of RPA) Overall mortality in 
four patients is noted at 11% with a 95% Cl (3.73, 26.49). No mortality is 
noted to be device related. Ninety (90)-day contact (n = IO) reveals one 
balloon dilatation of RPA stenosis 10%. ‘i80-day (n = 8) and one year (n = 
5) patient evaluaiions reveal neither serious adverse events nor hematologi- 
cal abnormalities. Core Lab review of echocardiography reveals absence of 
abnormalities in the prosthetic valvular function or mobility. 
Conclusions: Preliminary data collection and early trial results of the 
VenPro Contegra’” appear promising as an alternative to current therapy 
and available bioprostheses. Long-term follow up is ongoing and will be 
necessary to further evaluate safety and efficacy. 
/ 1103-l 04 Emergency Hospital Admission of Adults With Congenital Heart Disease, a Multicenter Study 
Sohrab Fratz, Harald M. Kaemmerer, Erwin Oechslin, Ulrike Bauer, 
Juraj Turina, Rolf Jenni, Peter Lange, John Hess. Deutsches Herzzentrum, 
Munich/Bed& Germany; Kantonsspital, Zurich, Switzerland 
Background: The number of adults with congenital heati disease (ACHD) 
is continuosly growing. Naturally also the number of emergency hospital 
admissions in this patient population is rising. The aim of this study was to 
determine the quantity, the reasons, and the nature of emergency situations 
that lead to an unscheduled hospital admission into a specialized center. 
Methods: During twelve consecutive months data of all ACHD (218 
years) that were acutely admitted to the one of the three participating centers 
was collected. 
Results: A total of 429 ACHD were 571 times admitted to the hospital. 122 
(21%) acute admissions were seen in 97 (23%) patients (pts) aged 18 to 72 
years (mean 34 * 13.1 years). The distribution of the underlying congenital 
heart disease was as follows: Fallot’s tetralogyipulmonary atresia (n = 31), 
univentricular heart after Fontan procedure (n = 23), atrial switch in complete 
transposition of the great arteries (n = 12), atrioventricular septal defect (n 
= 5), ventricular septal defect (n = 6), congenitally corrected transposition of 
the great arleries (n = 4). atrial septal defect (n = 18), others (n = 23). 62% 
of the admitted pts had been previously operated on. The indication for the 
acute hospital admission was: cardiovascular (n = 99, 81%) (dysrhythmia, 
acute heart failure, syncope, pacemaker problems, pericardial tamponade, 
sudden death), an Infection (n = IO. 8%) (cerebral abscess, endocarditis, 
pacemaker infection, pneumonia), acute chest pain (n = 7, 6%), or an acute 
abdomen (n = 6, 5%). All pts needed immediate emergency care, 30 pts 
(26%) underwent urgent surgery (heart, brain, or abdominal surgery). 6 pts 
deceased. The survivors were hospitalized for 8.9 f 11.4 days. 
Conclusion: ACHD can experience a broad number of serious emer- 
gency situations. Therefore management of this patient population is just 
successful if all associated specialities cooperate in a supraregional full ser- 
vice referral centre. 
[ 1103-l 65 1 Twenty-Year Experience With Anomalous Left 
Coronary Artery Arising From the Pulmonary 
Artery 
Jonah Odim, Vivik Allada, Hillel Laks. UCLA Medical Center, Los Angeles, 
California, USA 
Background: Anomalous left coronary artery arising from the pulmonary 
artery (ALCAPA) is associated with important left ventricular and mitral 
valvular dysfunction that requires prompt surgical attention. We reviewed 
retrospectively our institutional experience with this rare anomaly. 
Methods: Nineteen consecutive patients (median age, 7 months; range, 
1.3 months-24 years) underwent operations since 1978 to optimise coronary 
perfusion. 
Results: The repair consisted of ligation of LCA in a single patient, 
coronary re-implantation in 14 and intra-PA tunnel repair in 4. Five out of 19 
operations included concomitant mitral valve annuloplasty. Partial LV volume 
reduction was not performed in any case. LVAD support was required in 7 
infants (~6 months). Mean duration of LVAD support was 4.2 f 0.8 days 
(&SD). Mean hospital stay for LVAD supported patierits was 24.8 * 4.8 days. 
Mean hospital stay for all patients was 12.1 * 8.6 days. Two of 7 (28.6%) 
LVAD infants died early and long-term survival for this group was 71%. Eight 
infants, mean age of 3.8 (range, 1.3-5.8 months), required delayed sternal 
closure. Seven out of 8 (87.5%) survived. Mean preop EF was 25% (range, 
15-40%). Mean postop EF was 60% (range, 45f76%). Postoperatively, 12 
have no MR, 4 trace to mild MR and one patient has moderate MR. Two out 
of 17 long-term survivors have mild to moderate PS (mean peak gradient 33 
and 66 mm Hg). There were 2 early (10.5%) and I late (5.3%) death. Mean 
duration of follow-up was 90.7 (range, 22&250 months). 
Conclusions: Dual coronary system with direct re-implantation technique 
is preferable. Attention to optimal peri-operative myocardial protection is 
important. Mechanical circulatory support has a high salvage rate with good 
long-term recovery. Mitral valve and myocardial function normalizes in the 
majority of patients. 
I 1103 166 Systolic and Diastolic Function in Univentricular 
Hearts of Left Ventricular Morphology Pre- and 
Post-Fontan 
George G.S. Sandor, Angela Ryan, Derek G. Human, Michael 
W.H. Patterson, Jacques G. LeBlanc, Suvro S. Sett, James E. Potts. British 
Columbia’s Children’s Hospital and The University of British Columbia, 
Vancouver, B.C., Canada 
Purpose: This study compared systolic and diastolic function in 3 groups of 
patients with univentricular hearts (UVH) of left ventricular (iv) morphology. 
Methods: Gpl (Pre-Fontan with 2 Blalock-Taussig shunts (BT); n = 9); 
Gp2 (Pre-Fontan, post early BT, and bidirectional Glenn (BDG) shunt; n = 25); 
and Gp3 (post-Fontan (FON); n = 9). Twenty-two patients had classic tricuspid 
atresia (TA); IO had pulmonary atresia intact ventricular septum (HRH); and 
11 had UVH of LV morphology. During routine catheterization, with a hi-fidelity 
Millar catheter in the LV, a pulmonary artery angiogram was performed and 
the LV was filmed in the levophase with simultaneous pressure recording. 
From these pressure-volume data was calculated. Statistical analysis was 
performed using multivariate analysis of variance. 
Results: Mean ages and BSA were significantly different among the 
patients (BT > BDG > FON; p < 0.0001). Cardiac index was significantly 
lower in FON (2.3. vs 6.7, 5.8 I.min-’ , respectively; (p < 0.0001). Ejection 
fraction and end-diastolic pressure were similar among the groups. Peak 
+dp/dt (1173,825,710 mmHg.sec-‘) [Lab Normal (Norm) = 17801 and -dp/dt 
(1394, 1067, 1024 mmHg.sec-‘) [Norm = 23301 were significantly higher in 
BT (p < 0.01). Indexed end-diastolic volumes (132, 91, 64 ml.min-‘) [Norm 
= 751 and end-systolic volumes (55, 31, 26 ml.min-‘) [Norm = 191 were 
significantly higher in BT (p < 0.0004). Indexed LV mass (104, 82, 63 g.m-“) 
[Norm = 621 was higher in BT when compared to FON. (p < 0.01). MVCFc 
(0.85, 1.06, 0.74 circ.sec-I) [Norm = I.241 was higher in BDG compared to 
FON (p < 0.01). Stress at end-systole (219, 139, 153 g.cm-‘) [Norm = 1661 
was higher in BI (p < 0.002). Myocardial stiffness constant (KE) (16.4, 15.1, 
18.1) [Norm = II], operant chamber stiffness (b) (0.03, 0.06, 0.07) [Norm 
= 0.0341, and the time constant of relaxation (tau) (33, 30, 39) [Norm = 291 
were similar among the 3 groups of patients. 
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Conclusions: Avolume-loaded LV from 2 BTshunts increases LVvolume 
and mass, compromises systolic function, and does not normalize wall stress. 
A bidirectional Glenn has a lesser effect on LV volume and systolic function, 
while post-Fontan hearts have smaller volumes and masses, as well as a 
decrease in selected indices of systolic function. All 3 groups have abnormal 
passive diastolic function. 
ORAL 
Pediatric Cardiac Surgery II 
Monday, March 13, 2000, 2:00 p.m.-3:30 p.m. 
Hilton Anaheim, California A 
2:00 p.m. 
I 851 1 Incidence of Unexpected Death After Palliative 
Surgery for Hypoplastic Left Heart Syndrome 
William T. Mahle, Thomas L. Spray, J. William Gaynor, Bernard J. Clark. 
Children’s Hospital of Philadelphia, Philadelphia, PA, USA 
Background: Unexpected sudden death (UD) is a known complication after 
surgery for congenital heart disease; the reported incidence ranging from 0 
to 5.5/l ,000 pt-yrs. Little information is available regarding the incidence of 
and risk factors for UD in pts with hypoplastic left heart syndrome (HLHS). 
Methods: We recently completed follow-up evaluation of 840 pts who 
had undergone palliative surgery for HLHS at our institution between l/84 
and i/99. Using the existing database, we identified all patients who were 
discharged to home after stage I surgery and had subsequent UD. UD was 
defined as cardiovascular collapse from which the patient never regained 
consciousness. Medical records were reviewed and compared to data from 
53 additional, randomly selected survivors of stage I surgery in a nested 
case-control fashion. 
Results: UD occurred in 26 of 533 pts (4.9%) who were discharged 
to home after stage I surgery; the incidence was 11.2/1,000 pt-yrs. The 
median age at UD was 92 days, range: 25-1392 days. The majority of UD 
events (22/26) occurred after initial palliative surgery. In 4 pts UD occurred 
aider subsequent staging procedures. Autopsy reports were available for 12 
pts and identified residual lesions in 2 pts: obstruction of aortico-pulmonary 
shunt in 1 and obstruction of cave-pulmonary anastomosis in 1. Clinical 
history suggested the cause of death in 6 additional cases: seizure in 3 
pts and witnessed ventricular arrhythmia in 3 pts. In 18 pts clinical history 
and/or autopsy could not identify a clear etiology. Pre-existing ventricular 
dysfunction was present in only 2 of 26 pts. No pt was being treated for 
ventricular arrhythmia at the time of death. In the case-control analysis 
none of the variables including anatomic subtype, presence of aortic atresia, 
year of surgery, ventricular function, history of seizures or history of feeding 
difficulties was associated with UD. 
Conclusions: The incidence of UD in pts with HLHS is higher than that 
reported for other repaired congenital hear-l lesions and is greatest in the 
first months of life. The etiology of UD in this population is largely unknown. 
Further investigations into the mechanisms and preventive strategies for UD 
are warranted. 
215 km. 
r-I.. 851 2 Hypoventilation Improves Oxygenation After Btdirecttonal Superior Cavopulmonary Connection 
Scott M. Bradley, Janet M. Simsic, Denise M. Mulvihill. Medical University of 
South Carolina, Charleston, South Carolina, USA 
Background: Bidirectional superior cavopulmonary connection (BSCC) may 
be complicated by hypoxemia. Hyperventilation (hypocapnia) has previously 
been shown to impair oxygenation after BSCC. It is unknown whether the 
converse approach, hypoventilation (hypercapnia), improves oxygenation. 
We prospectively studied the effects of hypoventilation in IO patients within 
8 hours of BSCC. 
Methods: Patients were mechanically ventilated, on 100% oxygen and 
no PEEP. Median age was 8.7 months (range 6.1-15.5). Diaghoses were 
hypoplastic left heart syndrome (5), tricuspid atresia (2) pulmonary atresia 
(I), unbalanced AV canal (1) and DORV with mitral stenosis (1). Cerebral 
blood flow velocity was measured by transcranial Doppler of the anterior 
or middle cerebral artery. Hypoventilation was induced by decreasing the 
ventilator rate. To avoid acidosis during hypoventilation, sodium bicarbonate 
(4 mEq/kg) was given prior to hypoventilation. Patients were studied at 3 time 
points: baseline (Time 1; mean ventilator rate = 20); after being given sodium 
bicarbonate (Time 2; mean ventilator rate = 20); and during hypoventilation 
(Time 3; mean ventilator rate = 14). 
Results: are shown in the table. Hypoventilation after treatment with 
bicarbonate produced hypercapnia without acidosis (Time 3). Hypoventilation 
significantly increased systemic ~02, oxygen saturation and cerebral blood 
flow velocity (Time 3). 
mle PO2 02 sat CBFV pco2 PH 
(km) W (cm/set) (tom) 
1 (Baseline) 5Ozt6 86 * 7 36zt13 44f6 7.40 i 0.02 
2 (Bicarb) 5o*a 88zt6 43523 47*7* 7.47 * 0.03’ 
3 (Hypovent) 62 f 8’ 90 l 5* 51 i21’ 6OhlO” 7.36 5 0.04’ 
Values are Mean + SD. CBFV = cerebral blood flow velocity. *P < 0.05 vs. Time 1 
(ANOVA). 
Conclusion: Hypoventilation improves oxygenation after BSCC. The in- 
crease in pO2 may be due to hypercapnia increasing cerebral blood flow, 
in turn increasing flow through the superior vena cava and the pulmonary 
vascular bed. Hypoventilation may be particularly useful in patients who are 
hypoxemic after BSCC. 
2:30 p.m. 
I 851 3 Intermediate Term Follow-Up of the End-to-Side Aortic Anastomosis for Coarctation of the Aorta 
Adel K. Younoszai, V. Mohan Reddy, Frank L. Hanley, Andrew J. Party, 
Michael M. Brook. Universify of California San Francisco, San Francisco, 
California, USA 
Background: Most techniques for repairing coarctation of the aorta, including 
the extended end-to-end anastomosis, incorporate abnormal tissue in the 
final repair with a significant incidence of recurrent obstruction requiring 
intervention. By connecting the descending aorta to the proximal aortic arch, 
the end-to-side aortic anastomosis (ESAA) eliminates all ductal, hypoplastic 
and distal arch tissue. This study reviews our experience with the ESAA. 
Methods: Clinical course and echocardiographic data for all patients who 
underwent an ESAA via a lateral thoracotomy from 1992 until present were 
reviewed. A 20 mmHg or greater gradient between the right arm and a lower 
extremity on clinical exam and a flow velocity of 2.5 meters/second (m/s) or 
greater across the area of repair by Doppler interrogation was considered 
evidence of a recurrent obstruction. 
Results: 106 patients underwent the ESAA over the last seven years. 
Follow-up data were available on 76 (48 male, 28 female) with a median 
follow-up interval of 1.9 years (range: 0.1-6.3). The patients were divided 
into two groups based on age at operation. Group A included 48 patients 
that had the ESAA performed within the first 3 months of life. Group B 
consisted of 28 patients operated on after 3 months of age (range: 3.6 
months-14.6 years). A significant blood pressure difference was found in 
one patient in group A and none in group B. 41 patients in group A had an 
echocardiogram performed a median of 0.8 years post-operatively (range 
0.1-5.3). Of those, 3, including the patient with the clinical gradient, had a 
significant flow velocity (2.5, 3.0, and 3.2 m/s). 23 patients in group 6 had an 
echocardiogram a median of 2.1 years later (range 0.1-6.3). Of those, 2 had 
an increased velocity (2.5 and 2.6 m/s). Overall, only one patient out of both 
groups (1.3%) had corroborative evidence of mild recoarctation. No patient 
has required intervention. 
Conclusion: The ESAA through a lateral thoracotomy is an effective 
repair for coarctation of the aorta. Recurrence of coarctation, even when per- 
formed in the neonatal period, is rare and has not been clinically significant. 
2:45 u.m. 
851-4 Preoperative Identification of Coronary Artery Origin 
and Distribution is Unnecessarv Prior to the Arterial 
Switch Operation 
Howaida El-Said, Timothy F. Feltes, Carmen Watrin, Elizabeth Hess, 
Charles D. Fraser. Baylor College of Medicine/Texas Children’s Hospital, 
Houston, Texas, USA 
Background: Correlation between coronary artery (CA) origin/distribution 
pattern and arterial switch operation (ASO) outcome has made preopera- 
tive identification of coronary anatomy (echocardiography or angiography) 
standard practice. 
Purpose: 1) assess accuracy of preoperative CA evaluation 2) assess 
impact of CA distribution patterns on AS0 outcome. 
Methods: Records of all pts referred for AS0 at our institution between 
8/95 and 2199 were reviewed. lntraoperative CA origin/distribution findings 
and preoperative echocardiographic i angiographic data were abstracted. 
The Yacoub classification of CA origin/distribution was utilized. 
Results: 53 pts were referred for ASO. Median age was 9d (3d-15 
mo). Primary cardiac diagnosis included: TGA/IVS (33), TGA/VSD (17) 
TGAIDORV (3). Balloon atrial septostomy was performed in 48/53 pts prior 
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to AS0 (22 with bedside, echocardiographic guidance). lntraoperative CA 
findings were as follows: type A (35 pts, 66%), type B (3 pt, 6%), type D (9 
pt, 17%) and type E (5 pts, 9%). 52/53 pts (98%) had adequate echocardio- 
graphic studies to assess CA origin/distribution. In 43152 pts (83%) echocar- 
diographic description of the CA classification matched the intraoperative 
findings. I/3 type B pts were misdiagnosed. Of the 26 pts who underwent 
coronary angiography, 22 (85%) had operative-angiography correlation. An 
AS0 was successfully performed in all 53 pts using a modified Lecompte 
maneuver. 1 pt with single CA ostium + type B distribution pattern required 
RIMA to RCA bypass due to RCA obstruction. 30 d mortality = 0%. 
Conclusion: Ail CA origin/distribution patterns are “switchable”. Preoper- 
ative echocardiographic evaluation alone offers satisfactory assessment of 
CA origin/distribution in the infant referred for the AS0 thus making preoper- 
ative coronary angiography unnecessary. 
3:00 p.m. 
851-5 Influence of Coronary Anatomy and Re-implantation 
on the Long-Term Outcome of the Arterial Switch 
Paul A. Hutter, Lamise Ay, llse 8. Raes, Ger B.W.E. Bennink, Thijs 
W. Plokker, J. Francois Hitchcock, Erik J. Meijboom. Universify Medical 
Center; Utrechf, the Netherlands 
Background: Abnormal coronary artery anatomy (CAA) is reported to have 
a significant influence on the outcome of the arterial switch operation (ASO). 
This study examines the impact of CAA and the occurrence of late coronary 
obstruction on the left ventricular (LV) function and long-term outcome. 
Methods: CAA of 147 pts after AS0 (1977-l 998), was determined based 
on operative reports and pre-operative aortograms. Current status was eval- 
uated using ECGs, echocardiograms, scintigraphy, and post-operative coro- 
nary, angiograms. 
Results: In 117 pts, CAA consisted of an anterior descending (LAD) 
and circumflex artery (Cx) from the left cusp and the right coronary artery 
(RCA) from the right or posterior cusp. 12 had the LAD from the left and 
Cx and RCA from the right cusp. 7 had LAD and RCA from one cusp and 
Cx from the other. 4 had single ostium, and 3 had three separate ostia. 3 
pts had complex patterns and 1 pt had a supra commisural coronary. To 
date, in 54 pts follow-up angiography was performed. Surgical coronary se- 
quellae were found in 5 pts. 2 pts had an occluded lefl ostium. Initially, they 
were asymptomatic but showed polymorphic VES on ECG and moderate 
LV dysfunction with large irreversible perfusion defects on scintigraphy. Both 
developed ventricular fibrillation at the age of 14 years. 1 pt did not survive. 
The other pt required implantation of a defibrillator, I pt had occluded RCA, 
1 has stenosis of the right ostium, and 1 has multiple tortuous collaterals 
without obstruction of a major branch. In the latter 3 pts, coronary, sequellae 
were not suspected on ECG, echo, or scintigraphy and were only found on 
follow-up angiography. Retrograde collateral flow was noted in all 3 occluded 
coronaries. LV dysfunction with normal coronaries was noted in 3 pts. All, 
of these pts, had peri-operative ischaemia suggesting failure of myocardial 
protection. Two are now a symptomatic with mild LV dysfunction. One pa- 
tient continues to have severe myocardial dysfunction and secondary aortic 
insufficiency. A Ross-like procedure was performed placing the original aor- 
tic valve in the neo-aortic root. CAA did not influence early survival or late 
coronary sequellae. 
Conclusion: Abnormal coronary anatomy was not a determinant of out- 
come in our study. Surgical coronary obstruction is independent of original 
anatomy. It can be almost silent and is potentially fatal. Follow-up angiogra- 
phy must be considered in all patients after the arterial switch operation. 
3:15 p.m. 
/ . 851 6 A Novel Combined Approach to Severe Pulmonary Atresta and Ventricular Septal Defect in Infancy 
Results in improved Outcome 
Kagami Miyaji, Redmond P. Burke, Robert L. Hannan, Albert0 Justiniano, 
Evan M. Zahn. Miami Children’s Hospital, Miami, FL, USA 
Background: Pulmonary atresia, ventricular septal defect, diminutive pul- 
monary arteries (PA), and multiple aorto-pulmonary collaterals (MAPCAs) is 
still associated with high morbidity and mortality. We hypothesized that very 
early surgical and catheter intervention designed to maximize growth of the 
central PA and eliminate competitive sources of pulmonary blood flow would 
allow for successful complete repair at a young age. 
Methods:Since June 95, all infants (n = 15) presenting with this lesion 
underwent right ventricular outflow tract reconstruction (RVOTR) as initial 
palliation. Unifocalization of MAPCAs was not performed irrespective of flow 
distribution or degree of central PA hypoplasia. RVOTR was performed using 
trans.-annular patch (8), homograft implantation (3), or trans-catheter valvo- 
tomy (4). Early (median age 9 months) interventional catheterization was 
performed to enlarge central PA size, relieve distal stenoses, and eliminate 
MAPCAs. Ventricular septal defect closure (complete repair) was performed 
when the central PA supplied enough unobstructed lung segments to predict 
a post-operative right ventricular/systemic pressure ~60%. 
Results: Prior to RVOTR, Nakata index was 48 mm2/M2 (range 14-90) 
and z-scores for right and left PA were -5.4 i 1.5 and -4.6 + 1.9, respec- 
tively. RVOTR was performed at an average age of 2.8 f 4.6 months and 
weight of 4.2 * -2.1 kg. Following final intervention prior to complete repair, 
Nakata index and right and left PA z-scores increased to 243 mm’/M’ (range 
77-344), -0.4 f 1.2 and co.3 & l:l, respectively (p < 0.01). Twelve patients 
have had complete repair (median age 17 + 13 month) and are awaiting 
surgery. One patient, whose central PA remained severely hypoplastic, un- 
derwent successful unifocalization and is awaiting complete repair. At latest 
follow-up average right ventricular/systemic pressure was 0.47 * 0.13 and 
all patients were asymptomatic. There has been one re-operation for conduit 
stenosis and no early or late mortality. 
Conclusion: Early RVOTR and interventional catheterization during in- 
fancy results in impressive central and peripheral PA growth that allows for 
early complete repair of severe pulmonary atresia, ventricular septal defect. 
This combined algorithm reduces the need for complex unifocalization proce- 
dures and eliminates reliance on inherently abnormal MAPCAs for pulmonary 
blood flow. Longer follow-up is neeicled to determine if long-term survival and 
quality of life are improved using this new approach. 
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L-l! 1124 160 Quantification of Pulmonary Regurgitation From Pulmonary and Aortic Stroke Volumes 
Determined Using a 3 Dimensional Digital Color 
Doppler Method in a Chronic Animal Model 
Yoshiki Mori, Xiang-Ning Li, Timothy Irvine, Michael Jones, 
Vandana Sachdev, Arthur D. Zetts, Paul R. Detmer, Dan Lennon, 
Antoinette Kenny, David J. Sahn. Oregon Healfh Sciences University, 
Port/and, OR; NHLBI, Bethesda, MD, USA 
Background: Accurate noninvasivle quantification of pulmonary regurgitation 
has been difficult using standard echo Doppler methods. It is important 
clinically in pulmonary hypertensive or post-op CHD patients who require 
serial evaluation of right heart function. In this study, pulmonary regurgitation 
was quantified from pulmonary and aorlic stroke volumes, obtained using a 
new 3D digital color Doppler technique. 
Methods: Eight sheep, with chronic surgically induced pulmonary regur- 
gitation (regurgitant fractions 6 to 76%), had aottic Ao and pulmonary artery 
PA electromagnetic (EM) flow meters balanced against each other so that 
forward minus reverse PA EM flow equalled Ao EM flow. Physiology was 
altered by administration of blood, angiotensin and sodium nitroprusside to 
give a total of 29 hemodynamic states. Rotational 3D Doppler scans of pul- 
monary and aortic flow were performed using a multiplane TEE probe placed 
epicardially, interrogating parallel to the direction of flow. Following digital ve- 
locity data transfer from an ATL HDl5000 system to a SGI computer, analysis 
of the 30 flow reconstructions was performed perpendicular to the direction 
of flow to determine flow velocity, area and profile for Ao and PA forward flow. 
Results: The pulmonary regurgitant volume was calculated from the 3D 
data by subtracting the computed aortic stroke volume from the pulmonary 
stroke volume. There was good correlation with the EM regurgitant volume 
calculated in a similar fashion (r = 0.83, SEE 3.6 ml/beat). The 3D derived 
regurgitant fraction (regurgitant volume divided by pulmonary stroke volume) 
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also correlated closely with that derived from the reference data (r = 0.87, 
SEE 8%). 
Conclusion: Our in vivo study suggests that this new noninvasive method 
could be applied clinically to accurately quantify pulmonary regurgitation. 
I 1124 161 Power Angio Mode Images of the Fetal Heart Provide Helpful 3D Views of Great Artery 
Anatomy and Relationships 
Katherine M. Mizelle, Christopher P. Marcella, Robert W. McDonald, Anita 
M. Chambers, Randal L. Imus, Vicki L. Norka, Mary J. Rice, David J. Sahn. 
Oregon Health Sciences University: Portland, OR; Siemens Ultrasound, 
Issaquah, WA, USA 
Background: Great artery and “arch” views are oflen the most difficult to 
acquire during fetal echo studies. 
Methods: We used an onboard 3D acquisition and display method im- 
plemented on a Siemens Elegra@ scanner to acquire color encoded power 
angio mode vascular and chamber images in 14 normal fetuses and 5 with 
prenatally diagnosed heart disease. For acquisition, rapid (2-4 set) non- 
gated 45” rocking hand-held sweeps of a 3.5-6 MHz curved array were 
accomplished scanning across the fetal heart area; speed and progress of 
the sweeps were coordinated with an onboard guidance cursor, gradually 
generating a fan. Once completed, the 3D could be analyzed onboard with 
anyplane navigation of the cardiac anatomy with three views displayed at 
any one time. A 3D volume object of the power angio information could also 
be displayed and rotated, thresholded, and the shading cosmetic altered to 
improve perception. 
Results: For the 14 normal fetuses, the aortic arch could be developed 
in 3D space quickly and rapidly in all, regardless of fetal lie. The pulmonary 
artery including the ductal arch and branch PAS could be visualized in 12 
of the 14 along with the aottic arch. For 5 abnormal fetuses: 2 with single 
ventricle and transposition, 1 with tricuspid atresia, and 2 each with tetralogy, 
the great artery relations were also clearly defined - more clearly and more 
quickly than they had been by 2D and 2D color Doppler imaging. 
Conclusion: 3D power angio visualization of great artery anatomy, even 
without cardiac gating, can be perfomed from rapid guided sweeps of the 
image plane and provides helpful visualization of great artery, ductal and 
aortic arch anatomy. 
1124-I 62 Impact of Telemedicine on the Practice of 
Pediatric Cardioloav in a Communitv HosDital 
Neonatal Unit -- 
_ . 
Craig Sable, Matthew Picard’, Sharon Kiernan’, Steve Wyner’ , 
Jane1 Hino’, Beverly German’ , Lynn Sheller’, Gail Pearson, Eric Quivers, 
Lorraine Schratz, Susan Cummings, Gerard Marlin. Children’s National 
Medical Center, Washington, DC; Holy Cross Hospital, Silver Spring, MD, 
USA 
Background: Real time telemedicine (TM) transmission of neonatal echocar- 
diograms (ethos) has been shown to be of diagnostic quality. We evaluated 
the impact of TM on delivery of pediatric cardiology care in a community 
hospital neonatal unit. 
Methods: A desktop personal computer, capable of transmitting live 
ethos over 3 ISDN telephone lines, was installed in a community hospi- 
tal with capability of transmitting from a level Ill neonatal intensive care unit 
(NICU) or a well baby nursery. Studies were interpreted, additional views 
suggested, and management recommendations made in real time by a pedi- 
atric cardiologist 15 miles away. Utilization of echocardiography (echo) and 
referral patterns after the installation of TM was compared to the twelve 
months prior to installation. Accuracy of TM, impact on pediatric cardiologist 
time management and revenue were analyzed prospectively. 
Results: Between April 1998 and August 1999, 206 TM transmissions 
were performed in 148 patients. 80% of ethos were transmitted from the 
NICU and 20% from the well baby nursery. Indications for echo were sus- 
pected congenital heart disease (n = IOO), patent ductus arteriosus (n = 
88), pulmonary hypertension (n = 9), and clot/vegetation (n = 9). Diagnoses 
included congenital heart disease (n = 45), patent ductus arteriosus (n = 42), 
and normal (n = 98). TM diagnoses were confirmed by review of videotape 
in all studies. Utilization of echo before (36 echos/l,OOO births) and after (42 
echodl,OOO births) TM installation was not significantly different. The per- 
centage of neonatal ethos that were interpreted by our practice increased 
from 63% to 81% (p < 0.001) after the installation of TM. Teleconference 
time averaged 20 f 7 minutes. TM resulted in an estimated timesaving to our 
practice of 3.9 person-hours per week from averted (n = 69) and delayed (n 
= 21) consultations. Hospital charges from echo and patient care after trans- 
port ($1 ,OOO,OOO) greatly exceeded the total cost of TM equipment ($25,000 
for 2 sites) and 3 ISDN lines ($132/month). 
Conclusions: Availability of TM echo in a community hospital does not in- 
crease utilization of echo, increases referral of patients, improves cardiologist 
time management, and is cost-effective. 
I 1124 163 The Role of Harmonic Imaging in Pediatric Echocardiography 
Colin J. MC Mahon, Crystal M. Menzel, Carolyn A. Altman, Nancy A. Ayres, 
Ricardo H. Pignatelli, John P. Kovalchin. Texas Children’s Hospital, Baylor 
College of Medicine, Houston, Texas, USA 
Background: Noncontrast harmonic imaging (HI) has been shown to im- 
prove echocardiographic image quality in adults with poor acoustic windows. 
Echocardiography in some children may also be limited by poor acoustic 
windows. The role of HI in pediatric echocardiography has not previously 
been evaluated. The purpose of this study was to compare the quality of 
fundamental imaging (FI) and HI in children with poor acoustic windows. 
Methods: Fifty-seven children (median age 10.2 years, range 0.1-17.6) 
with poor acoustic windows had echocardiograms performed with both Fl 
and HI using the Acuson Sequoia imaging system (Mountainview, CA). Endo- 
cardial and valvar definition was graded as 0 to 3 (O-no, i-poor, 2-fair, 3-good 
visualization) with FI and HI in parasternal (PS) long-axis, PS short-axis, api- 
cal four-chamber, subcostal and suprasternal notch views by 2 reviewers in 
a blinded fashion. Reviewer scores were averaged and compared between 
FI and HI. 
Results: Data are presented as mean + SD. 
Table: Comoarison of FI and HI Scores 
View FI Score HI Score D value 
PS long-axis 
PS short-axis 
Apical 4-chamber 
Subcostal 
Suw&emal notch 
1 .I f 0.5 2.1 * 0.6 p < 0.0001 
1.2 A 0.6 2.1 * 0.5 p < 0.0001 
1.2 -c 0.5 2.2 f 0.5 p < 0.0001 
0.7 * 0.5 1.4 f 0.7 p < 0.0001 
1 .o * 0.7 1.7zkO.6 13 < 0.0001 
Mean HI scores were higher than mean FI scores for all views. The image 
quality of the endocardium and valves was enhanced by approximately 1 
grade with HI over FI, with more of an increase in the parasternal and apical 
4-chamber views than in the subcostal and suprasternal notch views. 
Conclusion: Harmonic imaging improves image quality over fundamental 
imaging in children with poor acoustic windows, and harmonic imaging is a 
useful adjunct to fundamental imaging in pediatric echocardiography. 
I 1124 164 Development of a Non-Invasive Ultrasound Color M-Mode Means of Estimating Pulmonary 
Vascular Resistance in Pediatric Pulmonary 
Hypertension 
Robin Shandas, Ewen Nicol, Craig Weinberg, Curt DeGroff, Jean Hertzberg, 
Dunbar Ivy, Lilliam Valdes-Cruz. The Children’s Hospifa/, Denver, CO, USA 
The use of vasodilatory agents such as inhaled nitric oxide (NO) to reduce 
pulmonary vascular resistance (PVR) has shown promise in the treatment of 
pediatric pulmonary hypertension (PPHT). However, the lack of an accurate 
non-invasive means of estimating PVR has severely hampered evaluation of 
clinical efficacy. 
Methods: We hypothesized that acute changes in PVR would cause 
concomitant changes in the speed of the pressure pulse propagation wave 
(PPW) within the main PA, and that these changes would be reflected via the 
Bernoulli principle by changes in the centerline velocity trace along the PA. 
An estimate of PVR should therefore be possible by measuring the velocity 
propagation (Vel,,,) slope using ultrasound color M-mode imaging of flow 
along the centerline of the main PA. This hypothesis was tested using math- 
ematical modeling and in vitro simulation of pulsatile flow within an elastic 
tube under varying downstream resistances, and in the clinical situation for 
15 patients with PPHT where PVR was lowered in the catheteriz,ation lab- 
oratory using NO or 100% 02. PVR was obtained clinically using standard 
catheterization techniques. 
Results: The mathematical model revealed that no differences in phase 
between the velocity and pressure tracings, indicating that velocity follows 
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PPW closely. Color M-mode results from the in vitro study showed that Velprap 
measured from the slope of the Nyquist color change is an excellent predictor 
of PVR (Figure). Clinically, Velprop was significantly different for the low versus 
high PVR conditions (mean Vel,,, = 153.2 f 36.2 cm/set - PVR < 5 Wood 
Units (Wu); mean Vel,,, = 89.4 ZL 22.3 cm&c - PVR > 8 Wu; p c 0.01). 
Conclusions: PF’W speed along an elastic artery changes as a function 
of downstream resistance. Velocity propagation along the main PA appears 
highly correlated to the pressure pulse propagation wave. Color M-mode is 
an accurate means of measuring velocity propagation. Velprap derived from 
color M-mode is a good predictor of PVR in the clinical setting. This technique 
should be extremely useful in routine follow-up of patients with PPHT and to 
assess treatment efficacy of pulmonary vasodilators. 
/ 1124 I65 Contrast Echocardiography vs. Cardiac Catheterization for Detection of Pulmonary 
Arterio-Venous Malformatians 
Jeffery Feinstein’ , Phillip Moore, David F. Teitel, Michael Pulchalski, 
Michael M. Brook. ‘Slanford University; University of California, San 
Francisco, USA 
Background: Pulmonary arterio-venous malformations (PAVMs) develop 
in some patients who have undergone cavopulmonary (Glenn) shunts. As 
clinical diagnoses of PAVMs is difficult, and cardiac catheterization (cath) 
invasive; contrast echocardiography (C-echo) has been utilized to aid in the 
diagnosis. Correlation between C-echo and cath in these patients remains 
poorly defined. 
Methods: We compared pulmonary vein (PV) oxygen saturation, pul- 
monary artery angiography (angio) and pulmonary artery C-echo in ail pa- 
tients status-post Glenn shunt who had selective pulmonary artery C-echo 
during cath. Angio and C-ethos were reviewed by blinded observers. An 
additional group of two ventricle patients were evaluated with C-echo during 
cath as a control. 
Results: Between 1995 and 1998, 27 patients were studied after Glenn 
shunt. The median age at cath was 3.2 years (range 0.45-36), and systemic 
saturation was 84% (range 69-89%). c-echo opacification of the left atrium 
was present in 30 of 50 lungs (60%); 12 were I+ (occasional return to the LA), 
7 were 2+ (moderate filling) and 11 were 31 (complete filling). PVdesaturation 
was found in 13 of 45 lungs sampled (29%). Desaturation was mild (290% 
< 95%) in 5, moderate (285% -< 90%) in 4 and severe (~85%) in 4. Only 
12/30 lungs with positive C-echo had PV desaturation, but only one patient 
had mild PV desaturation without positive C-echo. Degree of desaturation 
did not correlate with severity of C-echo return; 6111 with 3+ C-echo studies 
had normal PV sat. Angio showed PAVMs in 35 of 48 lungs (73%) and was 
graded as mild in 18, moderate in 12 and severe in 5. In a control group of 
two ventricle patients only l/l 9 (5.3%) C-echo injections showed I+ filling of 
the LA. 
Conclusions: C-ECHO correlates poorly with angio and PV sat for eval- 
uation of PAVMs. C-echo is extremely sensitive, and often present despite 
normal PV saturation. Occasional l+ return can be seen in the absence of 
PAVMs. PV sampling appears insensitive for diagnosing significant PAVMs. 
Assessment of PV desaturation in 100% Fi02 may improve its sensitivity 
and correlation with C-echo. 
1124-l 66 Multimodality Real Time 3D imaging Color 
Doppler Method for Evaluation of RV Function 
and Pulmonary Regurgitant Flow: An In Vivo 
Study on a Chronic Animal Model 
Petra S. Mehwald, Timothy Irvine, Rosemary A. Rusk, Yoshiki Mori, 
Michael Jones, Arthur D. Zetts, Vandana Sachdev, Julio A. Panza, David 
J. Sahn. Oregon Heaifh Sciences Universifl: Portland, OR: N/-LB/, 
Bethesda, MD, USA 
Background: Characterization of RV function and the amount of pulmonary 
regurgitation is an important aspect of post-operative evaluation for diseases 
like TOF and for patients with pulmonary hypertension. We tested the Real 
Time 3D Volumetrics@ scanner integrated 3D color Doppler imaging in an 
animal model of chronic pulmonary regurgitation to assess its ability to 
characterize RV stroke volumes and pulmonary regurgitant flow fraction. 
Methods and Results: Eight open-chest sheep were scanned with epi- 
cardial transducer (2.5 MHz) placement. Separate real time 3D loops (1 for 
the RV and another with color Doppler for the PA) were acquired over 32 
study states. Results were compared to electromagnetic flowmeters on the 
aorta and pulmonary artery balanced against each other so that pulmonary 
forward minus reverse flow equalled aortic flow. The RV volumes in diastole 
and systole were measured off-line from rotated multiple B scan 30 images. 
Stroke volumes (13-48 cc) calculated from RVEDV-RVESV correlated well 
with EM (r = 0.75, SEE = 5.49 cc), RV ejection fractions (EF) ranged from 
53-85%. The pulmonary forward flows and reverse flows were measured 
from color images sampled over a narrow pyramidal area in 3D space and 
Interrogated parallel to the direction of flow. Color Doppler results were ana- 
lyzed as color flow cross-sections just under the pulmonay valve. For forward 
and reverse flows aliasing limit was aitered to determine velocities. Maximum 
flow areas of forward and reverse tlows were then measured and expressed 
as a ratio which also had an excellent correlation to EM regurgitant fraction 
values (r = 0.94 over a range of RF 3-71%). 
Conclusion: This real time method allowed accurate characterization of 
stroke volumes and ejection fractions as well as an accurate estimate of 
pulmonary regurgitation seventy. 
CIRAL 
/859/ Pediatric Echocardiography and Magnetic 
Resonance lmagling 
Monday, March 13, 2000, 4:00 p.m.-5:30 p.m. 
Hilton Anaheim, California A 
4:00 p.m. 
increased Right Ventricular Outflow Tract (RVDT) 
Conduit Stiffness With Minimal Lumen Narrowing 
Produces Siqnificant Pressure Gradients snd 
Dverestimat&n of Gradients by Doppler: An In Vitro 
Study 
Suthep Wanitkun, James F. Pierce Ill, Yoshiki Mori, Rosemary A. Rusk, 
George D. Giraud, Susan L. Martin, David J. Sahn. Oregon Nealtb Sciences 
University, Portland, OR, USA 
Background: Pressure gradients and CW Doppler estimated gradrents in 
patients with conduits are often higher than the angiographic severity of the 
obstruction would suggest. 
Methods: Our study determined the effect of conduit wdll stiffness on 
production and estimation of pressure gradients across a model of an RV-PA 
conduit with a pulmonary valve ring 15% smaller than the conduit diameter 
and a 10 cm long conduit with 3 differing stiffness (B) indrces: 6.77 (stiff), 5.06 
(moderate), and 3.61 (compliant). The model was connected to a pulsatile 
flow pump with stroke volumes 20-60 ml/beat, 60 beatsimin. Siniultaneous 
catheter pressure recordings were obtained at the RVOT and mid portion of 
the conduit, along with proximal flow velocity (VI) and the peak maximal CW 
velocity across the condull (V2). 
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Results: At any given flow rate, pressure proximal to and gradient across 
the stiff conduit was highest, p < 0.001. Also, CW Doppler overestimated 
pressure gradients across all the conduits, most severely for the stiff one. In- 
corporating VI into the Doppler estimation lessened Doppler overestimation 
only modestly. 
Conclusion: Increased stiffness of an RVPA conduit alters pressure 
pulse wave propagation and increases generation of gradients and their 
overestimation by Doppler. 
4:15 p.m. 
I 859 2 Four Dimensional Magnetic Resonance Imaging of 
Congenital Heart Disease 
G. Wesley Vick Ill, Raja Muthupillai, Carolyn A. Altman, Roxann Rokey. 
Baylor College of Medicine, Houston, TX; Marshfield Cbnic, Marshfield, WI, 
USA 
Background: Three dimensional display methods are sometimes employed 
to demonstrate congenital cardiovascular malformations. However, the im- 
portant temporal movements of cardiac and vascular structures are not well 
defined by standard three dimensional techniques. We have developed com- 
puter procedures for four dimensional display of magnetic rebonance imaging 
datasets that facilitate visualization of these complex disorders. 
Purpose: To assess four dimensional computer display methods in the 
evaluation of congenital heat-t disease. 
Methods: Multiphasic bright blood segmented gradient echo magnetic 
resonance slab data sets were acquired with individually thin contiguous or 
overcontiguous slices. High performance magnetic field gradient coils were 
employed to minimize the number of shots per acquisition. Echo times were 
varied to optimize contrast effects from turbulent blood flow. After acquisi- 
tion, images were electronically reordered into separate three dimensional 
blocks for each cardiac phase. The blocks were then individually projected or 
rendered in each of multiple orientations. Multiple projection and rendering 
techniques were employed, including maximal intensity projection, shaded 
surface display, image order rendering, and object order rendering with spe- 
cialized texture mapping graphics hardware. Corresponding projections or 
renderings of each phase block were automatically performed in sequence 
to simulate the phasic motion of the original cardiovascular structures. Over 
200 studies were performed with these methods. Malformations included 
tetralogy of Fallot, pulmonary atresia, partial and total anomalous pulmonary 
venous connections, single ventricle pre and post Fontan, coarctation of 
the aolta, ascending and descending aortic aneurysms, and heterotaxy syn- 
dromes. 
Results: The four dimensional displays were compared to standard dis- 
plays. In every case, the four dimensional displays provided additional infor- 
mation by facilitating delineation of the extent of cardiovascular phasic motion 
and by facilitating differentiation of overlapping structures. Four dimensional 
displays of excellent quality were generated automatically and with minimal 
human interaction. They did not require additional patient imaging time. 
Conclusion: Four dimensional displays of magnetic resonance datasets 
are an important enhancement of representational imaging. They should be 
routinely employed in the study of congenital cardiovascular malformations. 
4:30 p.m. 
/ 859 3 Initial Clinical Experience With Pediatric Real Time Three Dimensional Echocardiography 
Ricardo H. Pignatelli, Louis I. Bezold, Mark B. Lewin, Carolyn A. Altman, 
Giles W. Vick, Nancy A. Ayres. Texas Chiidren’s Hospital and Bay/or College 
of Medicine, Houston, Texas, USA 
Background: Real time three-dimensional echocardiography (RTSD) has 
the potential to enhance the armamentarium of pediatric cardiologists in the 
diagnosis of congenital heart disease (CHD) and performance of interven- 
tional procedures. The non-invasive diagnosis of CHD often requires unique 
tomographic projections and is facilitated by rapid data acquisition time. We 
sought to repot-l our initial experience with this novel technique. 
Methods: Images were acquired by scanning a 65” pyramidal data set 
with a 2.5/3.5 MHz 512 element matrix array transducer. Each volume set 
allows electronic sweeping of standard 2-D images within the range of the 
scan volume. RT3D volume sets were analyzed in three selected patient 
groups to assess: (1) feasibility of identifying isolated congenital heart lesions, 
(2) accuracy of volume analysis and (3) utility of RT3D during endomyocardial 
biopsy. 
Results: 137 pts were scanned with RT3D. 108/137 pts had targeted 
anatomic evaluation (outflow tract defects 27, shunt lesions 19, normal 
anatomy 18, AVV defects 18, cardiomyopathy IO, fetal 5 and others 11 pts). 
Adequate 2-D views were obtained from ‘the following planes: parasternal 
89/89 (loo%), apical 70/71 (98.6%), subxiphoid 31/37 (84%), and supraster- 
nal 16/18 (89%). Quantitative LV volume analysis was performed in 17 pts 
with excellent correlation with MRI volumes (r = 0.89). Catheterposition was 
defined in 12 pts (85/90 biopsy samples = 94%). 
Conclusions: RTBD allows: (1) unlimited electronic sweeps within the 
volume set, (2) review of standard 2D pediatric views for anatomic diagnosis, 
(3) accurate measurement of ventricular volumes and (4) determination of 
catheter position during endomyocardial biopsy in pediatric patients. 
4:45 p.m. 
El 859 4 Aortic Valve Repair for Congenital Aortic 
Regurgitation. Precise and Varying Surgical 
Intervention Based on Preoperative Two- and 
Three-D Echocardiographic Imaging and Surgical 
Inspection 
Emile A. Bacha, Megan Sherwood, Craig Fleishman, Gerald R. Marx, 
Richard A. Jonas. Department of Cardiac Surgery and Cardiology, 
Children’s Hospital, Boston, MA 02f 75, USA 
Background: Congenital aortic regurgitation (CAR) is rare as an isolated 
lesion. Increasing concern with pulmonary autograft dilation after the Ross 
procedure in children prompted us to evaluate whether 2- and 3-D echocar- 
diography (3-DE), in correlation with intraoperative videoscopic imaging (IVI) 
from a head-mounted camera, would facilitate aortic valvuloplasty (AVpl). 
Methods: Selection of patients and surgical planning was based on 
preoperative 2- and 3-DE. Two-DE color flow doppler demonstrated the 
site of regurgitation corresponding to specific leaflets and commissures. 
Three-DE depicted the leaflet surfaces, and in dynamic motion provided a 
real-time display of leaflet coaptation. Thirty-two patients underwent AVpl 
between 4/88 and 7/99, of which 8 (age 6-22 years) had isolated severe 
CAR. The aortic valve was bicuspid in 6 patients, and tricuspid in 2. 
Results: A marked variation in leaflet morphology, site of regurgitation 
and ineffective coaptation was found. Preoperative assessment correlated 
well with surgical inspection, which was stored by IVI. AR was secondary to 
leaflet perforation in two patients, underdevelopment of a leaflet with fusion 
of the vestigial tissue to the other leaflet, underdevelopment of a leaflet with 
annular and ascending aortic dilation. underdevelopment of a leaflet with 
prolapse of the opposing leaflet, U-shaped defect within the free edge of a 
leaflet, and incomplete coaptation due to central prolapse secondary to a 
restrictive raphae in one patient each. Based on these findings, very specific 
surgical interventions were undertaken: Autologous glutaraldehyde-treated 
pericardial patch (PP) repair of leaflet perforation, partial or complete PP 
reconstruction of deficient leaflets (with reduction plasty of the ascending 
aorta in one case), commisural resuspension, and raphae release with de- 
bridement of excess fibrous tissue. There was no morbidity or mortality. On 
immediate postoperative echo, 4 patients had trace AR and 4 had mild AR. 
All patients had only mild AR at mosi recent follow-up (range 2 to 35 months; 
median 15 months). 
Conclusions: AVpl for CAR can be performed with excellent short-term 
results and no mortality. Individualized reconstructive surgery must be based 
on a comprehensive understanding of leaflet morphology and dynamic coap- 
tation. A compendium of 2- and 3-DE images with IVI will constitute a library 
for preoperative assessment of future AVpl. 
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859-5 Assessment of Ventricular Function and Pulmonary 
Regurgitation After Total Repair of Tetralogy of 
Fallot (ToF) During Supine Physical Exercise by 
Ultra-Fast Magnetic Resonance Imaging (MN) 
Arno A.W. Roest’~‘, Willem A. Helbing’, Patrik Ku&, Ernst E. van der 
Wall’~s, Hildo Lamb”, Albert de Roos’~“. ‘Intefoniversify Cardiology lnsfitute 
of The Netherlands, Utrecht; “Leiden University Medical Center, The 
Netherlands 
Background: Pulmonary regurgitation (PR) is common after repair of ToF. 
The amount of PR correlates with right ventricular (RV) function, arrhythmias 
and sudden death. No quantitative data exists on the change of RV function 
and PR in response to exercise (exe). PR and RV function can be quantified 
with MRI. Aim of this study was to evaluate changes in PR and RV function 
in response to exercise in Fallot patients, using MRI. 
Methods: Flow through the pulmonary trunk (PT) and RV and left ventric- 
ular (LV) function were examined at rest and during supine bicycle exercise 
in 10 ToF patients using a new fast MR sequence. Individualized exercise 
levels were set to 60% of measured maximal 0s uptake. Systolic forward 
flow (sfwf in ml), PRvolume (PRvol in ml) and PRfraction (PRf in %) were 
assessed with flow measurements. Ventricular parameters measured were 
end-diastolic volume (EDV in ml), end-systolic volume (ESV in ml), stroke 
volume (SV in ml = EDV-ESV) and ejection fraction (EF in %). 
Results: Maximal supine 0s uptake: ToF: 38 + 8, controls: 39 f 5 
ml/min/kg. Heart rate ToF: rest 68 * 5 vs exercise 117 f 9 bpm’. ” = p 4 0.05 
rest to exe. RV-EF did not change with exercise, while the LV-EF showed 
a normal response (EF + 5%). PRvol and PRf decreased in response to 
exercise. 
RV rest Fiv exe LV rest LVexe PT rest exe 
EDV 222+56 228&63 135124 133f24 sfwf 134k36 138538 
ESV 100132 101 h-39 56i14 44*13* pr!d 45h27 39 * 26’ 
SV 122*30 127zk32 79f14 89113’ pri 31* 15 26+15’ 
EF 56 * 7 57 * 9 59 5 5 66f5’ 
Conclusion: MRI allows evaluation of changes in PR and ventricular 
function in response to exercise in ToF patients. Despite normal 0s uptake 
and normal resting EF, the lack of increase in EF and SV of the RV suggests 
impaired response to exercise of the dilated RV in ToF patients. 
595 p.m. 
859-6 Effect of Balloon Aortic Valvuloplasty on Regression 
of Left Ventricular Mass 
David Shim, Erik Michelfelder. The Heart Center, Children’s Hospital 
Medical Center, Cincinnati, Ohio, USA 
Background: Regression of left ventricular mass (LVM) following balloon 
aortic vaivuloplasty (BAV) is not well known, therefore a retrospective analysis 
was performed by M-mode echocardiogram (MME). 
Method: All BAV performed i/89 to 1198 were reviewed and pts excluded 
if they had failed BAV (no relief of gradient or severe aottic insufficiency), 
other left-sided lesions, recurrence of stenosis during follow-up, or inade- 
quate MME. Peak instantaneous pressure gradient (PIPG) was measured 
by doppler echocardiogram. Left ventricular parameters by MME of end di- 
astolic dimension (LVID), posterior wall (PWT) and interventricular septal 
(IVST) thicknesses, and LVM were indexed (LVMI) to body surface area. 
Continuous data are reported as mean i SE and comparisons are made by 
ANOVA. P x 0.05 was considered statistically significant. 
Results: During the study period 25 pts met criteria with an average 
age at the time of BAV of 8.4 f 1.3 years and a weight of 34.5 i 5.6 kg. 
All patients had successful BAV (table). MME was performed pre-BAV and 
follow-up MME was obtained at a mean of 7.2 i 1.5 months after BAV with 
no significant change in LV measures. However at 2”d follow-up at 30.1 f 
3.9 months PWT, IVST and LVMI were significantly lower. 
‘D < 0.05 Pre-BAV 1” MME Last MME 
PIPG (mmHg) 
LVID (cm/m*) 
PWT (cm/m”) 
IVS (cm/m*) 
LVMI (urn’) 
79.0 * 5.0 42.4 + 2.6’ 41.6 zk 2.8’ 
4.7 + 0.4 4.5 ct 0.4 3.8 i 0.3 
1.2+0.1 l.OfO.1 0.7 * 0.1’ 
1.0+0.1 0.9 5 0.1 0.6 -i- o.o* 
89.6 f 6.2 79.8 * 5.7 72.4 f 4.0’ 
Conclusion: LVM trends towards regression after BAV however regres- 
sion may occur over a period of a few years. Therefore, successful BAV 
appears to positively effect MME measurements of left ventricular muscle 
mass. 
ORAL 
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El 804 2 Clinical Status of Adults With Prior Fontan 
Procedures: A Multicenter Investigation 
Samuel Wang, Elyse Foster, Thomas P. Graham, Jr.. For the /SACCD 
Investigators; University of California, San Francisco, CA; Vanderbilt 
Medical Center, Nashville, TN, USA 
Background: The Fontan procedure has been performed since the early 
1970’s for surgical palliation of tricuspid atresia and functional single ventricle. 
The International Society of Adult Congenital Cardiac Disease (ISACCD) has 
undertaken a multicenter study of the clinical outcome in adults with Fontan 
physiology. 
Methods: A data sheet was mailed to all members of ISACCD. Inclusion 
criteria: (I) age 2 18 yrs currently or at the time of death, and (2) status post 
Fontan procedure (any form of total cave-pulmonary connection). Data were 
entered into a relational database designed for this purpose arid analyzed. 
Results: 217 pts (114 M, 103 F; mean age = 30.0 f 8.7 yrs (18 to 55)) 
from 19 centers are included. Mean follow-up = 11.6 f 5.3 yrs. Previous 
surgery included a systemic to pulmonary artery (PA) shunt in 55% and a 
Glenn shunt in 24%. Mean age at the first Fontan was 17.1 * 9.4 yrs (1.5 
to 43). 18% underwent Fontan revision after 10.2 + 6.5 yrs (0.1 to 23). 
8 pts (4%) underwent transplant. Mortality was 9.2%, with a mean age of 
death 30.2 & 10.4 yrs. Causes of death: arrhythmic or sudden death (n = 
8), heart failure (n = 2), post initial Fontan (n = 2) post Fontan revision (n = 
3), post transplant (1 early, 1 late), other or unknown (n = 3). The congenital 
heart disease (CHD) functional class in 108 of the living pts is: I - 43%, II - 
40%, Ill - 15%, IV - 2% Among these, 62% can perform full-time work; 35% 
part-time work; 3% cannot work due to symptoms; and 1% have extreme 
limitation of activities. There were 18 pregnancies in 13 females, resulting 
in 15 live births, 3 spontaneous abortions, no therapeutic abortion, and no 
maternal mortality. Survival according to the primary lesion: tricuspid atresia, 
86/98 (88%); single ventricle-left, 85/91 (93%); single ventricle-right, 24127 
(89%). Survival according to the type of Fontan: atrio-PA connection, 90% 
(103/115), with right atrial appendage to PA connection, 94% (45/48); total 
cave-pulmonary connection, 93% (91/98). Survival according to previous 
surgery: 88% (45/51) with prior Glenn, and 91% (109/120) with prior systemic 
to PA shunt. 
Conclusions: The majority of adults with Fontan physiology are in CHD 
functional classes I and II, and lead productive lives. Successful pregnancy 
resulting in live birth is achieved in a significant number of females. Survival 
in adults does not appear to be significantly affected by the primary lesion or 
a previous palliative shunt procedure. 
9:00 a.m. 
804-3 Pulmonary Valve Replacement in Adults Late After 
Repair of Tetralogy of Fallot: Are We Operating on 
Too Late? 
Judith Therrien, Sam C. Siu, Peter R. McLaughlin, Peter P. Liu, Gary 
D. Webb. University of Toronto Congenital Cardiac Center for Adults, 
Toronto, Ontario, Canada 
Background: Chronic pulmonary regurgitation (PR) following repair of Tetral- 
ogy of Fallot (TOF) leads to right ventricular dilatation and an increased 
incidence of sudden cardiac death. The purpose of this study is to evaluate 
right ventricular volume and function following pulmonary valve replacement 
(PVR) and address the issue of optimal surgical timing in these patients. 
Methods: We studied 25 consecutive adult patients who underwent PVR 
for significant PR late after repair of TOF. Radionuclide angiography was 
performed in all patients at a mean of 8.2 months (f8 months) prior to PVR 
and a mean of 28.0 months (f22.8 months) after the operation. Right ven- 
tricular end systolic volume (RVESV), right ventricular end diastolic volume 
(RVEDV) and right ventricular ejection fraction (RVEF) were measured. 
Results: 
Mean RVEF at rest 
Pre PVR 
35.6 * 13.0 
Post PVR 
34.7f11.7 
P value 
0.78 
Mean RVESV at rest 157.4 i 95.6 155.4 f 125.9 0.94 
Mean RVEDV at rest 227.1 i 119 214.9 * 138 0.74 
Of the IO patients with RVEF 2 0.40 prior to PVR, 5 patients (50%) 
maintained a RVEF z 0.40 following PVR whereas only 2 out of 15 patients 
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(13%) with pre operative values < 0.40 reached an RVEF 2 0.40 post 
operatively (p < 0.001). 
Conclusion: Potential for right ventricular recovery following PVR for 
chronic significant pulmonary regurgitation after repair of TOF seem to be 
compromised in the adult population. In order to maintain adequate right 
ventricular contractility post operatively, pulmonary valve implant in these 
patients should be considered before right ventricular ejection fraction falls 
below 0.40. 
9:15 a.m. 
I 804 4 Doppler Evidence of Restrictive RV Physiology in 
Late Follow Up of Adolescents With Repaired 
Tetralogy of Fallot: A Meaningful Finding? 
Theresa A. Tacy, Anita Moon, Wanda Miller-Hance, Einat Birk. University of 
California San Francisco Medical Center, California, USA 
Background: Restrictive right ventricular (RV) physiology, as characterized 
by antegrade diastolic pulmonary arterial (PA) flow on pulsed Doppler echo- 
cardiography, is acommon finding late after repair of tetralogy of Fallot (TOF). 
It is indicative of abnormal hemodynamics, yet has been related to improved 
exercise performance in adults. This study investigates the relationship be- 
tween this Doppler finding and symptoms in late follow up of in a pediatric 
population, 
Methods: Echocardiograms from 37 patients aged 9-26 years with post- 
operative TOF and at least moderate pulmonary regurgitation were reviewed. 
All but 2 of these had transannular patch repair, mean age at repair 1.7 years 
(range: 0.2-9.6). The mean follow tip time was 11.4 years (range: 3.7-i 8). 
We reviewed echocardiograms for A-wave related late diastolic forward flow. 
Two reviewers blinded to Doppler findings subjectively rated RV size. based 
on the 4 chamber view. Clinical records concurrent with the studies were 
reviewed for reports of symptoms of exercise intolerance. 
Results: Of ibis study group of TOF patients 30% had restrictive RV 
physiology. 45% of these patients reported symptoms, compared with 19% 
of patients without restrictive RV physiology. This trend in proportions lacked 
statistical significance (p = 0.10). Of the symptomatic patients. 88% had RV 
enlargement, compared with 70% of asymptomatic patients. The proportion 
Of patients with RV enlargement was equivalent between the restrictive 
(70%) and nonrestrictive (77%) groups, 
Conclusion: There is an association between restrictive RV physiology 
and reported symptoms in our population that does not support previous 
studies of improved exercise tolerance. There was no subjective difference 
in RV size between patients with and without RV restrictive physiology. We 
conclude that restrictive RV physiology in late follow up of postoperative TOF 
patients is more likely to be associated with symptoms of exercise intoler- 
ance, related to the abnormal hemodynamics associated with RV diastolic 
dysfunction. 
9:30 a.m. 
804-5 Coronary Artery Abnormalities in Patients With 
Anomalous Left Coronary Artery From the 
Pulmonary Artery: Redefinition of a Syndrome 
Mary P. Mullen, Stanton B. Perry, Campbell D.K. Rogers, Richard 
R. Liberthson, Michael J. Landzberg. Boston Adult Congenital Hearf 
Service, Children’s Hospital, Brigham & Women’s Hospital, Massachusetts 
General Hospital, Harvard Medical School, Boston, MA, USA 
Background: Anomalous left coronary artery from the pulmonary artery (AL- 
CAPA) is a rare congenital coronary lesion that may present with myocardial 
ischemia or infarction. Young adults may continue to experience chest pain 
syndromes after surgical repair, raising the possibility of ongoing coronary 
insufficiency. 
Methods: We retrospectively identified 60 pts with ALCAPA who under- 
went surgical repair between 1969 and 1999 at our institutions, 6 pts repaired 
at outside institutions and 1 pt followed without surgical repair. Median age 
at operation was 5 months (range l-176 mos). Mean follow-up after surgical 
repair was 54 months (range O-292 mos). Of the 66 repaired pts, 29 had 
coronary reimplantation, 28 transpulmonary artery baffle procedure, and 9 
left coronary ligation. Coronary angiograms were reviewed on 35 of the 39 
pts who underwent catheterization. 
Results: Twenty-eight of these 35 pts (80%) had coronary vascular ab- 
normalities beyond ALCAPA, including: systolic compression of left anterior 
descending artery (LAD) and/or septal perforators (23; 66%); dilated and/or 
ectatic LAD (22; 63%); or dilated fight coronary artery (RCA) (19; 54%). 
Eleven pts had only preoperative catheterization. Of 24 pts with postopera- 
tive angiograms, 16 (67%) had either persistent or newly recognized coronary 
abnormalities. Three pts required subsequent coronary interventions (1 per- 
cutaneous transcatheter angioplasty (PTCA)/stent, 1 PTCA/coronary artery 
bypass graft (CABG), and 1 CABG) for systolic compression of the LAD with 
ischemia. At CABG, 2/2 pts were found to have intramyocardial coursing of 
the LAD. 
Conclusion: ALCAPA includes not only abnormalities of coronary origin 
but marked coronary structural and flow changes that may persist after sur- 
gical repair. These alterations may have profound consequences. Improved 
understanding of the etiology and nature of these changes may lead to better 
long term management of pts with ALCAPA and other coronary syndromes. 
9:45 a.m. 
I 804 6 The Effects of Losartan in Patients With a Systemically Functioning Morphologic Right 
Ventricle (RV) in Transposition of the Great Arteries 
(-=A) 
Steven J. Lester, Doff B. McElhinney, Wayne Tworetzky, Esperanza Viloria, 
Gautham Reddy, Elizabeth Ryan, Nelson 8. Schiller, Elyse Foster. 
University of California, San Francisco, CA, USA 
Background: In patients with d-TGA who have undergone a palliative atrial 
switch procedure or I-TGA (congenitally corrected), the morphologic RV 
serves the systemic circulation. Survival into adulthood is the norm, but 
longer term survival may be affected by functional vulnerability of the RV. 
The efficacy of afterload reduction for myocardial preservation of a systemic 
RV is unknown. We performed a randomized trial to test the hypothesis that 
chronic therapy with Losartan, an angiotension-2 receptor antagonist, would 
result in measurable improvement in systolic function and exercise capacity 
in patients with a systemic RV. 
Methods: Eight subjects (7 atrial switch, 1 congenitally corrected, age 26 
& 8 yrs) who were not receiving afterload reduction therapy were randomized 
to receive either Losartan or placebo for 8 weeks and were then crossed over 
to receive the alternate therapy for 8 weeks. Function of the systemic RV 
and tricuspid valve (TV) was evaluated by transthoracic cross-sectional and 
Doppler echocardiography. Exercise capacity was evaluated with a symptom 
limited supine bicycle exercise test. 
Results: The mean dose of Losartan was 31.25 mg per day. The systolic 
blood pressure decreased from 115 f 7 to 107 f 12 mmHg (p = 0.10) on 
Losartan. Losartan resulted in an increase in RV ejection fraction from 47 & 
10 to 54 f 7% (p = 0.008) and a reduction in the acceleration time of the 
aottic velocity from 133 f 24 to 117 f 19 ms (p = 0.04). TV regurgitant orifice 
area and regurgitant volume were reduced with Losartan, from 13 f 4 to 6 
f 6 mm* (p = 0.01) and 22 f 13 to 8 f IO ml (p = O.Ol), respectively. An 
improvement in exercise time from 12 5 4 to 14 f 4 min (p = 0.03) was seen 
with Losartan. 
Conclusions: Therapy with Losartan has salutary effects on the systolic 
function of the systemic RV and improves the exercise capacity in patients 
with a systemic RV. 
MODERATED POSTER SESSION 
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9:00 a:m. 
1007-I 67 Rapid Decrease of Right Ventricular Volume 
Overload Followina Transcatheter Closure of 
Secundum Atrial S$ptal Defects 
Sharon E. O’Brien, Wei Zhu, Qi-Ling Cao, i’iyad M. Hijazi. Tufts-New 
England Medical Center, Boston, MA, USA 
Background: Secundum atrial septal defect (2” ASD) is a common lesion 
which can result in significant volume overload of the right atrium and right 
ventricle (RV). These lesions have been closed in the catheterization labo- 
ratory via transcatheter devices with excellent results, offering a minimally 
invasive alternative to open-heart surgery. The purpose of this study is to 
evaluate the extent and timing of RV volume overload reduction following 
transcatheter closure of 2s ASD. 
Methods: Echocardiographic evaluation was performed in all patients 
undergoing transcatheter closure of 2” ASD. M-Mode measurements from 
the short-axis view were used to assess RV end diastolic dimension (RVEDD) 
prior to closure, 1 day, 1, 3, 6 and 12 months post closure. 
Results: Between 5/97 and 8/98, 74 patients, (59 female, 15 male) un- 
derwent successful closure of 2” ASD using the Amplatzer@ Septal Occluder 
at our institution. The mean age of the patient was 22.7 f 21 years, the 
mean weight 46.2 f 25.6 kg and a mean balloon-stretched, ASD diame- 
ter was 17 * 5.7 mm. Five patients had 2 defects. Forty-seven patients 
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had echocardiographic evaluations pm-closure and 1 day post-procedure for 
comparison. This revealed a significant decrease of 9 i 14% in RVEDD (P 
= 0.04). Twenty-eight patients had follow-up echocardiograms at 1 month 
which demonstrated a significant decrease in RVEDD of 21 f 25% as com- 
pared to pre-procedure (P = 0.0004). Likewise, at 3, 6 and 12 months there 
was continued significant reduction of RVEDD when compared with pre-pro- 
cedure (P < 0.05). There was a significant change between 1 day and 1 
month measurements, however, after 1 month there was no significant differ- 
ence in RV dimension when compared to the previous examination. Neither 
age nor ASD size had a significant impact on the degree of RVEDD reduction 
at any time point. RV size pre-closure significantly affected the degree of RV 
volume reduction at one year. 
Conclusion: Transcatheter closure of 2” ASD results in significant de- 
crease of RV volume overload as early as 1 day post-closure. Continued 
significant reduction is seen at I, 3, 6 and 12 months. The degree of reduc- 
tion does not depend on age of the patient or size of the defect. However, 
RV size affects the degree of volume reduction at one year. 
9:12 a.m. 
1007-I 68 Extrasystolic and Post-Extrasystolic Beats 
Provide Unique Insight Into the Function of 
Single Ventricles in Children 
Anirban Banerjee’,‘, Francine G. Erenberg’ ‘Children’s /-/~@a/, 
Cincinnati, OH; “Tufts-N.E. Medical Cenfer, Boston, MA, USA 
Background: Contractile properties of single ventricles (SV) of children 
have not been evaluated using invasive indices reflecting Ca*+ cycling by 
sarcoplasmic reticulum (SR) Mechanical restitution (MR) is the phenomenon 
of restoration of contractility in premature beats, introduced at progressively 
longer extrasystolic intervals (ESI). MR and post-extrasystolic potentiation 
(PESP) are reflective of intracellular activator Gas’. 
Methods: We studied MR and PESP in 5 children (age: 7 months-3 
years) with SV 8 5 age matched controls (C). During atrial pacing at constant 
cycle length, premature beats were generated at increasing ESI. LV dP/dt,,, 
measured from micromanometric tracings was normalized to the preceding 
normal beat. MR is characterized by a steep ascending limb & a subsequent 
plateau phase. Time constant of restitution (TCR) indicates steepness of 
ascending limb of MR &thus rapidity of MR. ESIM~ (arrows) was ESI at which 
contractility was fully restored. Post-extrasystolic beats were introduced at 
fixed coupling intervals (700 ms) and at fixed ESI (300 ms). 
Indices Control arow Shale ventricle arow 
dP/dtmax at 120 bpm (mmHg/s) 1771 i 480 1140 * 320’ 
TCR (ms) 47.3 i 13.3 76.8 i 14.2’ 
ESIMR (ms) 396.7 zk 22.6 445.5 * 24.3* 
PESP 0.85 f 0.26 1.2 * 0.2” 
Mean i- SD, Student’s t test, ‘p < 0.05 
Conclusions: In children with SV at matched heart rates contractility is 
significantly, depressed. MR is impaired as evidenced by prolongation of TCR 
and ESlhnn. Post-extrasystolic beats were more potentiated. These changes 
reflect slower Ca’+ cycling by SR. Extrasystolic and post-extrasystolic beats, 
iherefore, provide a unique insight into function of SV and can be obtained 
during catheterization. 
9:24 a.m. 
1007-l 69 Myocardial Blood Flow and Flow Reserve After 
Coronary Reimplantation in Patients After 
Arterial Switch and Ross Operation 
M. Hauser, F. Bengel’; A. Kuhn, S. Nekolla, M. Schwaiger’, J. Hess. 
German Heart Centre, Lazarettsfr: 36, 80636 Munich; ’ Nuklearmedizinische 
Kiinik der TU Mijnchen, Ismaningerstr. 22, 81675 Munich, Germany 
Background: Children and adolescents after anatomical correction (ASO) 
of TGA and after Ross operation in patients with aortic stenosis are sub- 
sequently asymptomatic. However the final outcome and possible coronary 
insufficiency remains unclear. It has been considered that coronary flow 
reserve (CFR) may be reduced in both populations. 
Methods: Myocardial blood flow (MBF) was assessed at rest and during 
maximal hyperemia using N-13 ammonia positron emission tomography 
(PET) before and after intravenous adenosine infusion in 22 children after 
arterial switch (mean age 12 f 2 years) and IO patients after Ross operation 
(19 f 7 years). MBF and CFR were compared with a group of healthy 
volunteers. 
Results: Stress induced perfusion defects were noted in 5 patients after 
AS0 and in none of the Ross patients. Coronary stenosis could not be 
demonstrated in selective angiography. Mean resting MBF was higher after 
AS0 than in volunteers (0.97 i 0.27 vs. 3.48 + 0.59, p = 0.04) while stress 
MBF was reduced (2.74 & 0.44 vs. 3.48 f 0.59, p = 0.001). CFR in AS0 
patients was significantly lower than in controls (2.96 f 0.60 vs. 4.75 rt 0.81, 
p = 0.0001). Myocardial vascular resistance (MVR) was lower at rest after 
AS0 (97.9 i 21.3 vs. 125.08 & 25.06, p = 0.006), while stress MVR tended 
to be higher. There was no significant difference in PET imaging between 
Ross patients and healthy volunteers. 
Conclusion: Patients with surgically corrected TGA show reduced CFR 
compared with healthy young adults and patients after Ross procedure. 
Quantitative PET assessment of CFR may thereby reveal functional abnor- 
malities in patients after AS0 prior to the appearance of perfusion defects 
and in absence of detectable coronary stenosis. There may be an additional 
risk factor which needs further investigation. 
9:36 a.m. 
1007-l 70 Sudden Death in Heterotaxy Syndrome 
Mei-Hwan Wu, Jou-Kou Wang, Hung-Chi Lue. Departments of Pediatrics, 
National Taiwan Universify, Taipei, Taiwan 
Objectives: This longitudinal study sought to define the risk of sudden death 
in patients with heterotaxy syndrome after various palliations. 
Background: Patients with heterotaxy syndrome (including right atrial 
isomerism, RAI, and left atrial isomerism, LAI) are commonly associated with 
complex congenital heart disease as well as abnormal cardiac conduction 
system. The risk of sudden death has been well documented in patients with 
isolated abnormalities of the cardiac conduction system. 
Methods: The patients of heterotaxy syndrome were identified from the 
patient files of pediatric cardiology of this hospital from 1980 to 1998. Tele- 
phone interview or mailed questionaire was sent to those patients who lost 
to follow-up. Sudden death was defined as acute cardiovascular collapse 
from which biological death occurred within 24 hours Survival was estimated 
by the Kaplan-Meier method. Statistical significance between the survival 
curves were compared by log rank test. 
Results: A total of 145 patients (122 RAI and 23 LAI) were identified, 
from whom a total follow-up of 756 patient-years (579 patient-years for RAI 
patients and 177 patient-years for LAI patients) were derived. Five-year sur- 
vival was 56% and 84% for RAI and LAI patients, respectively. There were 
a total of 20 sudden unexpected deaths (incidence, 14%, and event rate, 
26.5/1,000 patient-years). For RAI patients, there were IS sudden death 
events (incidence, 16% and event rate, 32.8/l ,000 patient-years). For LAI 
patients, only one sudden death occurred (incidence, 4%, and event rate, 
56/l ,000 patient-years). Sudden death in RAI patients tended to occur in the 
infancy or early childhood (onset age IO i IO mo., median 6 mo.). Sudden 
cardiac death occurred in 16 patients: 2 due to tachyarrhythmias and 14 
manifested as sudden onset cyanosis and bradycardia. In another 3 cases, 
positive blood culture (bacterial in 2 and fungus in one) was reported. Free- 
dom from sudden death decreased with age but remained stationary after the 
age of 3 years. The only sudden death in LAI patients occur at the age of 5 
years and was preceded by the development of junction ectopic tachycardia. 
Conclusions: Incidence of sudden death in heterotaxy syndrome, espe- 
cially in RAI patients, is relatively high and occurs early. The significance 
of abnormal conduction system properties linked to sudden death in these 
patients was only suggested in LAI patients. 
9:48 a.m. 
1007-l 71 Clinical Significance of Pulmonary 
Arteriovenous Malformations After Staging 
Bidirectional Cavopulmonary Anastomosis 
William T. Mahle, Jack Rychik, Jonathan J. Rome. Children’s Hospifal of 
Philadelphia, Philadelphia PA, USA 
Background: Pulmonary Arteriovenous Malformations (PAVMs) are a known 
complication of the classic Glenn shunt and may result in progressive 
cyanosis. PAVMs can also develop in pts who undergo a bidirectional 
cavopulmonary anastomosis (BCPA) as an intermediate stage before the 
Fontan operation. The clinical significance of PAVMs in this setting, however, 
is not known. 
Methods: We sought to determine the prevalence and clinical impact of 
PAVMs in patients who undergo the BCPA as a staging procedure. The study 
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population consisted of 372 pts who had undergone BCPA between l/90 and 
6/98 and had subsequent catheterization. Pts with PAVMs were identified by 
review of the cardiac catheterization database. To screen for additional cases, 
we reviewed the angiograms of all pts (n = 45) who had undergone a BCPA 
and had arterial desaturation (~80% in room air (RA)) at catheterization and 
all pts who had undergone a Kawashima-type BCPA. Studies were reviewed 
in a blinded fashion. PAVM was diagnosed by angiographic appearance and 
confirmed by pulmonary venous desaturation. 
Results: For the 372 study pts the mean age at BCPA was 8.8 i 5.4 
mos; the mean interval from BCPA to catheterization was 10.9 f 6.6 mos, 
and the mean interval from BCPA to Fontan was 11.7 f 7.0 mos. PAVMs 
were identified in IO pts (2.7%). PAVMs were more common in patients 
with polysplenia, 4 of 8 (50%), than in the remaining population, p < 0.001. 
Surgical management included a two-ventricle repair in 1 pt (intraoperative 
death). The remaining 9 pts with PAVMs underwent and survived Fontan 
surgery. Cardiac catheterization after Fontan surgery was performed in 6 of 9 
pts. All 6 pts demonstrated angiographic resolution of PAVMs and had arterial 
saturations > 90%. The 3 pts who did not undergo catheterization after the 
Fontan procedure had RA saturations > 93% measured by pulse oximetty. 
At a median follow-up of 2.1 yrs after Fontan surgery all 9 pts demonstrated 
RA saturations > 90%. 
Conclusions: The development of PAVMs after staging BCPA is rare 
and does not result in significant mortality in pts who proceed to the Fontan 
procedure. Resolution of PAVMs after the Fontan procedure is common. 
IO:00 a.m. 
I 1007 172 Does Myocardial Flow Reserve Limit Exercise Performance in Patients With a Systemic Right 
Ventricle? 
Tajinder P. Singh, Richard A. Humes, Otto Muzik, Nancy M. Sullivan, Peter 
P. Karpawich, Marcel0 F. Di Carli. Children’s Hospital of Michigan, Wayne 
State UniversiN Detroif, AN, USA 
Background: There is a high prevalence of systemic right ventricular dys- 
function and impaired exercise performance in long-term sutvivors of Mustard 
operation. A mismatch between myocardial blood supply and systemic ven- 
tricular work demand has been proposed as a potential mechanism. The 
purpose of this study was to relate myocardial flow reserve to exercise 
performance in long-term survivors of Mustard operation. 
Methods: Myocardial blood flow (MBF) was assessed at rest and dur- 
ing i.v. adenosine hyperemia (140 mcg/kg/min) in 13 long-term survivors of 
Mustard repair (age 19.4 f 5.7 years, median age at repair 0.8 years, fol- 
low-up after repair 18.4 f 5.2 years) using N-13 ammonia and PET imaging. 
Patients also underwent an incremental bicycle exercise test with metabolic 
monitoring. 
Results: Right ventricular free wall MBFs increased significantly with 
adenosine hyperemia (baseline MBF 0.84 f 0.17 vs hyperemic MBF 2.14 f 
0.82 ml/gm/min, p < O.Ol), resulting in myocardial flow reserve of 2.57 f 0.91 
(ratio of hyperemic to baseline flow). Exercise performance was impaired in 
patients (VOnmax 61 f 16% predicted and work rate 62 * 24% predicted) 
due to both chronotropic impairment (peak heart rate 76 f 9% predicted) and 
impaired stroke volume increase (maximum 02 pulse 75 =t 18% predicted). 
However, there was no relationship between VOzmax or maximum 02 pulse 
with hyperemic MBF or myocardial flow reserve (r = 0.13). 
Conclusions: We conclude that exercise performance in survivors of 
Mustard operation is not limited by impairment of myocardial flow reserve in 
these patients. Other mechanisms such as abnormal ventricular mechanics 
during exercise, impaired chronotropic response and conditioning may be 
the more important determinants of exercise performance in these patients. 
IO:12 a.m. 
1 1007-l 73 1 Prevalence and Progression of Neoaortic 
Insufficiency Following Staged Reconstruction 
for Hypoplastic Left Heart Syndrome 
Meryl S. Cohen, Bradley S. Marino, Jack Rychik, Thomas L. Spray, 
Gil Werndvsky. The Children’s Hospital of Philadelphia, Pennsylvania, USA 
Background: The pulmonary valve functions as the systemic semilunar 
valve following palliative surgery for hypoplastic left heart syndrome (HLHS). 
Previous short-term follow-up has suggested that neoaortic insufficiency 
(neoAl) is common. We sought to assess the mid-term prevalence and 
progression of neoAl in HLHS. 
Methods: All patients > 4 years old, with a diagnosis of HLHS and at 
least two serial echocardiograms assessing the competency of the neoaottic 
valve were included (n = 64); mean age at most recent follow-up was 9.0 * 
2.7 years. 
Results: The prevalence of neoAl is summarized in the chat-l below. Of 
the 64 patients, 38 (59%) showed progression of neoAl during the course 
of the study. In 6/64 (9.4%) the neoAl progressed to at least moderate. 
Neoaortic valve replacement was pet-formed in one patient who developed 
severe neoAl after antegrade balloon angioplasty of recurrent coarctation. 
No other patient had severe neoAl. 
Conclusion: NeoAl is common following staged reconstruction for HLHS. 
Although mild in most cases, neoAl is progressive in the majority (59%) of 
patients, and is of moderate severity in nearly 10% of patients at mid-term 
follow-up. 
IO:24 a.m. 
/ 1007-I 74 1 The Fate of Clinical Arrhythmia Following 
Pulmonary Valve Replacement After Repair of 
Tetralogy of Fallot: A Multicenter Study 
Judith Therrien, Sam C. Siu, Louise Harris, Annie Dore, Koichiro Niwa, 
Jan Janousek, William G. Williams, Gary D. Webb, Michael A. Gatzoulis. 
University of Toronto Congenifal Cardiac Center for Adults, Toronto, Ontario, 
Canada 
Background: Chronic pulmonary regurgitation (PR) following repair of Tetral- 
ogy of Fallot (TOF) may lead to right ventricular dilatation, ventricular tachy- 
cardia and sudden death. We aimed to examine the effects of pulmonary 
valve replacement (PVR) on 1) electrocardiographic markers predictive of 
ventricular arrhythmia and sudden death and 2) clinical arrhythmia. 
Methods: We studied 70 consecutive patients, identified from the database: 
of the 4 participating institutions, who underwent PVR for significant PR late 
after repair of tetralogy of Fallot. Maximum QRS duration and QT dispersion 
was measured from standard electrocardiograms. Late clinical arrhythmia 
was defined as sustained atrial flutter/fibrillation or sustained ventricular 
tachycardia occurring after the first 3 post-operative months. Concomitant 
intraoperative electrophysiological mapping and/or ctyoablation was per- 
formed in 15 patients (56%) with pre-existing arrhythmia. 
Results: Perioperative mortality was 4% with a IO year survival of 86%. 
QRS duration remained unchanged in the study group (p = 0.46) whilst it 
prolonged significantly (p < 0.001) in a comparable group of patients with 
repaired TOF who did not undergo PVR. At a mean follow up of 4.7 years, 
the incidence of clinical arrhythmia diminished from 39% preoperatively to 
21% (p = 0.005); Intra-operative ablation prevented recurrence of pre existing 
tachyarrhythmia (O/15 recurrence). 
Conclusion: PVR in patients with previous TOF repair and chronic PR 
leads to stabilization of QRS duration and in conjunction with intra-operative 
ablation, leads to a decrease in the incidence of pre existing arrhythmias. 
This should be considered as a risk modification procedure for ventricular 
tachycardia and sudden death late after TOF repair. 
IO:36 a.m. 
I 1007 175 MRI and Echocardiographic Assessment of Pulmonary Insufficiency Following Surgical 
Repair of ietralogy of Fallot - - 
Derek G. Human, J.A. Gordon Culham, John B. Mawson, Jacques 
G. LeBlanc, Mary T. Potts, James E. Potts. B.C.‘s Children’s Hospital and 
The University of British Columbia, Vancouver, B.C., Canada 
Purpose: MR imaging may be considered the gold standard for quantifying 
pulmonary insufficiency (PI). We undertook this study to assess the utility 
of echo markers of RV volume loading in identifying patients with severe PI 
following surgical repair of Tetralogy of Fallot. 
Methods: A total of 29 studies were performed in 26 consecutive patients 
between July 1995 and March 1999, all of whom had clinical evidence 
of PI. MR was performed using a Picker 1.5 T magnet. Phase contrast 
flow sequences allowed direct calculation of flow in the MPA, over a full 
cardiac cycle. Regurgitant fraction (RF) was calculated from both forward 
and backward flow orthogonal to the long axis of the MPA (MPA RF; n = 
29), and in the segment of the MPA with maximal regurgitation (Seg RF; n 
= 17). Echo RV loading was assessed by the RV/LV ratio and the degree of 
abnormal septal motion (n = 24). 
Results: MPA RF ranged from l&56% (median = 38); Seg RF ranged 
from 4-66% (median = 16); r = 0.10; p < 0.71. Echo RF (n = 8) ranged from 
31-68 (median 57.5) and did not correlate with either MPA or Seg RF (r = 
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0.55; p < 0.16 and r = 30; p < 0.70, respectively). RV overload (n = 24) was 
mild (RV/LV < 0.6) in 4 patients; moderate in 14; and severe (RV/LV 1 0.9) 
in 6. When compared to MPA RF definitions of mild (MPA RF < 30), mod- 
erate, and severe (MPA RF 2 50) PI, only l/4, 11114, 2/6, respectively, were 
correctly assigned by echo. Septal motion was abnormal in all patients, but 
severe dyskinesia was equally represented in those with mild and severe PI. 
Conclusions: Echo indicators of RV overload are poor surrogate markers 
for the severity of PI. Echo RF and Seg RF do not correlate with MPA RF, 
demonstrating an important source of error when utilizing limited sample 
volumes. 
lo:48 a.m. 
1007-l 76 Pulmonary Neovascularity - A New Chest 
Radiological Feature of the Eisenmenger 
Syndrome 
Joseph K. Perloff, Donald B. Fisher, Denise Aberle, Michael C. Fishbein. 
Ahmanson/UCLA Adult Congenital Heart Disease Center, Los Angeles, CA, 
USA 
Background: Hitherto undescribed confluent pulmonary soft tissue densi- 
ties were identified in chest x-rays in adults with the Eisenmenger syndrome. 
Pulmonary computerized tomographic angiography (PCTA) disclosed clus- 
ters of small vascular channels that represented minute collaterals around 
pulmonary resistance vessels. Because these x-ray and PCTA features did 
not correspond with known vascular abnormalities in the Eisenmenger syn- 
drome, the term neovascularity was selected. 
Methods: A prospective PCTA study was undertaken in 23 patients aged 
19-53 yrs. (avg. 31 yrs.) with the Eisenmenger syndrome and chest x-ray 
evidence of neovascular lesions. Ten acyanotic primary pulmonary hyper- 
tension (PPH) patients aged 18 to 32 yrs. (avg. 23 yrs.) were included in 
the study. PCTA was performed on either a GE HiSpeed Advantage CT 
scanner or on a Siemens Evolution EBT scanner. One hundred twenty cc 
of nonionic contrast material [lohexal 350 mg/ml (Omnipaque 350)] were 
power injected at a rate of 2.5 cc/set. Technical parameters used with the 
GE HiSpeed Advantage CT scanner included one second helical acquisi- 
tion, 3-5 mm detector collimation, and pitch 1-2. For the Siemens Evolution 
EBT scanner, technical parameters included 300 ms CVS mode acquisition 
and 3 mm slice thickness. To allow adequate opacification of the pulmonary 
arterial tree, image acquisition commenced 30-35 seconds following initia- 
tion of the contrast bolus. PCTA data were reconstructed into overlapping 
transaxial sections using a standard reconstruction algorithm. Images were 
photographed and reviewed at mediastinal (width 400 HU, level 40 HU) and 
lung (width 1600 HU, level 550 HU) window settings. Chest radiographs of 
patients with the Eisenmenger syndrome or PPH were reinterpreted by 2 
of the authors blinded to the PCTA data that were separately interpreted 
by a third author. Necropsy lung sections were examined histologically for 
plexiform lesions in 5 patients with PPH. 
Results: PCTA in patients with the Eisenmenger syndrome disclosed 
neovascularity that coincided with chest radiographic lesions. Chest radio- 
graphs and PCTA in patients with PPH detected no neovascularity despite 
the presence of plexiform lesions at necropsy. 
Conclusions: We describe in the Eisenmenger syndrome a new chest 
radiologic sign - pulmonary neovascularify Plexogenic pulmonary arteri- 
opathy was not the cause of neovascular lesions. Even when marked and 
widely distributed, neovascular lesions had no apparent adverse functional 
consequences. Recognition is important to avoid interpretive error. 
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1146-l 60 Reversible Cardiac Dysfunction Associated With 
Zidovudine Exposure in HIV-Infected Children 
Tamir Dagan, Craig Sable, Perdita Taylor’, Judy Zuckerman’ , 
Sheryl Zwerski’, Gerard Martin, Lauren Wood. Children’s National Medical 
Center, Washington D.C.; National Cancer Institute, ‘N/H, Bethesda, MD, 
USA 
Background: A recent prospective study reported a 10%-l 5% cumulative 
incidence of cardiac dysfunction in pediatric HIV patients in 2 years of follow 
up. Animal models of Zidovudine (AZT) induced cardiomyopathy secondary 
to mitochondrial toxicity and the established skeletal myopathy associated 
with AZT toxicity warrant consideration of AZT exposure as a risk factor for 
cardiomyopathy in children with HIV infection. 
Methods: Six index patients undergoing routine echocardiographic surveil- 
lance as part of research protocols presented with left ventricular (LV) dys- 
function. Patients had no prior history of cardiac disease or encephalopathy 
and were treated with AZT at the time of diagnosis. Control patients (n = 15) 
were matched for age, CDC class and body surface area. Two-dimensional 
ejection fraction (EF), CD4 count, HIV polymerase chain reaction (PCR) viral 
load, Troponin T, and duration, cumulative exposure, and dose intensity of 
AZT were measured in all patients. 
Results: Age was not significantly different between index (10.6 f 4.5 
yr.) and control (11.1 rt 3.5 yr.) patients. CDC classification for index cases 
was Al-l, B2-1, B3-3, and C3-1. EF at baseline, time of dysfunction, 
and recovery was 62 f 5%, 43 j, 2%, and 59 * 4% respectively. Time to 
normalization of function after discontinuation of AZT was 4.5 f 3.2 weeks. 
EF in control patients was normal at base line and time of matching. Trends 
towards increased cumulative AZT dose/kg (35.7 f 9 vs. 26.6 f 9 g/kg) 
and duration of therapy (64 f 12 vs. 52 f 24 months) in index patients 
were obsen/ed (p < 0.15). There were no significant differences in total AZT 
dose, dose/M’, dose intensity (g/M’/month), CD4 count, and PCR viral load. 
No evidence of myocardial injury by plasma Troponin T measurement at 
baseline, LV dysfunction, and recovery was found. 
Conclusion: A cohort of HIV infected children with LV dysfunction, that is 
rapidly reversible upon discontinuation of AZT therapy, has been identified. 
Our results suggest an association with cumulative dose of AZT per body 
weight and duration of AZT exposure. Normal Troponin T levels in this 
population implies cell injury and death do not play a role in the pathogenesis. 
1 1146-l 61 / Long-Term Consequences of Coronary 
Aneurysms After Kawasaki Disease: Vascular 
Wall Morphology and Endothelium Function 
Masahiro Ishii, Kanoko Hashino, Motofumi lemura, Rumi Yamakawa, 
Hiromi Muta, Wakako Himeno, Teiji Akagi, Hirohisa Kato. Kurume 
University, Kurume, Japan 
Background: The vascular wall morphology and endothelium function of 
the coronary arteries in children after Kawasaki disease (KD) over the long 
term as yet remains uncertain. This study investigated the vascular wall 
morphology at the long-term coronary aneurysms after KD using intravas- 
cular ultrasound (IVUS) imaging, and evaluated the endothelium function of 
these sites using intracoronay infusion of acetylcholine chloride (ACh) and 
isosorbide dinitrate (ISDN). 
Methods: A total of 75 patients, 65 KD patients and IO controls, were 
studied. All KD patients were followed over more than 10 years from KD 
onset. The 6.5 patients comprised 4 groups: Group 1 consisted of 15 patients 
with persistent aneurysms. Group 2 consisted of 18 patients with coronary 
artery stenosis. Group 3 consisted of 26 KD patients with regressed coronary 
aneurysms, Group 4 consisted of 6 patients with normal coronary angiog- 
raphy (CAG) findings at the acute stage of KD. We carefully examined the 
coronary arterial wall morphology on IVUS imagings. During CAG, we in- 
fused 15 pg ACh and 0.5 mg ISDN into the coronary artery. The luminal 
diameter the sites was measured using a tine-videodensitometric analyzer 
to examine the distensibility of the coronary artery wall. 
Results: The IVUS imaging in Groups 1 and 2 showed intima hyperpla- 
sia and various degree of calcification at sites of both persistent coronary 
aneurysms and stenosis. However, IVUS imaging in Group 3 showed vari- 
ous degrees of the intimal thickening without calcification. All IVUS findings 
in the Group 4 were similar to those in the control patients. The Group 1 
and 2 demonstrated almost no change in the lumen diameter (ACh: 0.08 f 
6.5%, ISDN: 4.6 f 1.8%). In Group 3, there was significantly more vascular 
constriction by ACh, and poorer dilation by ISDN than in control (Group 3: 
ACh: -7.6 & 11.5%, ISDN: 9.5 f 8.2%, control: ACh: 15.5 I 5.6%, ISDN: 
16.6 f 7.1%, each p < 0.05 respectively). With infusion of ACh, and of ISDN, 
Group 4 showed no significant difference from control (ACh: 11.3 i 4.6%, 
ISDN: 18.0 f 8.2%). 
Conclusions: We conclude that long-term persistent coronary aneurysm 
and regressed coronary, aneurysms after KD have abnormal vascular wall 
morphology and vascular dysfunction. These patients should be counseled 
to avoid potential risk factors for atherosclerosis and that long-term follow-up 
is needed into adulthood. 
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1146-l 62 Soluble Forms of P-, and E-Selectin in Children 
With Immune Globulin-Resistant Kawasaki 
Disease 
Jun Furui, Masahiro Ishii, Kanoko Hashino, Hiromi Muta, Wakako Himeno, 
Teiji Akagi, Hirohisa Kato. Kurume University: Kurume, Japan 
Background: Cell adhesion molecules play important roles in the inflamma- 
tory process, Among the adhesion molecules, P-selectin exists on platelet 
and endothelial cell (EC), E-selectin on EC. These selectins play an active 
role in mediating those cellular interaction in the initial process of inflamma- 
tion. Kawasaki disease (KD) is known as a multisystem vasculitis associated 
with cardiac complications in children. Recently, administration’of high-dose 
intravenous immune globulin (IVIG) was observed to reduce both the duration 
of fever and the incidence of coronary artery aneurysms when given within 
a few days of the onset of KD. Nonetheless, approximately 10% of patients 
have persistent or recurrent fever despite IVIG. Therefore, the purposes 
of our study are to investigate the pathophysiological role of cell adhesion 
molecules in the patients who had not responded to the initial IVIG treatment 
and to look for the evidence of direct relationship between the soluble cell 
adhesion molecules and the severity of KD vasculitis. 
Methods: The plasma levels of P-, and E-, selectins were measured with 
ELISA in 43 patients with KD inbefore and after IVIG treatment. The 43 
patients comprised 2 groups: Group I consisted of 30 patients who had well 
responded to the initial IVIG treatment. Group 2 consisted of 13 patients with 
IVIG resistant KD. In Group 2, 8 patients had coronary aneurysm. 
Results: Plasma levels of P- and E-selectin in Group 2 before IVIG 
treatment were significantly higher than those in Group 2 (P-selectin; 312 f 
212 vs. 167 + 84 rig/ml, E-selectin; 123 f 31 vs. 70 f 25 rig/ml, p < 00.05). 
After IVIG treatment, there was no significant difference in P-selectin levels 
between Group 1 and 2 (307 i 104 vs. 310 i 84 rig/ml), whereas, plasma 
E-selectin levels in Group 2 remained to be higher than those in Group I 
(175 f 73 vs. 57 f 13 ngfml, p < 0.01). In Group 2, there was no significant 
difference of plasma levels of P-selectins between patients with coronary 
aneurysm (n = 8) and patients with intact coronary artery (n = 5) after IVIG 
treatment (238 f 66 vs. 322 f 106, p = NS). However, significant differences 
in E-selectin levels were found in patients with coronary aneurysm after IVIG 
treatment (162 + 49 vs. 101 f 30 rig/ml, p < 0.01). 
Conclusion: The alterations in plasma selectin levels are important clin- 
ical molecular markers for the understanding of the pathophysiology in KD 
patients. Soluble cell adhesion molecules, especially E-selectin, may have 
possibility to became useful predictor of coronary artery lesion in patients 
with IVIG resistant KD. 
I 1146 163 Prenatal and Postnatal Cardiac Functional Assessment in Patients with Family History of 
Cardiomyopathy 
Simone RF. Fontes Pedra, Lisa K. Hornberger, Samira M. Leal, Glenn 
P. Taylor, Jeffrey Smallhorn. The Hospital for Sick Children, Toronto, 
Ontario, Canada 
Background: Cardiomyopathies (CM) may be familial in 20 to 55% of cases. 
Although serial echocardiographic surveillance of family members of index 
cases is useful in detecting development of disease, little is known about 
the role of fetal echocardiography in patients with a family history of CM. 
The purpose of this study was to evaluate the cardiac function serially both 
prenatally and postnatally in this particular group of patients. 
Methods: Twenty-six patients from 16 families with a family history of CM 
were prospectively studied. Three fetal echocardiograms were performed 
at or near 18, 25 and 32 weeks gestation for complete cardiac functional 
assessment. The postnatal protocol included a clinical evaluation, ECG and 
an echocardiogram within the first 6 months of life, and serial reevaluation 
for those identified with CM. The mean follow-up was 46 & 9 months. 
Results: Abnormal cardiac function was observed in eight patients (30%). 
Six had a previously affected sibling, 1 had another family member affected, 
and 1 had both antecedents. Four were identified with dilated CM prenatally, 
of which 2 died in utero and 1 soon after birth. The other recovered after 3 
years of age. The remaining 4 had normal fetal echoes but were diagnosed 
with abnormal cardiac function in the first 3 months of life. Three of them 
had dilated CM with recovery, and the other restrictive CM requiring cardiac 
transplantation. 
Conclusion: This study demonstrates a high familial recurrence rate of 
CM. Fetal echo is a useful tool for early diagnosis, although a normal study 
does not preclude ventricular dysfunction at a later stage, justifying serial 
pre and postnatal evaluation. Early identification may expedite listing for 
transplantation. 
I 1146 164 Re-Treatment for Immune Globulin-Resistant Kawasaki Disease: A Comparative Study of 
Additional Immune Globulin and Steroid Pulse 
Therapy 
Kanoko Hashino, Masahiro Ishii, Wakako Himeno, Yoko Sugahara, 
Teiji Akagi, Hirohisa Kato. Department of Pediatrics and the Cardiovascular 
Research Institute, Kurume University School of Medicine, Kurume, Japan 
Background: Recently, administration of high-dose intravenous immune 
globulin (IVIG) was observed to reduce both the duration of fever and the 
incidence of coronary artery aneurysms when given within a few days of 
the onset of Kawasaki disease (KD). Nonetheless, approximately 10% of 
patients (pts.) have persistent or recurrent fever despite IVIG. 
Objective: We compared the efficacy of additional IVIG treatments and 
steroid pulse therapy for patients with IVIG-resistant KD. 
Method: From January 1993 to September 1998, 262 pts. with KD were 
treated at Kurume University hospital. All of these pts. had been treated by 
the 9th day of illness with a single dose of IVIG (2 s/kg) and aspirin (30 
mgikglday). Thirty-five pts. (13.4%) who did not respond to the initial IVIG 
treatment, received an additional single-dose treatment with IVIG (1 g/kg) 
within 48 hours after the initial treatment. Seventeen pts. (6.5%) still did 
not respond to the additional IVIG treatment. We randomly divided these 
17 pts. into 2 groups. Group 1 consisted of 8 pts. who were treated with a 
single additional dose of IVIG (1 g/kg). Group 2 consisted of 9 pts. who were 
treated with steroid pulse therapy (methylprednisolone 20 mgikglday, 3 days). 
We look for the coronary artery lesions (CAL) using serial two-dimensional 
echocardiography and coronary angiography. 
Results: The pts. without response to initial IVIG treatment had high 
incidence of CAL (486%). Five pts. (62.5%) in group 1 had a CAL, 2 pts. had 
a giant aneurysm and 3 pts. had a small aneurysm. On the other hand, 7 pts. 
(77.8%) in group 2 had CAL, 2 pts. had a giant aneurysm, 2 pts. had a small 
coronary aneurysm and 3 pts. had a transient dilatation during steroid pulse 
therapy. The incidence of CAL in group 2 tended to be higher than in group 
1, but there was not a statistically significant difference among the 2 groups. 
The duration of high fever after the additional treatment in group 2 (1.4 f 
0.7 days) was significantly shorter than in group 1 (4.8 * 3.4 days) (p < 
0.05). The medical costs of group 2 (113,012 f 22,084 yen) were significant 
cheaper than those in group 1 (144,194 f 12,914 yen) (p < 0.05). C-reactive 
protein levels in group 2 were significantly lower than in group 1 within 48 
hours after re-treatment. 
Conclusion: Steroid pulse therapy may be considered in pts. with IVIG- 
resistant KD for reducing both the duration of high fever and medical costs. 
However, the transient dilatation of the coronary artery was observed dur- 
ing steroid pulse therapy. The serial echocardiographic examinations should 
be underwent during steroid pulse therapy to detect the coronary artery 
abnormalities and to follow its consequences, 
L---l-- 1146 165 Aortic Stiffness is Affected in Marfan Patients Without Aortic Dilation 
Maarten Groenink, Albert de Roos, Barbara J.M. Mulder, Ben Verbeeten Jr., 
Jos A.E. Spaan, Janneke Timmermans, Ernst E. van der Wall. Academic 
Medical Center Amsterdam, Leiden University Medical Center, Nijmegen 
University Hospital the Netherlands 
Background: Marfan patients may develop unanticipated dissection and 
rupture in the entire aorta. Aortic stiffness parameters are related to aortic 
rupture behavior and may serve as additional risk factors for aorlic compli- 
cations before the aorta is dilated. 
Methods: In 78 Marfan patients (A&age 31 f 8 years) with no other known 
aortic dilation than of the aortic root (diameter 43 f 6 mm) and 23 age and 
sex matched controls (Ct), the entire aorta was investigated with magnetic 
resonance imaging (MRI). At 4 chosen levels (Figure I), aortic distension 
and velocity profiles through the aorta were assessed, using gradient echo 
velocity mapping. Distances between levels were measured. Distensibility at 
the 4 levels and the propagation velocity of the flow wave (FWV) along the 3 
aortic segments encompassed by the 4 levels (A: aortic arch, B: descending 
thoracic and C: descending abdominal aorta) were calculated and considered 
to represent local and segmental aortic stiffness, respectively. 
Results: Aortic diameter of the patients did not differ from that of the 
controls at any aottic level. Although average distensibility (10m3 mmHg-‘) 
was significantly decreased at level 1 (n/1:3 i 3 vs. 04 & 2) level 2 (A&3 
f 2 vs. Ct5 -+ 1) and level 4 (M:4 i 2 vs. Ct5 & 3) in the patients, 
large variations were shown at all aortic levels in both groups. Considerable 
variability in flow wave velocities was only shown in the patient group (Figure 
2). In all segments, a significant increased FWV (ms-‘) was shown in patients 
(A:M4.4 vs. Ct4.0, B: M6.6 vs. Ct4.6, C: M5.5 vs. Ct4.6). 
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Conclusions: Marfan patients show increased aortic stiffness along the 
entire aorta in the absence of aortic dilation. Flow wave velocity could be a 
potent marker for increased aortic stiffness in individual patients, because of 
relatively small variability in normal values. 
11146-l 66 1 Ehlers-Danlos Syndrome is not Associated With 
Significant Echocardiographic Abnormalities 
Susan E. Wiegers, Jennifer M. Farmer, Martin G. Keane, Craig H. Scott, 
Frank E. Silvestry, Ted Plappert. nllartin Sr. John Sutfon Dept of Medicine 
University of Pennsylvania Medical Center, Philadelphia, PA, USA 
Ehlers-Danlos syndrome (EDS) is a heterogeneous group of heritable dis- 
orders characterized by connective tissue abnormalities. Cardiac abnormal- 
ities, including mitral valve prolapse (MVP) and regurgitation (MR), aortic 
dilatation (AOD) and aortic regurgitation (AR), have been reported to be 
common in this population. 
Purpose: To evaluate the incidence of echo abnormalities in a large group 
of patients (pt) with confirmed EDS. 
Methods: We performed ethos on EDS pts who attended a genetics 
conference at our institution. Classification of the of EDS type was made ac- 
cording to the revised nosology: Classical (Class), Hypermobile (Hyper) and 
Vascular (Vast). Aortic dimensions and valvular regurgitation were measured 
in the standard fashion. Pts completed a questionaire regarding history and 
symptoms (SYMP). 
Results: Complete ethos were obtained on 65 pt with EDS (average age 
= 38; range 3-84; 58% female) 
EDS type MVP MR AR AOD SYMP 
Class 16 2 (13%) 8 (50%) 
Hyper 38 5 (13%) 8 (21%) 
vasc11 0 4 (36%) 
Total65 7(11%) 20(31%) 
*p < 0.01 compared to other groups 
1 (6%) 1 (6%) 13(81%) 
0 1(3%) 33 (87%) 
3 (27%)' 0 9 (82%) 
4 (6%) 2 (3%) 55 (85%) 
When present, MVP was mild except 1 with moderate MVP and I+ MR. 
3 pt with MVP did not have MR. Isolated MR was common, but mild in 15 
(23%) and 21 in 5 pt (8%). AR was trace in 1, I+ in 2 and 2+ in 1. Aortic root 
dilatation (defined as greater than upper limit of normal for age and sex) was 
present in 2 pts (5%). In subgroup analysis, only a greater prevalence of AR 
in Vast EDS was statistically significant. MVP was not more common in any 
EDS type. 55 pts (85%) had cardiovascular symptoms including dizziness, 
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palpitations, chest pain, dyspnea. 19 (29%) had syncope. There was no 
association between echo abnormalities and symptoms. 
Conclusion: We report the largest series of echocardiograms in EDS 
pts. Mild MR is common but significant MR is rare. Moderate MVP was 
present in only 1 patient. Myxomatous degeneration of the valve was not 
seen, AR and aortic root dilatation were also uncommon and mild when 
present. AR was more common in the Vascular type. Despite the paucity of 
echocardiographic abnormalities, our patients reported a high incidence of 
significant cardiovascular symptoms. 
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/ 1170 160 Potential for Intra-Atrial Reentrant Tachycardia Prior to the Fontan Operation 
Ian H. Law, Anna R. Crocenzi, Peter S. Fischbach, Ralph S. Mosca, Edward 
L. Bove, Thomas R. Lloyd, Albert P. Rocchini, Macdonald Dick II. University 
of Michigan Congenital Heart Centeer, University of Michigan Health 
Systems, Ann Arbor; Michigan, USA 
Background: Clinical intra-atrial reentrant tachycardia (IART) is a well known 
sequelae of the Fortran operation, occurring in IO-40% patients. Little is 
known about the potential for IARl- prior to the Fontan operation. 
Methods: A prospective study was performed to examine the incidence 
and associated risk factors of inducible IART in a pre-Fontan population 
(n = 39, male = 27). Diagnoses, patient characteristics, echocardiographic, 
catheterization, and electrophysiologic data were recorded. IART induction 
protocol included atrial burst and extrastimulation, with and without isopro- 
terenol. 
Results: Mean age of the study population was 1.8 yrs (1.2-5.2 yrs). Di- 
agnoses of the 39 patients included: hypoplastic left heart syndrome (n = 18), 
pulmonary atresia with intact ventricular septum (n = 5) double outlet right 
ventricle (n = 3) unbalanced atrial ventricular septal defect (n = 3), and other 
single ventricle malformations (n :: 10). 37 patients were in sinus rhythm, 1 
in junctional rhythm, and 1 in low atrial rhythm at baseline. 11 patients (28%) 
had inducible sustained (>I minute), IART (SIART); 9 had the hemi-Fontan 
procedure (HFP), 2, a bi-directional Glenn. An additional 3 patients (8%) had 
inducible non-sustained IART, all following HFP. Patients who had SlARTwere 
significantly older (1.7 v 2.1 yrs, p = 0.029), had longer baseline cycle lengths 
(BCL) (743 v 543 ms, p O.OOOl), had prolonged atrial effective refractory peri- 
ods (AERP) (237 v 181 ms, p = 0.015), and were more likely to have atrioven- 
tricular valve regurgitation (AWR) by echo (p = 0.044). No significant differ- 
ences were found in patients’ gender, diagnoses, sinus node recovery times, 
total sinoatrial conduction times, pulmonary artery pressure and resistance, 
left atrial pressure, ventricular function, or semi-lunar valve regurgitation. 
Conclusion: Inducible SIART in a pre-Fontan population is 28% (similar 
to a reported 27% inducible SIART in a post-Fontan population) and is 
associated with older age, longer BCL, prolonged AERP, and AVVR. 
1170-I 61 Flecainide and Sotalol: A New Combination 
Therapv for Refractory Supraventricular 
Tachycardia in Infants . 
Jack F. Price, Naomi J. Kertesz, Christopher S. Snyder, Richard 
A. Friedman, Arnold L. Fenrich, Jr.. Texas Children’s Hospital, Baylor 
College of Medicine, Houston, Texas, USA 
Background: Supraventricular tachycardia (SVT) in infants can be refractory 
to single and combination drug therapy. Radiofrequency ablation (RFA) for 
SVT in infants poses a high risk of morbidity and mortality. The purpose of 
this study was to assess the efficacy and safety of the combination therapy 
of flecainide and sotalol for refractory SVT in infancy. 
Methods: A retrospective chart review was performed, identifying infants 
who required flecainide and sotalol to control refractory SVT. Patient (pt) 
age, previous drug therapy, duration of treatment, flecainide trough levels 
and corrected QT intervals were recorded. 24-hour Holter monitoring was 
utilized to gauge efficacy of treatment. Efficacy was defined as suppression 
of SVT to no more than rare 3-beat runs of tachycardia or slowing of SVT to 
a clinically tolerable rate. 
Results: Nine infants (median age 14 days, range l-241 days) failed at 
least two antiarrhythmic agents including either flecainide or sotalol before 
initiating combination therapy of flecainide and sotalol. During combination 
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therapy, efficacy was achieved in all 9 pts. SVT was suppressed in 8 pts, 4 
with Wolff-Parkinson-White Syndrome (WPW), 3 with the permanent form of 
junctional reciprocating tachycardia (PJRT), and 1 with atrial ectopic tachy- 
cardia. SVT was slowed to a clinically tolerable rate (145 bpm) in 1 pt with 
PJRT. The mean doses used were: flecainide 101 mg/m*/day (range 65-150) 
and sotalol 174 mg/m2/day (range 100-250). Flecainide trough levels ranged 
from 125-775 ng/mL. In non-WPW pts, corrected QT intervals all remained 
less than 440 msec. No proarrhythmia occurred and no pt exhibited signs 
of compromised cardiac function during follow up. The mean duration of 
combination therapy was 17 months (range 6-33). Four pts, all >I6 months 
of age, underwent RFA: 1 with slowed PJRT and 3 with recurrence of S/T 
after discontinuation of combination therapy. Of the remaining 5 pts, 3 are 
off combination therapy and free of SVT, 1 is still treated with combination 
therapy and 1 was lost to follow up 14 months after beginning therapy. 
Conclusion: These data suggest that the combination of flecainide and 
sotalol can safely and effectively control refractory SVT in infants. Because of 
the high incidence of resolution of infant-onset SVT, this therapy may obviate 
the need for RFA in infancy. When SVT does not resolve, it may allow for 
delay of RFA to an older age. 
1 1170-I 62 1 Comparison of Acute and Chronic Performance 
of lntramyocardial Versus Epicardial Steroid 
Eluting Ventricular Pacing Electrodes 
Gerald A. Serwer, Ian H. Law, Peter S. Fischbach, Macdonald Dick II, 
Sarah Leroy, Kristen George. University of Michigan Congenital Heart 
Center, Ann Arbor, Ml, USA 
Background: Since the introduction in late 1996 of the epicardial steroid 
eluting pacing electrode (Medtronic 4965), it has become widely used for 
epicardial pacing in children largely replacing the intramyocardial (Medtronic 
5069) electrode. Yet comparison of the. acute and long-term performance of 
these 2 electrodes in a similar patient population has not been performed. 
Methods: Since January 1997 the 4965 electrode has been used exclu- 
sively at our institution with 44 implanted. They were compared with 37 5069 
electrodes implanted from 1995 through 1996 in a similar patient population. 
Acute thresholds (mean rt SD) were determined at a pulse width of 0.5 ms. 
Chronic pulse width thresholds in ms (mean f SD), measured at 2.5 V am- 
plitude, were performed within 1 week of implant, 2-4 mos, 6 mos, 1 yr, and 
2 yrs post implant. 
Results: Acute thresholds were: 
4965 5069 p value 
Volts (V) 0.93 * 0.59 0.69 * 0.35 0.03 
Current 2.87 5 2.0 1.69 + 0.13 0.003 
Resistance(n) 358A62 428+110 0.001 
Sensing (mv) 13.5 * 6.0 17.6f14.0 0.40 
No electrode fractures occurred during the study period. One in the 4965 
group would not pace at 2.5 V by 2-4 mos. Six in the 5069 group would not 
pace at 2.5 V - 1 by 2-4 mos, 3 by 1 yr, 2 by 2 yrs. Chronic thresholds were: 
4965 5069 p value 
lweek 0.06 h 0.02 0.07 f 0.03 >0.3 
2-4mos 0.12 * 0.06 0.19 AZ 0.06 0.01 
6mos 0.15 5 0.06 0.40 f 0.2 0.015 
1 Yr 0.12 i 0.04 0.35 * 0.22 0.015 
2yrs 0.10 f 0.01 0.33 + 0.21 0.005 
Conclusions: Acute 5069 thresholds are superior to the 4965, yet chronic 
4965 thresholds remain low showing no significant rise (p = 0.2) over 2 yrs. 
Chronic 5069 thresholds begih as low as the 4965 thresholds but show 
an elevation (p = 0.001) by 2-4 mos with no significant change thereafter. 
From 2-4 mos on they are significantly higher than the 4965 thresholds. Low 
long-term thresholds make the 4965 a superior electrode in children, who 
require long-term pacing, by allowing lower generator output settings. 
I i i 70 163 Endocardial Mapping and Radiofrequency Catheter Ablation of Atrial Reentrant 
Tachycardia in Young Patients After Surgical 
Correction of Congenital Heart Disease With a 
Novel Non-Contact Mapping System 
Thomas Paul, Jtirgen Tebbenjohanns’ , Harald Bertram, Thomas Kriebel, 
Gerd Hausdorf. Depfs. of Pediatric Cardiology; ‘Cardiology, Hannover 
Medical School, Hannover, FR Germany 
Background: Results of radiofrequency catheter ablation of atrial reentrant 
tachycardias (ART) in young patients after surgical correction of congenital 
heart disease are impaired by the limitations of standard mapping techniques. 
Methods: In 5 young patients (status post Fontan operation n = 3, status 
post Mustard procedure for d-transpostion of the great arteries n = 1, sta- 
tus post surgical correction and mitral valve replacement for atrioventricular 
septal defect; mean age 13.8 years, range 10.8-18 years) electrophysiolog- 
ical study using the Ensite 3000’” system was performed due to recurrent 
ART resistant to medical treatment. The multielectrode Ensite balloon array 
was inserted into the systemic venous atrium. After introducing a standard 
7 F mapping and ablation catheter the anatomy of the atrial chamber was 
reconstructed using the Enguide signal. 
Results: 7 different forms of atrial reentrant tachycardia were inducible 
in the 5 patients studied. From all those tachycardias the activation wave 
front could be characterized and localized with respect to anatomical land- 
marks like atriotomy scars, intraatrial patches/baffles and cardiac structure 
using the display of m&e than 3000 calculated electrograms within the 
3-dimensioval model of the endocardial surface. Pattern of activation front 
was verified by analysis of virtual electrograms. In 4/7 tachycardias (in 3/5 
patients) the critical area of slow conduction could be localized within the 
systemic venous atrium. All these tachycardias could be terminated by cre- 
ation of linear radiofrequency current lesions (75 “C, 180-240 set) between 
anatomical landmarks and structures of electrical isolation. Completeness of 
linear lesions was proven by atrial pacing techniques after radiofrequency 
current delivery. Mean duration of the procedures was 308 (250375) min, 
fluoroscopy time ranged from 15-33.8 (21.7) min. 
Conclusion: In young patients with ART after surgical correction of con- 
genital heart disease, the use of the non-contact mapping system allows 
characterization of the tachycardia and guidance of effective radiofrequency 
current delivery. 
U Children 
1170 164 Electroanatomical Mapping of Arrhythmias in 
Jose L. Pumarino, Ming-Long Young, Grace S. Wolff. Department of 
Pediatrics, University of Miami, Miami, Florida, USA 
Background: Mapping of cardiac arrhythmias is pet-formed routinely with a 
2-D fluoroscopic method. For complex arrhythmias this method cannot pro- 
vide detailed information. The non-fluoroscopic 3-D electromagnetic mapping 
system (Carto@) displays anatomical images and electrical data simultane- 
ously and provides greater precision for radiofrequency ablation. 
Methods: We present 7 children with complex arrhythmias (age IO f 
3.5 years old, weight 37 f 12 kg) in whom we performed 3-D mapping 
and radiofrequency ablation. Four patients had atrial flutter (AF). Three of 
them were surgical AF (s/p Fontan operation: 1, s/p ASD repair: 2). Two 
patients had ectopic atrial tachycardia (EAT), and one patient had recurrent 
preexcitation syndrome. Three of the 7 patients had previous unsuccessful 
radiofrequency ablation by conventional method. 
Results: For patients with AF, 3-D mapping showed a counterclockwise 
reentry loop around the tricuspid valve ring in 1 patient; clockwise reentry 
loop around the right atrium in 2 patients, and reentry loop around patches of 
atrial scar tissue in 1 patient. Three of these patients had successful lineal ra- 
diofrequency ablation. In the patient with reentry loop around scar tissue, the 
AF was modified from incessant into intermittent pattern. One of the patients 
with EAT had multiple foci located at the right and left upper pulmonary veins, 
and at the posterior wall of the left atrium. These were ablated successfully. 
The other patient with EAT had a focus in the basal portion of the left atrial 
appendage and was successfully ablated. The patient with preexcitation syn- 
drome had a right lateral accessory pathway with intermittent conduction that 
made it difficult to map and perform radiofrequency ablation. In summary, 
this procedure was successful in 5 of the 7 patients. 
Conclusion: This system allowed detailed reconstruction of the cardiac 
geometry and activation sequence of complex arrhythmias in children, and 
enhanced the chance for a successful radiofrequency ablation. 
1 1170-l 65 1 A Comparison of Transesophageal and 
Intracardiac Induction of Atrial Fibrillation in 
Children: Implications in Wolff-Parkinson-White 
Syndrome 
Brian A. Jacquette, Michael P. Carboni, Jennifer S. Li, Ronald J. Kanter. 
Duke University Medical Center, Durham, NC, USA 
Background: Risk assessment in children with Wolff-Parkinson-White syn- 
drome (WPW) requires induction of 260 s atrial fibrillation (AF), traditionally 
by intracardiac pacing (ICP). We compared induction of AF (?I0 s duration) 
by transesophageal pacing (TEP) with ICP during electrophysiologic testing 
under anesthesia. 
Methods: 38 pts (10.4 years; 2-17) thought to have supraventricular (37) 
or ventricular tachycardia (1) were studied. 17 had WPW. From 2-4 pacing 
protocols were performed: TEP-I and ICP-1 (lower output, random order), 
followed by TEP-2 and ICP-2 (higher output, random order). Each protocol 
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went from less to more aggressive (S2+S3+S4+8 beat runsirapid burst), 
and endpoint for each site (TEP; ICP) was sustained AF (?60 s). 
Results: AF was induced in 18/38 pts by TEP, but >S4 was required in 
13. In WPW pts, TEP was as likely as ICP to induce AF; TEP was more likely 
to induce AF in WPW vs other pts: 
MMedvxl omcinrg: TEF ICP Either 
SustainedAF was induced in 10138 pts (7117 WPW vs 3/21 non-WPW, p = 
0.067). Measurements of atrial refractqriness did not explain any of the above 
findings. Among the 7 WPW pts having su.sfainedAF, measurements known 
to be related to risk of sudden death are plotted in IO s cumulative intervals: 
400 
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m* 
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Conclusions: 1) In WPW pts only, TEP is as useful as ICP for induction 
of AF lasting 210 s; 2) TEP is more likely to induce AF > 60 s in WPW vs 
other pts; 3) Induction of AF required more aggressive TEP than is used in 
diagnostic studies; and 4) The clinical usefulness of AF z IO s but ~60 s is 
yet to be determined. 
1170-l 66 Autonomic Abnormalities After Tetralogy of 
Fallot Repair 
Ruchir Sehra, Susan P. Straka, Joyce E. Hubbard, Douglas P. Zipes. 
lndiana Universify School of Medicine, Indianapolis, Indiana, USA 
Background: Patients who have undergone tetralogy of Fallot (TOF) repair 
have a 16% incidence of arrhythmic sudden death. As autonomic abnor- 
malities can be risk factors for sudden death aider myocardial infarction, the 
objective of this study is to determine whether TOF patients exhibit autonomic 
abnormalities. 
Methods: 11 TOF patients (7 F, 4 M; 6 pediatric (mean 15 y.o.) and 5 adult 
(mean 26.2 y.0.)) and 34 normal subjects (17 F, 17 M; 10 pediatric and 24 
adult) underwent three standard autonomic function tests (deep breathing, 
handgrip stress, Valsalva maneuver) and 24 hour Holter monitoring for time- 
and frequency-domain heart rate variability (HRV) analysis. Two way analysis 
of variance (ANOVA) was used for statistical comparisons. 
Results: During the handgrip test, TOF patients did not exhibit as high 
an increase in heart rate as controls (TOF mean 6.1%, Controls 17.2%; p = 
0.032) indicating higher resting sympathetic tone. No differences were noted 
during deep breathing or Valsalva tests. Significant (p < 0.05) differences, 
all consistent with increased sympathetic tone, were noted in the following 
HRV measures: standard deviation of RR intetvals (TOF mean 128 ms vs 
control 171 ms), root mean square of the standard deviations (37.5 vs 52), 
percent of consecutive RR intervals with ~50 ms difference (15% vs 24%), 
low frequency power (6.1 In (ms)” vs 7.1), high frequency power (5.2 vs 6.1), 
and total power (7.2 vs 7.9). Decreased high frequency power is also noted 
with altered parasympathetic tone. 
Conclusion: Autonomic abnormalities consistent with increased sympa- 
thetic tone and altered parasympathetic tone can be demonstrated in patients 
who have undergone TOF repair. Whether these abnormalities help predict 
those TOF patients who will experience ventricular tachycardia and/or sud- 
den death remains to be determined. 
POSTER 
El 1192 Fetal and Neonatal Cardiology 
Tuesday, March 14, 2000, 3:00 p.m.-%00 p.m. 
Anaheim Convention Center, Hall A 
Presentation Hour: 3:00 p.m.-4:OO p.m. 
III 1192 160 Fetal Ductal Constriction and Its Relation to Perinatal Cardiopulmonary Development 
to cause ductal constriction and right ventricular (RV) failure in the fetus. RV 
failure may induce a reduction in RV output and subsequent morphological 
changes in pulmonary vasculature. However, there is no information about 
the effect of fetal ductal closure on perinatal vascular development. We 
therefore examined the effects of fetal ductal closure on the morphological 
and histological changes in cardiopulmonary system. 
Methods: IND 10 mgikg was administered to the maternal rat on the 21 st 
day of pregnancy. Using the whole body freezing technique, morphology of 
the cardiac chambers and pulmonary vessels of the fetus at 24 hours after 
drug administration and neonatal rats at 2 days after birth was studied. Pul- 
monary histopathoiogical study was also performed. Results were compared 
with values of normal controls. 
Results: The fetal ductus was constricted (-93%, p < 0.01) by maternally 
administered IND. In the treated fetal rats, concentric RV hypertrophy was 
shown by a diminished RV volume (-51%, p < 0.01) and increased RV wall 
thickness (+65%, p < 0.01). The diameters of pulmonary artery (PA) and 
vein (PV) showed no significant differences between the IND group and the 
controls. In the neonatal rats maternally administered IND, further decrease 
in RVvolume was observed (-72%, p < 0.01) with increases in left ventricular 
volume (+35%, p < 0.05) and the diameter of foramen ovale (+95%, p x 0.01) 
compared with controls. In addition, the PA and PV diameters were smaller 
than those in the normal neonatal rats (-35% and -38%, respectively, p 
< 0.01). Histopathological study revealed no significant change in medial 
thickness of treated neonatal pulmonary artery. 
Conclusion: In our experimental animal model, severe RV failure during 
uterine life induce an underdevelopment of pulmonary vessels after birth 
without histological changes in persistent pulmonary hypertension. 
L--L 1192 161 Studies of Flow in Accurate Models of Early Embryonic Human Heart 
David J. Sahn, Kent L. Thornburg, Brandon L. Thornburg, Jeffrey 
0. Pentecost, Morteza Gharib, Hilla Shaviv, Susan L. Martin. Oregon Health 
Sciences University, Port/and, OR; California /n&&e of Technology, 
Pasadena, CA, USA 
Background: In this study, we developed accurate models of the lumen of 
stages 9 and 11 human embryonic hearts and developed 3D velocity vector 
maps of flow by high speed digital video imaging of laser fluorescent particles 
in an embryonic heart flow simulator. 
Methods: Stages 9 and 11 hearts from the Armed Forces Institute of 
Pathology collection of early human embryos were digitized as calibrated 
cross-sectional microscope slide sets and a computer 3D model of the lumen 
shape was developed using Alias software on a Silicon Graphics workstation. 
The 3D data lumen files were programmed into a laser stereolithography 
system to make accurate solid lumen objects scaled up to 6 and 11 cm 
length, exactly matching the 3D shapes developed in the computer model. 
Around these were cast compliant, transparent silicon jackets to yield lumen 
tubes exactly matching the shape of the lumen models. The embryonic flow 
simulator had dual caval inlets and dual arch outlets and was programmed 
for a minimally sinusoidal flow pressure waveform with pressures 0.2-l .7 
mmHG and mean inlet velocities of 4-10 cm/set. 
Results: Consistent observations of major importance at these 2 stages 
were: 1) twin vortices in the inlet ventricular portion of the stage 9 model, 
which increased the pulsatility of flow in the outlet portion by phase interaction; 
and 2) ventral-dorsal/right-left separation of flow in the outlet arch portion of 
stages 9 and 11, a precursor of spiral flow in the bulbus conus and arches. 
Conclusion: The models provide a unique opportunity for study of fluid 
dynamics in the early embryonic human heart, in shapes that reproduce the 
embryonic lumen of the heart in blumans. 
Tomomi Orino, Kenji Harada, Goro Takada. Akita University School of 
Mediicine, Akita, Japan 
Background: Maternally administered indomethacin (IND) has been known 
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L-.-L-- II 92 162 Is There an Indication for the Use of Sotalol in Fetal Tachycardia? 
Martijn A. Oudijk, Maaike M. Michon, Charles S. Kleinman, Livia Kapusta, 
Philip Stoutenbeek, Gerard H.A. Visser, Erik J. Meijboom. Wilhelmina 
Children’s Hospital, University Medical Center; UtrechtlNijmegen, The 
Netherlands; Yale New Haven Hospital, CT; USA 
Background: Fetal tachycardia may cause fetal hydrops and subsequently 
lead to fetal death. Unanimity of opinion regarding the optimal treatment has 
not yet been reached. This study evaluates our experience with transplacen- 
tal sotalol therapy in the treatment of fetal tachycardias in terms of safety and 
efl icacy. 
Methods: Patients (n = 21) treated with sotalol for fetal tachycardia were 
studied retrospectively. 
Results: Atrial flutter (AF) occurred in 10/21, 10121 had supraventricular 
tachycardia (SVT) and l/21 had ventricular tachycardia (VT). Fetal hydrops 
was present in Q/21 fetuses at the moment of diagnosis. Pharmacological 
intervention resulted in the establishment of sinus rhythm in 7d (SEM f 3.12) 
in 8/10 fetuses with AF and in 6/10 fetuses with SVT. Resolution of fetal 
hydrops occurred in all fetuses treated successfully in a mean period of 14 
days (SEM f 4.43). Intra-uterine death occurred in 4/21 (19%). All deaths 
were related with medication changes, 3 just days after initiation of sotalol 
therapy, 1 other after dosage increase, SVT was present in 3, only 1 had AF. 
At birth, tachycardia was present in 6 fetuses, 3 SVT, 2 AF and 1 VT. This last 
patient proved to have a VT based on a prolonged QT- segment syndrome 
with a Torsade de Pointes type of VT. Two patients converted in utero to 
sinus rhythm, but were found to suffer from neurologic pathology postnatally. 
Maternal adverse effects were encountered in two cases and were due to 
the B-blocking properties of Sotalol, both were mild and temporarily. 
Conclusions: Fetal tachycardia is a serious condition in which treatment 
should be initiated especially in the presence of fetal hydrops. The high 
success rate in fetal AF suggests that sotalol should be considered as drug 
of first choice for AF. The low conversion rate and high mortality indicate that 
in the treatment of fetal SVT the risks of sotalol therapy outweigh the benefits 
and should therefore be omitted. 
I 1192 163 Outcome of Prenatally Diagnosed Congenital 
Heart Disease Detected Between 1993-l 999 
David H. Brick, Lindsey D. Allan. The New York Presbyterian Hospital, 
Columbia University New York, New York, USA 
Background: The diagnosis and management of prenatally diagnosed con- 
genital heart disease is an important aspect of pediatric cardiology practice. 
The natural history of fetal congenital heart disease is known to be different to 
that seen in postnatal life. This report describes the outcomes of patients with 
prenatally diagnosed congenital heart disease as a group, and by diagnostic 
groups. 
Methods: All of the patients referred to our institution for fetal echocar- 
diography, where the fetus was found to have congenital heart disease, were 
included in this report. The reason for referral, diagnosis made, and current 
status of these patients were documented. 
Results: Congenital heart disease was identified in 367 patients who had 
fetal echocardiograms at The New York Presbyterian Hospital. The com- 
monest diagnostic categories involved abnormalities of the four-chamber 
view such as the hypoplastic left heart syndrome (51 cases) and atrioventric- 
ular canal defects (55 cases). The mean gestational age at diagnosis was 
27 weeks. Of the total group, 23% of pregnancies were interrupted and 4% 
suffered intrauterine demise. There was a 70% survival rate in the continu- 
ing pregnancies. The majority of deaths in this group (74%) occurred in the 
neonatal period. The rates of termination, intrauterine demise, and postnatal 
survival varied according to the underlying diagnosis and the association with 
other anomalies. 
Conclusion: Appropriate management of prenatally diagnosed congeni- 
tal heart disease requires knowledge of the natural history of different forms of 
cardiac lesions. The pediatric cardiologist offering prenatal counseling must 
have a clear understanding of the outcome from the time of fetal presenta- 
tion. This data must be updated as new surgical techniques and interventions 
change the prognosis of specific heart lesions. 
I 1192 164 The Use of Flecainide in the Treatment of Fetal 
Supraventricular Tachycardia 
Eric S. Ebenroth, Timothy M. Cordes, Robert K. Darragh. James Whitcomb 
Riley Hospital for Children, Indiana Universiv School of Medicine, 
Indianapolis, IN, USA 
Background: Fetal supraventricular tachycardia (S/T) is a common reason 
for referral for fetal cardiac evaluation. Digoxin has been widely demonstrated 
as a safe and effective treatment for fetal SVT. Second line therapy, however, 
remains more controversial. 
Methods: This study evaluated the efficacy of maternal flecainide as sec- 
ond line therapy in the treatment of fetal SVT. The charts of women referred 
to Indiana University Hospitals for fetal echocardiography were reviewed. 
Forty cases were identified from August 1988 to July 1999. 
Results: Thirty-seven patients received digoxin as first line therapy, while 
three were delivered outright. Seventeen fetuses (46%) converted and main- 
tained sinus rhythm until delivery. Flecainide was used in 13/15 patients who 
required second line therapy converting the SVT to sinus rhythm in 12/13 
(92%). Six of eight patients with fetal hydrops failed to convert on digoxin 
alone. Four of these hydropic fetuses were then treated with flecainide and 
successfully converted. The improved efficacy of flecainide as compared to 
digoxin alone in conversion of fetal SVT was statistically significant with a 
p value < 0.05. Complete follow up was available in 13 digoxin treated in- 
fants and in 10 of the infants requiring second line therapy. Prolonged and/or 
multiple drug therapy for postnatal arrhythmia management was required in 
3/13 (23%) patients in the digoxin group and in 6/10 (60%) patients requiring 
second line therapy. Although this was suggestive of a correlation between 
complex disease and need for second line fetal therapy, it was not statistically 
significant with a p value of 0.10. 
Conclusions: Digoxin remains a safe and effective first line therapy in 
the treatment of fetal SVT. Flecainide is a very effective second line therapy, 
especially in the face of fetal hydrops. With appropriate management, it 
should be possible to convert nearly any fetus, including those with hydrops 
fetalis, to a stable rhythm and deliver at or near term. Use of second line 
therapy in fetal SVT may also be a predictor of more complex postnatal 
course and these patients should be followed more closely. 
I 1192 165 Outcome of Children With Fetal, Neonatal or Childhood Diagnosis of Isolated Complete Heart 
Block (CHB). A Single Institution’s Experience of 
30 Years 
E. Jaeggi, R.M. Hamilton, E.D. Silverman, L.K. Hornberger. The Hospital for 
Sick Children, University of Toronto, ON, Canada 
We reviewed our institution’s 30 years experience with isolated Crib to identify 
predictors of prenatal and postnatal outcome. Since 1965, CHB was diag- 
nosed in 102 cases at our tertiary referral center, 29 in utero (F) at 26.1 & 5.6 
gestation weeks, 33 as newborn (N), and 40 during childhood (C) at 5.7 f 4.8 
years of age. Maternal Anti-ROSS-A antibodies were demonstrated in 95% 
of F and 90% of N, but only in 17% of C mothers tested (p < 0.0001). Mean 
age at delivery was 35.1 f 3.5 (F) and 39.2 f 2.5 (N) gestation weeks (p < 
0.0001). Figure 1 shows mortality rate and figure 2 freedom from pacemaker 
implantation for the 3 patient groups. 
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Mortality was associated with fetal diagnosis of CHB (13/15 deaths), 
hydrops (6/6; p < 0.01) endocardial fibroelastosis (5/5; p = O.Ol), and 
delivery 5 32 weeks gestation (4/6; p < 0.001). 
Conclusions: Prenatal diagnosis of CHB is associated with high fetal 
and neonatal mortality (43%). Among survivors, most require pacemaker 
implantation during infancy (F) or childhood (N,C). 
1192-l 66 lschemia Tolerance of the Neonatal Rabbit Heart: 
The Role of the KArp Channel 
Jun Feng, Hong-Ling Li, Eliot Ft. Rosenkranz. The Children’s Hospifal of 
Buffalo and The State University of New York at Buffalo, Buffalo, New York, 
USA 
Backgroun,d: Neonatal rabbit hearts are more tolerant to ischemia than adult 
rabbit hearts. This study tests the hypothesis that mechanisms dependent on 
activation of the ATP-sensitive potassium channel (KATP channel) improve 
ischemia tolerance in neonates and can be attenuated by pretreatment with 
the KATP channel blocker Glibenclamide. 
Methods: Neonatal and adult rabbit hearts were retrogradely perfused 
with Kreb’s Henseleit solution (KHB) on a Langendorff apparatus. All hearts 
underwent 20 minutes of 37°C global ischemia followed by IO minutes of 
reperfusion. Seven neonatal and 5 adult rabbits received intraperitoneal 
saline pretreatment prior to harvesting the heat-i (Control). Five neonates 
received pretreatment with intraperitoneal Glibenclamide (0.3 mgfkg) before 
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harvesting the heart and were perfused with 10 PM Glibenclamide in the 
KHB. LV developed pressure (LVDP) and +dP/dt were recorded. 
Results: Saline treated adult hearts showed significant depression of 
LVDP (54%)t and +dP/dt (51 %)t after reperfusion compared to 84% recovery 
of both LVDP and +dP/dt in saline treated neonates. As shown in the table 
below, Glibenclamide pretreatment in neonates significantly reduced their 
recovery of LVDP and +dp/dt compared to saline treated neonates. 
Glibenclamide (Glib) Pretreatment in Neonatal Hearts 
Group LVDP (mmHg) 
Preischemia Reoerfusion 
+dP/dt (mmHg/sec) 
Preischemia ReDerfusion 
Control 84 f 4 68 & 4 (84%)+ 1471 * 34 1236 * 36 (84%) 
Glib 61 & 6’ 41 + 5 (67%)‘+ 1274*51’ 797 i 86 (62%)“+ 
* = p < 0.01 vs Control (t-test), () = % Preischemia, 7 = p < 0.01 vs Preischemia 
Conclusions: Glibenclamide pretreatment of neonatal hearts significantly 
reduced their tolerance to global ischemia. We believe this demonstrates that 
an endogenous K,,rp channel-dependent mechanism contributes to their 
superior ischemia tolerance compared to adult hearts. 
ORAL 
/9031 Pediatric Interventional Catheterization III 
Wednesday, March 15, 2000, 8:30 a.m.-l 0:OO a.m. 
Hilton Anaheim, California A 
8:30 a.m. 
I 903 1 Stenting of Severely Hypoplastic Pulmonary 
Arteries in Pulmonary Atresia With Venticular Septal 
Defect (PA/VSD) Following Early Repair 
Mark Vranicar, David F. Teitel, Phillip Moore. University of California, San 
Francisco, San Francisco, California, USA 
Background: Branch pulmonary artery stenosis occurs in PANSD even 
with early unifocalization of aottic to pulmonary artery collaterals. Balloon 
dilation in very hypoplastic vessels is often unsuccessful. We reviewed our 
experience with treatment of these small vessels in young children using 
balloon expandable stems. 
Methods: In an attempt to promote distal pulmonary artey growth in 
hypoplastic pulmonary arteries, 15 small stents were placed in 12 severely 
stenotic pulmonary artery lesions in IO patients with TOF/PA between April 
1995 and July 1999. All patients had prior surgery including right ventricle 
to pulmonary artery homograft and either unifocalization of multiple aorta to 
pulmonary artery collaterals (n = 7) or patch augmentation of hypoplastic 
confluent pulmonary arteries (n = 3). Six of 10 had VSD closure at surgery. 
Median age at stent placement was 1.4 yrs (range 1 .I to 4.7 yrs) and time 
from surgical repair was a median of 12 mos (2 to 49 mos). One patient had 
3 stenotic segments stented, while all others had a single segment or branch 
stented. Three of the 12 stenotic lesions required 2 stents. All but 1 stent was 
delivered using either a 3, 3.5, or 4 mm balloons. 
Results: Following stent placement there was an increase in stenosis 
vessel diameter from 1.5 i 0.6 to 3.4 i 1 .O mm (p < 0.0001). There was no 
immediate change in right ventricle to aortic systolic pressure ratio in those 
whose VSDs were closed. Complications were limited to balloon rupture 
during stent placement in one patient resulting in adventitial staining without 
sequela. Pre and post lung perfusion scans were performed in 9/l 0 patients 
with an increase in blood flow to the stented lung (27% vs 34%, p c 0.05). 
Three of IO patients required repeat catheterization at 1.5, 4 and 5 months 
for stent re-stenosis. Two of these had additional stents placed with acute 
improvement while one lesion had total occlusion and could not be dilated. 
One patient underwent surgical pulmonary artery reconstruction and stent 
removal 4 months later after distal vessel growth had occurred. Two patients 
died late (at 6 and 24 months) unrelated to stent placement. 
Conclusion: Stenting of hypoplastic pulmonary arteries in PAiVSD results 
rn immediate improvement in vessel size and blood flow. Distal bed growth 
occurs in some patients. Stent r-stenosis is common due to the small stent 
size used in these hypoplastic vessels. Stenting of these lesions should be 
reserved for only those patients unresponsive to other interventions. 
8:45 a.m. 
I Arch 
903-2 Stenting of the Hypoplastic Transverse Aortic 
C. lgor Mesia, John F. Rhodes, Lourdes R. Prieto, Larry A. Latson. The 
C/eve/and Clinic Foundation, C/eve/and, Ohio, USA 
Background: Surgical management for hypoplasia of the transverse aortic 
arch associated with coarctation requires cardiopulmonary bypass and cir- 
culatory arrest Stem implantation to enlarge the hypoplastic segment has the 
potential to avoid these surgical risks. There are no available data concerning 
intermediate results of stenting of the transverse arch. 
Methods: Between 1993 and 1999, ten of twenty-three patients treated 
by stent implantation for aortic obstruction had a hypoplastic transverse aortic 
arch as the major site of the gradient. Stents were implanted under general 
anesthesia between the left carotid artery and the left subclavian artery in 
six patients and just distal to the left carotid artery in four patients who had 
previous coarctation repair with a left subclavian flap. 
Results: All patients had previously undergone a surgical procedure for 
repair of typical coarctation of the aorta. The median age at stent placement 
was 15 (range from 12 to 63) years. Peak systolic pressure gradients by 
blood pressure cuff prior to stent implantation were 18 to 70 (mean 43) 
mmHg. Under general anesthesia, during the catheterization procedure, the 
peak systolic pressure gradient was reduced from 32.7 & 22.7 to 2.9 & 4.2 
mmHg (p < 0.001). PalMaz P308 (8 patients) or NuMED CP (2 patient) 
stems were expanded by balloons increasing the narrowest diameter of the 
arch from 8.6 & 2.7 to 14.8 & 2 mm @ < 0.001). In all cases, there was 
no or minimal extension of the stent into the carotid lumen. There were no 
early or late complications associated with the stents. One patient had further 
expansion of the stent 39 months after initial placement with resolution of 
the gradient. At a mean follow up of 17.7 (range 0 to 67) months, 8 patients 
were normotensive (systolic BP < 140 mmHg). One patient, with a known 
residual stenosis proximal to the stent, had a 24 mmHg gradient. Another 
patient, with a diffusely small aorta and a gradient of 18 mmHg is due for stent 
re-expansion. Excluding these two patients, the arm/leg pressure gradient 
was 0 to 7 (mean 2.6) mmHg. 
Conclusion: Stent implantation to relieve stenosis or hypoplasia in the 
transverse aortic arch is effective and can be performed with low morbidity. 
Intermediate term follow up indicates persistent relief of obstruction. 
9:00 a.m. 
903-3 Intermediate Term Outcome of Fledilation of 
Endovascular Stems 
Colin J. McMahon, Howaida G. El Said, Ronald G. Grifka, Michael R. Nihill, 
Charles E. Mullins. Baylor College of Medicine, Texas Children’s Hospital, 
Houston, Texas, USA 
Background: Endovascular stent implant for congenital heart disease (CHD) 
is well established as an effective therapeutic modality. The intermediate term 
outcome following redilation of endovascular stents to accommodate somatic 
growth or restenosis remains unknown. 
Methods: We retrospectively analyzed all patients who underwent en- 
dovascular stent redilation and repeat stent implant between 1 O/90 and 5/99. 
Pts were divided into six groups according to anatomy. 
Results: Of 752 stents that were placed in 347 pts, 192 stents in 98 pts 
(28%) underwent redilation once (40 of whom were restented), 22 redilated 
twice, and 4 redilated three times. Follow-up ranged from 0.1 to 8.0 years 
(mean 1.98 years). Group A: Tetralogy of Fallotfpulmonay atresia repair 
(TOFIPA) 71/98, Group B: Native branch pulmonary stenosis 8198, Group 
C: status post Fontan (6/98), Group D: Arterial switch operation (ASO) 6/98, 
Group E: Ilio-femoral vein obstruction (IFO) 4/98, Group F: Miscellaneous 
3/98 (coarctation, Blalock-Taussig shunt, SVC conduit). Pts age ranged 0.4 to 
40.7 yrs (median 11.9). 344/347 patients were reevaluated for restenosis. Of 
those, 71/202 were Group A (35%) B/28 Group B (28%), 6/39 Group C (20%), 
602 Group D (50%), 4/l 9 Group E (21%), 3/44 Group F (7%). Neointimal pro- 
liferation occurred in 9/98 (mild 5, moderate 2, severe 2). There was no mor- 
tality. Complications included: pulmonary edema (l/98), stent fracture (l/98), 
stent migration (2/98), LPA aneurysm (l/98), hemothorax (1198). The luminal 
diameter increased from a median of 9 to 12.8 (p = 0.19). For patients with 
branch pulmonary stenosis (Group A, B & D) there was a significant decrease 
in gradient across the stents from a median of 18 to 5 mmHg (p = 0.004), 
and the RV to FA ratio decreased from a median of 0.62 to 0.43 (p = 0.5). 
Conclusion: In patients who have intravascular stents implanted for 
CHD, 25% require redilation at intermediate follow up for somatic growth 
or restenosis. The incidence of neointimal proliferation is very low (9%). 
Redilation and repeat stent implant is a safe and effective procedure. 
9:15 a.m. 
903-d Improved Efficacy and Long-Term Outcome of 
Balloon Valvuloplasty for Critical Pulmonary 
Stenosis in Newborns 
Wolfgang A.K. Radtke, Duraisamy Balaguru, Henry B. Wiles, Ashby 
B. Taylor. Children’s Heart Center, Medical University of South Carolina, 
Charleston, South Carolina, USA 
Backaround: Procedural success rate and outcome of balloon pulmonary 
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valvuloplasty (BPV) for neonatal critical pulmonary valvar stenosis (PS) has 
been less reproducible than in older children. Low profile balloons, steerable 
guide wires and refinement of techniques have lead to improved outcome in 
this group of newborns. 
Method: We reviewed medical records of all newborns treated for critical 
PS by BPV in the past 10 years. 
Results: 39 newborns were treated during the study period. The median 
age at BPV was 7 days and the median body weight was 3.7 kg (Range: 
2.2-5.2 kg). BPV was accomplished in all patients, The systolic pressure 
gradient was reduced from 67 f 25 mmHg (Mean f SD) to 17 f 12 mmHg. 
The median fluoroscopy time was 24 min. Residual peak Doppler gradient on 
the day after procedure was 25 f 13 mmHg. There was no procedure-related 
death. Two hospital deaths occurred. One newborn with a hypoplastic right 
ventricle (RV), underwent Blalock-Taussig shunt (BTS) at 5 days of age and 
died of progressive myocardial dysfunction at 8 days of age. The second 
death occurred 6 days after BPV in a 2.2 kg preterm baby with RV endo- 
cardial fibroelastosis, Grade IV intraventricular hemorrhage who had been 
resuscitated twice prior to catheter intervention. Surgical intervention was 
necessary in 5 patients (13%) at a median interval of 8 days after BPV. All 
patients who needed surgery had hypoplastic RV, hypoplastic pulmonary 
annulus or myxomatous dysplasia. The surgical procedures were RV outflow 
tract patch (l), pulmonary valvectomy (1) and BTS (3). Repeat BPV was 
performed in 3 patients (8%) at median age of 3 months. Median follow-up 
duration was 46 mo (Range: 1-92 mo). No patient needed late surgery. Suc- 
cessful transcatheter occlusion of BTS, stent placement for shunt-related 
pulmonary artery stenosis and device occlusion of atrial septal defect was 
performed in 2 patients at the ages of 3 and 5 years. One other patient 
underwent device closure of atrial septal defect after 6 yrs. Peak Doppler 
gradient available in 29 patients at the latest follow-up was 17.6 f 10 mmHg. 
Trivial to moderate pulmonary regurgitation was present in 22 patients. RV 
enlargement was evident in 11 of 28 (39%) patients. 
Conclusion: BPV is the primary therapy for critical PS in newborns. 
9:30 a.m. 
rr I. 903 5 CritIcal Care Management of Critical Aortic Stenosis 
Janet M. Simsic, Peter Laussen, Stanton B. Perry, John F. Keane, David 
L. Wessel. Children’s Hospital, Boston, Boston, MA, USA 
Background: Aortic valve balloon dilation (BD) in newborns with critical 
aortic stenosis (AS) and normal sized or dilated left ventricles is an effective 
therapeutic intervention. However, the critical care management of these 
patients at presentation and after BD can be complex and has not been 
previously described. 
Methods: We retrospectively reviewed 24 consecutive newborns pre- 
senting to our CICU with critical AS since 1993. 
Results: The median age of presentation was 2 days (range 1-29). Prior 
to BD, 19 patients (79%) required mechanical ventilation (IMV); 14 (58%) 
PGEl; 16 (66%) inotropic support; and 14 (58%) had moderately to severely 
depressed ventricular function by ECHO. Nine patients (38%) presented 
with a pH < 7.30; 10 (42%) required bicarbonate infusion. The median time 
spent for resuscitation prior to BD was 8 hours (range l-570). The average 
reduction in aortic valve gradient after BD was 64%; 9 patients (38%) had 
increased aortic valve regurgitation. Following BD, 4 patients (17%) required 
PGEl for up to 4 days until the LV function improved; 13 (54%) prolonged 
(>48 hr) inotropic support; and 4 (58%) IMV for a median of 4 days after BD. 
Renal insufficiency occurred in 3 patients, ventricular tachycardia in 2, and 
one patient required support on ECMO after successful BD complicated by 
coronary ischemia. The median length of ICU stay was 6 days (range O-l 38); 
hospital stay 8 days (range 1-l 62). Twenty-two patients (92%) survived to 
hospital discharge. One patient died from complications related to prematurity 
and the other to multi-system organ failure at the time of referral. 
Conclusion: Shock from a low output state is a common presentation of 
newborns with critical AS: and a period of stabilization is recommended prior 
to BD. While BD is an effective treatment, an extended period of critical care 
support may be necessary after BD until ventricular function improves. 
9:45 a.m. 
903-6 Long-Term Risk of Recurrent Thromboembolism 
After Percutaneous Closure of Patent Foramen 
Ovale 
Stephan Windecker, Andreas Wahl, Tushar Chatterjee, Ali Garachemani, 
Christian Seiler, Franz R. Eberli, Bernhard Meier. Swiss Cardiovascular 
Center Bern, University Hospital, Bern, Switzerland 
Background: Patients with patent foramen ovale (PFO) and paradoxical em- 
bolism are at risk for recurrent thromboembolic events. The purpose of this 
study was to prospectively assess the long-term risk of recurrent thromboem- 
bolism in patients with PFO and paradoxical embolism after percutaneous 
PFO closure. 
Methods and Results: A total of 80 patients underwent percutaneous 
PFO closure between April 1994 and April 1999 at our institution, Five differ- 
ent device types were utilized for percutaneous PFO closure. There were 30 
women and 50 men. The implantation was successful in 78 (98%) patients. 
A periprocedural complication was noted in 8 (10%) patients. Patients were 
prospectively followed for recurrent thromboembolic events including tran- 
sient ischemic attack (TIA), cerebrovascular accident (CVA) and peripheral 
embolism. At 5 years of follow-up (mean 1.6 f 1.4 years), the average annual 
recurrence rate was 0% for CVA, 2.5% for TIA, 0.9% for peripheral embolism, 
and 3.4% for the combined endpoint of TIA, CVA and peripheral embolism. 
The only predictor of recurrent thromboembolism was a residual shunt of 
some degree after percutaneous PFO closure (relative risk- RR = 4.2, 95% 
confidence interval - Cl 1 .I-17.8, p = 0.03). Patients with both PFO and an 
atrial septal aneurysm (ASA) had no increased risk of recurrence following 
percutaneous PFO closure as compared with patients with PFO only (RR 
1.1, 95% Cl 0.2-5.2, p = 0.9) 
Conclusions: Percutaneous PFO closure can be performed with a high 
success rate and acceptable complication rate. The procedure is a promising 
therapeutic modality for prevention of recurrent thromboembolism in patients 
with PFO after a first event. A residual shunt following percutaneous PFO 
closure appears to be a risk factor for recurrent thromboembolism. Patients 
with both PFO and ASA had the same risk of recurrence as patients with 
only PFO. 
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1215-I 60 Anticoagulation and Afterload Reduction During 
Staged Single Ventricle Palliation - A Survey of 
Pediatric Cardiology Centers 
Michelle Steltzer, Peter C. Frommelt, Michele A. Frommelt. Medical Colege 
of Wisconsin, Children’s Hospital of Wisconsin, Milwaukee, Wisconsin, USA 
Background: The utility of anticoagulation and afterload reduction in pts with 
single ventricle physiology during the various stages of surgical palliation is 
unclear despite potential theoretical benefits in preventing thrombosis and 
preserving ventricular function, 
Methods: Surveys were sent to 59 major pediatric cardiology centers in 
North America, asking for their consensus approach in the long-term use 
of anticoagulation, either aspirin (ASA) or warfarin (WAR), and afterload 
reducing.medications in pts with hypoplastic left heart syndrome (HLHS) s/p 
Norwood, other forms of single ventricle (SV) after aortopulmonary shunt 
placement (APS), and in all forms of SV after bidirectional Glenn (BDG) and 
Fontan palliation. 
Results: Of the centers surveyed, 34/59 responded (58%). The table 
summarizes the percentage of centers who use the following strategies: 
Non.3 
Anticoagulation 
ASA ASA* 
alone WAR 
WAR 
alone 
Afterload 
Reduction 
HLHS s/p Norwood 
sv s/p APS26% 
SV s/p SDG 
SV S/D Fontan 
24% 
74% 
41% 
6% 
76% 
0% 
53% 
56% 
3% 
0% 
3% 
i 8% 
0% 
36% 
3% 
i 8% 
56% 
47% 
71% 
ASA dose was 3-10 mglkgid, and targeted INR in pts on warfarin was 
1.53 with a mean of 2.18. The choice of drug for afterload reduction was 
exclusively ACE inhibitors; many centers commented that afterload reduction 
was most commonly utilized in pts with AV valve insufficiency, poor function, 
and/or cardiomegaly. 
Conclusions: Current strategies in the medical management of the pt 
with SV physiology after palliation vary widely between institutions. Based 
on practice protocols, increased risk groups for thrombotic complications 
appear to be the Norwood and Fontan populations, with more aggressive 
anticoagulation reserved almost exclusively for the Fontan group. Afterload 
reduction is also more commonly used in these 2 groups, and it is usually 
prescribed in the pt with ventricular dysfunction and/or in those at later stages 
of surgical palliation. 
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( 1215-l 61 / The Spectrum of Parachute Mitral Valve: 
Morphologic Descriptors and Outcome 
Bradley S. Marino, Jack Rychik. Chiidren’s Hospifal of Philadelphia, 
Philadelphia, Pennsylvania, USA 
Background: Parachute mitral valve (PMV) is an anomaly in which the mitral 
valve chordae insert into a single papillary muscle (PM). The degree of func- 
tional abnormality [stenosis (MS), regurgitation (MR)] varies. PMV may be 
associated with other left sided obstructive lesions or conotruncal anomalies. 
The purpose of this study was to describe the morphologic features, asso- 
ciated lesions, interventions, and outcome of PMV and a similar anomaly, 
parachute-like asymmetric mitral valve (PLAMV), in which most or all chordal 
attachments are to one PM, with hypoplasia of the other. 
Methods: We reviewed our database to identify patients with PMV or 
PLAMV seen at our center between January 1987 and April 1999. Medical 
records and echocardiograms were reviewed. 
Results: 56 patients with either PMV (n = 37) or PLAMV (n = 19) were 
identified. Chordal attachments were more common to the postero-medial PM 
(82%) (27137 PMV; 13/l 9 PLAMV) than to the antero-lateral PM. Associated 
lesions included: ventricular septal defect (n = 35), coarctation of the aorta 
(n = 31), aortic stenosis/atresia (n = 18), left ventricle hypoplasia (n = ii), 
subaottic stenosis (n = If), tetralogy of Fallot (n = 4), double outlet right 
ventricle (n = 4), transposition of the great arteries (n = I), and interrupted 
aortic arch (n = 1). Single ventricle palliation was undertaken in 20 patients, 
of which 12 died. Biventricular repair (BVR) was undertaken in 33 patients, 
of which 6 died. Median follow-up time of survivors in the BVR group is 4.8 
years (range 0.1-17.1 years). Of the 27 survivors in the BVR group, 5 (19%) 
had MS on their most recent echocardiogram (mean gradient > 3 mmHg), 
however only 1 patient had intervention (mitral valvuloplasty followed by 
replacement) and 9 (33%) had mild MR. No patient had more than mild 
MR. Neither the presence of PMV, PLAMV, or specific PM attachment was 
associated with death or the development of MS. 
Conclusions: Parachute mitral valve has a broad spectrum of morphol- 
ogy and associated lesions. The majority of patients who have PMV and 
undergo BVR have good mitral valve function and do not develop MS or MR 
at mid-term follow-up. 
1215162 Sudden Cardiac Death in the Young: Japanese 
Nationwide Survey 
Teiji Akagi, Hirohisa Kato, Yoshinori Koga, Ryozo Okada, Morie Sekiguchi, 
Masami Nagashima, Tetsuro Kamiya, Kensuke Harada, Sunao Honda, 
Kazuo Momma. Kurume Universifx Kurume; Juntendo University: Tokyo; 
Sinsyu Universif~ Nagano; Nagoya University, Nagoya; National 
Cardiovascular Center, Osaka; Nihon University: Tokyo; Fukuoka Children’s 
Hospital, Fukuoka; Tokyo Women’s Medical College, Tokyo, Japan 
Background: Although sudden death from cardiac causes in active and 
apparently healthy children or adolescents is a major catastrophe, unsolved 
problems still remain. 
Methods: To clarify the clinical feature in this age group, questionnaires 
were sent to all major hospitals in Japan. Patient inclusion criteria were (1) 
death within 24 hours from the events or within 48 hours if resuscitation was 
performed, (2) age of 6 to 29 years, (3) death between 1988 and 1997. 
Results: From 20 institutions, 234 cases were reported. There were 
33 cases with congenital heart disease who have not previous surgery, 54 
with postoperative congenital heart disease, 56 with myocardial disease, 
2 with Kawasaki disease and 3 with congenital coronary abnormalities, 16 
with arrhythmia, 12 with primary pulmonary hypertension, 6 with Marfan 
syndrome, 4 with long QT syndrome, 1 with aortic valve stenosis and 47 with 
absence of cardiac abnormalities. Peak age group was age of 12 through 
18 years old. Number of sudden death was apparently decreased 218 
years old. Sudden death occurred at the time of exercise (41%), at rest 
(50%), and during sleep (9%). In cases with congenital heart disease without 
previous operation, 82% of death were seen at rest. Similarly, 83% of death 
occurred at rest in cases with primary pulmonary hypertension. On the other 
hand, sudden death tends to be seen during the exercise in cases with 
post-operative congenital heart disease (45%), myocardial disease (62%), 
and arrhythmia (63%). In this cohort, the possibilities of sudden death were 
suspected only in 19% of cases by the reviewing of cardiologist. 
Conclusion: Situation of sudden cardiac death may be different by ba- 
sic conditions of heart. Appropriate exercise limitation should be required 
especially in cases with postoperative heart disease, myocardial disease or 
arrhythmia. 
1 1215-l 63 1 Role of Glycogen Synthase Kinase-3P in 
Cardiomyocyte Hypertrophy 
Syed Haq, Gabriel Choukroun, Zhaobin Kang, Alessandro Alessandrini, 
Wolfgang Boecker, Yoshiaki Terao, Takashi Matsui, Anthony Rosenweig, 
Roger Hajar, James Woodgett, Thomas Force. Cardiovascular Division, 
Massachusetts General Hospital, Charlestown, MA, USA 
Background: Protein kinase B (Akt) has been shown to exhibit both anti- 
apoptotic and pro-hypettrophic properties, but the downstream targets medi- 
ating these effects are not dear. One possible candidate is Glycogen synthase 
kinase-3/? (GSK-3b). In contrast to most protein kinases, GSK-3fi exists in 
the active form (unphosphorylated) under resting conditions. Akt inactivates 
GSK-3fi through phosphorylation of a specific Ser9 residue when stimulated 
by certain agonists. GSK-3B plays a key role in embryonic development and 
has been implicated in pathologies as diverse as apoptosis, and tumoro- 
genesis. The purpose of our study was therefore to investigate the role of 
GSK-3p in hypertrophy. 
Results: We found that treatment of primary culture neonatal rat car- 
diomyocytes with endothelin-I (ET-I) and phenylephine (PE), inactivated 
GSK-3B to a degree equivalent to that of IGF-I. When we inhibited GSK-3B 
activity with LiCl (10 mM), a potent inactivator of the kinase, we markedly 
increased protein synthesis as measured by [SH]-leucine incorporation, and 
increased ANF expression as determined by Western blotting. Inhibition 
of GSK-3/l activity via adenovirus-mediated gene transfer of constitutively 
active Akt also increased protein synthesis. We created an adenovirus ex- 
pressing the active form of GSK3B (A9), in which serine 9 was mutated to an 
alanine residue. Our data indicated that A9 blocked the increase in cell size, 
sarcomeric organization and ANF expression in response to ET-I or PE. The 
effect of A9 was reversed by LiCI. GSK-3~ has been shown to phosphoylate 
and thereby inactivate, nuclear factor of activated T cells (NF-AT), a family of 
transcription factors which may play a role in hypertrophy. We found that ex- 
pression of A9 reduced ET-l or PE induced nuclear translocation of NFATS. 
This effect was also reversed by LiCI. 
Conclusion: This study is the first to demonstrate that hypertrophic stim- 
uli inactivate GSK-3B, and that this activation plays an important role in the 
hyperlrophic response of cardiomyocytes. This may be mediated via effects 
on NF-ATs. Since we also found that GSK-3B activity is significantly de- 
pressed (32%) in the hearts of patients with a advanced heart failure (n = 
13), as compared to non-failing control hearts (n = 8), inhibition of GSK-3fl 
may not only play a significant role in the development of hypertrophy, but 
also in the progression to failure. 
121.5164 Developmental Changes in Calcium Regulatory 
Protein Gene Expression in the Human Heart 
Devyani Chowdhuy, Agnes Kenessey, Vincent A. Parnell, Irwin Klein, 
Kale Ojamaa. North Shore University Hospital/NYU School of Medicine - 
Long Island Jewish Health System, Manhasset, New York, USA 
Background: Developmental alterations in cardiac function and pharmacol- 
ogy are well described and result in part from developmentally regulated 
expression of cardiac-specific genes. To better understand the regulation of 
human myocyte calcium transients and the known sensitivity of the neonatal 
heart to L-type calcium channel blockers, we studied the expression of sar- 
coplasmic reticulum calcium-activated ATPase (SERCA2), sodium-calcium 
exchanger and sodium-potassium ATPase, known T3-responsive cardiac 
genes. 
Methods: Tissue samples were obtained from 21 patients undergoing 
open heart surgery, for congenital heart disease. Ages of the patients varied 
from 3 days to 15 years. Informed consent was obtained from all patients 
and atrial tissue samples were obtained at the end of surgery before the 
insertion of the modified ultrafiltration atrial canula and were immediately 
frozen in liquid nitrogen. Northern blot analysis using gene specific cDNA 
probes was used to measure mRNA content in the atrial tissue. RNA values 
were normalized to 18s rRNA content. 
Results: There was a significant positive correlation between atrial SERCA2 
mRNA content and age from 3 days to 15 years (r = 0.573; p < 0.03). The 
correlation was of greater significance when analyzed within the first year (r 
= 1.000; p < O.OOOl), and within the first two years (r = 0.828; p < 0.03). No 
correlation was found between patient age and sodium-calcium exchanger 
and between age and sodium-potassium ATPase mRNA. 
Conclusion: These observations suggest that the relative contribution 
of sarcoplasmic reticulum to sarcolemmal calcium in myocyte contractile 
function is greater as reflected in ratio of SERCA2 to sodium-calcium ex- 
changer, which increases with age. Conversely, these data may explain the 
known sensitivity of the neonatal heart to negative inotropic effects of L-type 
calcium channel blockers. Since serum thyroid hormone levels rise in the 
neonate and remain elevated during infancy, this suggests that SERCA2 
gene expression is regulated by thyroid hormone in the human heart similar 
to that reported in animal models. 
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L---l. 1215 165 Left Ventricular Mass is increased in Patients With Well Repaired Coarctation of the Aorta and 
Correlates With Exercise Blood Pressure 
Response 
Curt J. Daniels, Kelley Clem, Tonia Caserta, Douglas Knight, Hugh D. Allen. 
Children’s Hospital and The Ohio State University, Columbus, Ohio, USA 
Background: Long term data show a higher than expected incidence of 
sudden death in patients with repaired coarctation of the aorta (rCOA). 
The etiology for sudden death in this population has not been investigated. 
Increased left ventricular mass (LVM) in patients with hypertension is a 
known risk for sudden death, proportional to the mass quantity. Therefore, 
we sought to determine if LVM is increased in patients with rCOA following a 
good operative result and whether historical or clinical factors correlate with 
the quantity of LVM. 
Methods: Patients with rCOA were recruited with the following criteria; 1) 
resting arm/leg blood pressure gradient and Doppler gradient across the re- 
paired coarctation < 20 mm Hg, 2) normotensive at rest 3) no aortic stenosis 
and 4) at least 2 years from coarctation repair. Patients and age, sex, and 
body surface area matched controls underwent surface Doppler echocardio- 
graphy with M-Mode measurements for LVM calculation by standard method. 
LVM was indexed to body surface area (LVM/ma) and height (LVM/m). Pa- 
tients underwent a bicycle exercise protocol to determine blood pressure 
response and exercise arm/leg gradients. LVM/ma and LVM/m were com- 
pared between patients and controls by unpaired t-test. Stepwise regression 
was utilized to evaluate independent variables correlating with LVM. 
Results: The study consisted of 45 patients (mean age 19.4 f 6.6 years) 
and 45 controls (mean age 19.2 f 7.2 years). End-end anastomosis was 
performed in 26/45 (58%). Patients were repaired at mean age of 6.5 j, 6.3 
years (22% were ~1 yo at repair). Study was performed 13 f 6.3 years 
following repair. LVM/m’ and LVM/m were significantly greater in patients vs 
controls, (96.4 f 30.5 vs 74.6 * 19.9) and (92.3 i 25.2 vs 68.4 & 20.1) 
respectively, p < 0.001. For patients, type of surgery, age at surgery, years 
since surgery, resting BP, resting arm/leg gradient, and exercise arm/leg 
gradient did not correlate with LVM. Only older age at study and maximal 
exercise systolic BP correlated with increased LVM, p < 0.005, r = 0.4. 
Conclusion: Patients with rCOA and a good operative result can develop 
increased LVM. Our data show that increased LVM correlates with systolic 
BP response to exercise. These findings suggest that therapeutic interven- 
tions to prevent or regress elevated LVM, especially in the face of exercise 
I 1215 166 Transcatheter Closure of Atrial Communications (ASDIPFO) in Adult Patients > 18 Yr. of Age 
Using the Amplatzer Septal Occluder: Immediate 
and Mid-Term Results 
Ziyad M. Hijazi, Qi-Ling Cao, Hitendra T. Patel, David Waight. The 
University of Chicago, Chicago, IL; Tufts-New England Medical Center, 
Boston, MA, USA 
Background: Little has been reported on the mid-term results of tran- 
scatheter closure (TCC) of atrial communications [secundum atrial septal 
defects (ASD) and patent foramen ovale (PFO) associated with either stroke 
or right-to-left shunt] in adult patient > 18 yr. of age using the Amplatzer 
septal or PFO occluder (AS0 or APFOO). 
Methods: 40 patients (32 female/8 male) who were all symptomatic (4 
patients had severe orthodeoxia/platypnea) underwent an attempt at TCC 
using the AS0 or APFOO with continuous TEE monitoring at a median age 
of 47.9 yr. (19-87.5 yr.) and median weight of 63.8 kg. The median Qp/Qs 
was 1.9 (0.7-5.3). Four patients had more than one atrial communication. 
Thirty-three patients had secundum ASD; 6 had PFO and one had fenestrated 
Fontan. 
Results: The median size of the communication by 2-D TEE was 14 mm 
(2-25 mm), the median balloon stretched diameter of the communication 
was 18.5 mm (635 mm) and the median size of device (diameter of the 
connecting waist between the two disks) used to close the ASD was 20 mm 
(635 mm). The median fluoroscopy time was 9.8 min. (3.6-32 min.). One 
device (26 mm) embolized to the main pulmonary artery the following day in a 
patient who received 2 devices for two ASD’s. No other complication. There 
was immediate complete closure (C) of the communications documented 
by color Doppler TEE in 70% of the patients; 12.5% had trivial (color jet 
width < 1 mm) shunt (TS), and 17.5% had small (color jet 4 2 mm) shunt. 
At 24 hours, TTE with color Doppler revealed C in 87.5%, 7.5% had TS, 
2.5% had S, and in one patient, the device had embolized resulting in large 
shunt (color jet width > 4 mm) (LS). 26 patients completed 6 months TEE 
follow-up, this revealed C in 92%, and in one patient each there was SS 
and LS. The patient with LS underwent implantation of a second device 
with C. There was significant improvement in the cardiac size on follow-up 
chest radiograph and improvement in symptoms, including the 4 patients 
with orthodeoxia/platypnea. So far, there have been no episodes of device 
wire disruption or delayed device migration. 
Conclusion: TCC of atrial communications (ASD/PFO) in adult patients 
hypertension, should be considered. is safe and effective. Further clinical trials are underway 
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